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Asbestos is a naturally occurring fibrous silicate mineral which has
extensive industrial and domestic application: exposure to asbestos is
associated with pulmonary fibrosis, lung cancer and mesothelioma.
Following inhalation of asbestos the fibres are rapidly taken up by
alveolar macrophages and macrophages have been implicated in develop¬
ment of the asbestos related pulmonary diseases. In this thesis
macrophages harvested from the peritoneal cavity of mice following
intra-peritoneal injection of asbestos (UICC samples) were used as
convenient models to study the effect of asbestos on macrophages in vivo
with particular reference to membrane characteristics.
Macrophages harvested from the peritoneal cavity 3-70 days after
injection of asbestos were found to be activated by several criteria.
Latex spheres and saline, injected as controls, failed to induce
activated macrophages. An in vitro nucleotide release assay using
syngeneic fibrosarcoma cells as targets revealed that asbestos activa¬
ted macrophages were negligibly cytotoxic to tumour cells. Super-
natants from asbestos activated macrophages were not cytostatic to
fibrosarcoma cells in vitro. The results from the in vitro assays were
in general confirmed by in vivo assays for tumour growth modulating
effects of asbestos. Thus intraperitoneal injection of asbestos into
animals with concomitant experimental subcutaneous fibrosarcomas in
the main had no significant effect on tumour growth although an inter¬
mediate dose (5 mg) did cause small significant reductions in tumour
growth.
Supernatants from asbestos activated macrophages suppressed thymo¬
cyte mitogenesis, by Concanavalin A, by up to %0% but did not affect
proliferation of fibroblasts. Latex and saline induced macrophage
supernatants had no suppressive activity.
(ii)
In studies on the membrane of asbestos activated macrophages
Concanavalin A was used as a probe for membrane glycoprotein.
Concanavalin A was used to visualise its specific receptor glyco¬
protein in the membrane of macrophages interacting with asbestos using
both light microscopy and electron microscopy; some rearrangement of
Concanavalin A receptor glycoprotein was observed. Incubation of
asbestos activated macrophages with fluoresceinated Concanavalin A
resulted in aggregation of the Concanavalin A receptor glycoprotein
into caps in approximately one third'of asbestos induced macrophages;
this phenomenon was microfilament mediated. Radioactively labelled
Concanavalin A showed that absolute numbers of Concanavalin A binding
sites was not a major factor in this capping phenomenon.
In attempts to detect differences in surface antigenicity between
asbestos activated and control macrophages, anti-sera were raised in
rabbits and an [j^l\ Protein A binding assay was utilised. Absorption
of activity against non-specific mouse antigens, however, left a very
small specific anti-macrophage component and so differences could not
be detected; this was confirmed by fluorescence and complement mediated
lysis assays. An Protein A assay was also used to try and detect
autoimmune deposition of antibody on to asbestos activated macrophages
in vivo. There was no evidence of increased levels of ^ij Protein
A binding to macrophages from dusted animals in either the short or long
term.
Limited studies were carried out on malignant cell lines derived
from peritoneal cells harvested from mice which had been injected with
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1.1 Asbestos; history and uses
Asbestos is a fibrous silicate mineral occurring in areas of the
earth's crust, it can be spun and woven into textile which has good
insulating properties, very large surface areas and is resistant to
attack from weathering and chemicals. These unique properties of
asbestos assured that even in early history, in the pre-minimg era
when asbestos was encountered in surface strata, its properties were
recognised and recorded. Thus articles made from a substance which
was unmistakably asbestos were mentioned in the writings of Theophrastus
(372-287 BC), Plutarch (6U-120 AD), Pliny (23-79 AD) and Marco Polo
(Ca 12^0) (Harington 1976). These recordings of asbestos, however,
tended to emphasise the novelty value of asbestos woven into "unburnable
cloth" and the systematic utilisation of th» unusual physical and chemical
properties of asbestos were not undertaken at these times. Slowly,
however, the potential of asbestos was realised and it is recorded that
"everlasting wicks" made of asbestos were manufactured in Norway in the
early eighteenth century (Selikoff and Lee 1978). Large scale utilisation of
asbestos, however, awaited the industrial revolution when, amongst other
things, the invention of the steam engine produced a demand for cheap
efficient insulating and packing material; simultaneously a demand was
also created for high friction material for the brakes and clutches of
this new technology. The enlightened social attitudes of the late 19th
Century also brought with them a housing and general construction
programme which created an ideal market for asbestos, for example as
roofing felt and in cement. To meet this opportunity and capitalise
on a new market for a new material, the Canadian chrysotile deposits
begun to be worked in earnest in 1876, the first year's output being
50 tons; within 60 years this figure exceeded 1,000 tons per annum.
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The same pattern of development was repeated during the late 19th and
early 20th Century in other major asbestos mining countries of the world -
South Africa, Italy, USSR, USA, Rhodesia and the handful of minor asbestos
producing countries (Selikoff and Lee 1978). The description of asbestos
as the 20th Century mineral (Gilson 1965) is particularly apt since
annual world asbestos output has increased 1,000 fold in the first 60
years of this century being estimated at U.3x10^ tons of chrysotile in
1973 (Lincoln 1975) and an annual amphibole production of 2.8x10'' tons
(Hodgson 1975).
This massive asbestos output has been, and is, incorporated into a
huge array of manufactured goods and materials. The list is too extensive
to attempt here (see Selikoff and Lee 1978) but asbestos products may
be broadly grouped into textiles, friction materials, paper products
and asbestos cement (Table 1.1). The incorporation of asbestos into
such a wide range of products ensured that the maximal benefit accrued
from the special properties of asbestos, but it also meant that many
different occupational groups and ordinary members of the public were
exposed to asbestos and thereby to its associated health hasards. It
is notable that risk occurs at both the manufacturing end - miners,
spinners, weavers, etc., and user end - construction workers, plumbers,
householders.
1.2 Asbestos: shape and surface chemistry
The geology, physics and chemistry of asbestos and its subsequent
properties are complex as is mineralogical analysis and a detailed review
is beyond the scope of this monograph. The literature on this subject
is however extensive and has been brought together periodically as reviews
(for example Poncelot et al 1971; Gravatt et al 1978; Michaels and Chissick
1979). In this short review only the major physicochemical features of
-2a-
TABLE 1.1 Principal industrial uses of asbestos





























to all of these should be
added the property of
cheapness
after Lindell 1973
asbestos, considered salient to its biological effects, will be discussed.
Asbestos is the name given to a family of naturally occurring,
crystalline, fibrous minerals which differ in chemical composition
and are formed by the action of geological forces:- heat, cooling and
pressure, in the earth's crust.
Asbestos is divided into two mineralogical types;-
(i) serpentine - comprising chrysotile (white) asbestos, the major
asbestos type utilised in industry.
(ii) amphibole - comprising^in decreasing order of commercial importance
crocidolite (blue), amosite (brown), anthophyllite, tremolite and
actinolite (Hendry 1965; Champness 1976).
1.2.2 Chrysotile (Mg^(0H)gSi^01(-))
The structure of chrysotile in its natural state is straight silky
fibres formed across veins; during industrial processing the fibres are
released as white wispy bundles.
At electron microscopy, following even gentle treatment, individual
fibres can be seen to be dissociating into the primary fibrils which are
hollow. By X-ray diffraction and electron microscopy the tubular
structure is not simple but is composed of a rolled up molecular sheet
producing a "Swiss roll" appearance in cross section (Hodgson 1965;
Zussmann 1978). Chrysotile is typified by a high percentage of Mg, OH
and water and the molecular configuration is such that in the rolled sheet
structure the Mg^H)^ (brucite) layer is outermost. The tight packing
of the innermost tetrahedral silicon/oxygen layer produces the curvature
of the sheet (Gaze 1965). The outer MgtOH^ layer provides an active




Crocidolite is taken as a representative amphibole since it is the
one used in this thesis. Crocidolite differs from chrysotile in that
its tensile strength is greater, and compared to chrysotile the fibres
are straighter, thicker and cannot be defined by single fibre units,
unlike chrysotile. The form of crocidolite is probably a consequence
/
of occasional interruptions in the double chain silicate crystal lattice
by multiple chains; this structural disturbance may lead to parallel
sets of preferential planes of fracture (Whittaker et al 1982).
1.3 Asbestos: Properties
The principal properties of asbestos which led in the first instance
to its extensive use in industry were its low thermal conductivity
rendering it valuable in insulation, and its -relative indestructibility
by the common modes of attrition - weather, microbiological, friction etc.
These properties are reviewed extensively elsewhere (e.g. Selikoff and Lee
1978) but for the present study only the properties which are considered
relevant to the biological activity will be discussed.
1.3.1 Shape
The most obvious property of asbestos is its fibrous shape due, in
the case of amphiboles, to systematic disruption of the normal double
chain silicate crystal lattice in the native mineral. With chrysotile
the strength of individual fibrils is greater than the binding between
fibrils and so fracture tends to occur parallel to the fibres. In each
case stress then results in partial break-up of the mineral yielding
elongated fibrous fragments. This contrasts with the non-fibrous nature
of some other dusts which cause lung disease on inhalation such as quartz
or coal dust. A fibre is generally defined as a particle with an aspect
ratio (length:diameter) of >3. Chrysotile asbestos forms silky fibres
which separate to individual fibrils of 0.02-0.03 jum diameter and
▼ariable length. Amphiboles such as crocidolite cleave into coarser,
more brittle fibrils down to 0.1 ^um diameter (Chowdhury 1975; Selikoff
and Lee 1978).
1.3.2 Surface properties
As predicted by physical laws thin fibres hare a very high
surface:volume ratio and so any effect of mineral fibre on a biological
system could be related not only to the fibrous shape but to a factor
involving the large surface area which accompanies the fibrous habit.
As discussed above the surface layer of chrysotile is largely
Mg(0H)^ which is positively charged at physiological pH, the charge
residing in the ionised Mg+. At lower pH, for example in HC1, the Mg
groups are stripped off the fibre surface exposing the silica layer
(Morgan et al 1977;. Oberdorster et al 1980). In protein containing
solution the charge on chrysotile at physiological pH results in ad¬
sorption of protein onto the surface (Morgan 197U) with subsequent
masking of the surface charge. This adsorption appears to be largely
due to the Mg in the brucite layer since the adsorption capacity for
protein decreases with HC1 (Morgan et al 1977^ or EDTA (Valerio et al
1980) mediated leaching in parallel with the surface charge (Light and
Wei 1977).
Crocidolite, in keeping with the other amphiboles, has a surface
which is essentially silicate and exhibits a negative charge at physio¬
logical pH (Light and Wei 1977) but, like chrysotile,trace elements such
as Fe, Cr, and Co do leach from crocidolite (Oberdorster et al 1980).
In contrast to chrysotile, continued leaching of crocidolite results in
an increase in the surface charge (Light and Wei 1977) which presumably
increases protein adsorption. While experiments on the leaching of
elements frcm asbestos are, of necessity, carried out under controlled
in ritro conditions it is evident that there is elemental dissolution
of asbestos in vivo (Morgan et al 1971; Hart et al 1981; Crawford and
Miller 1981).
1.3.3 Aerodynamic properties
With regarcf to the health ha*ards of asbestos the most important
property asbestos possesses, by virtue of its tendency to break up into
small fibres, is its ability to become airborne as a fine dust where it
is available for inhalation. This is directly related to the free
falling speed of the fibres which is most closely related to diameter;
thus the likelihood of any fibre becoming airborne (or' settling) is a
function of 1/d where d = diameter of fibre. A fibre of 0.5 3™
diameter is thus 16 times more likely to remain airborne than a fibre
2.0 jm. in diameter (Acheson and Gardner 1979a)• Fibre dimensions also
determine which fibre fraction of an inhaled dust will be trapped in the
nasal passages, which will be deposited in the alveoli and which will be
exhaled without deposition. The behaviour of fibres in this respect is
more complex than that of amorphous/spherical particles as shown by the
finding that inhaled compact particles 10 jam in diameter never reach the
alveoli whereas fibres > 200 _pm in length have been found there (Vorwald
1951).
The factors affecting particle deposition in the lung are complex
and involve inertial impaction, sedimentation, diffusion, interception
and electrostatic precipitation. In pulmonary deposition of asbestos
all of these factors apply to varying degrees and have been brought
together in a computer generated model by Harris and Fraser (1976);
this model shows in general that there is a maximum alveolar deposition
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of fibres with equivalent diameter of 0.5-2 jun and of shortest length
(25 ;um in their model).
1 .li UICC samples
While the basic structure of the asbestos minerals is fairly
constant, differences in the proportion of the lesser elements are
present in samples of one asbestos type from different regions (Hodgson
1965); also differences in fibre dimensions can be produced by handling
or treatment of samples and by different methods of sample collection.
The UICC (Union Internationale Contre Cancer) Working Group (1965)
therefore recommended that standard asbestos reference samples of
respirable size should be prepared frctn the main asbestos types. It was
envisaged that such samples would be extensively characterised and
distributed to research centres so that research into asbestos physics,
chemistry, biological effects, etc. would be comparable. Such standard
reference samples were subsequently prepared (Timbrell et al 1968;
Timbrell 1969). The target respirable range which was sought in the
UICC samples was <3 jxn in diameter and < 200 jam in length.
To date these UICC samples have been characterised extensively, for
example by gravimetric analysis, atomic absorption spectrometry, neutron
activation and emission spectroscopy, optical and electron microscopic
size distribution, surface adsorption studies and using many other
analyses (Timbrell 1980). In addition the UICC samples have been
extensively utilised in numerous experiments into the biological effects
asbestos.
The UICC samples thus introduced a necessary uniformity into the
field of asbestos research particularly with regard to biological effects.
1.5 Asbestos related disease
The classical epidemiological approach has contributed greatly to
an understanding of the relationship between asbestos and disease and
the following is an introduction to epidemiological evidence for the
role of asbestos in disease. This topic has been reviewed extensively
elsewhere (BecklaJce 1976; Selikoff and Lee 1978; Preger 1978).
1.5.1 Asbestosis (Asbestos related pulmonary interstitial fibrosis)
Asbestosis is a chronic lung disease caused by inhalation of asbestos
fibres and is characterised by diffuse interstitial fibrosis of the lung.
It is a slowly developing and often progressive (continues when exposure
ceases) disease characterised by the presence of small irregular pulmonary
opacities at X-ray. Accompanying asbestosis, and a consequence of it,
can be one or any of the following;- respiratory impairment, dyspnoea,
cyanosis, pulmonary rales and finger clubbing. Pulmonary hypertension
may be precipitated and right sided heart failure is often the cause of
death (DHEW NIOSH 1976).
The first recognition of asbestosis is attributed to Murray in
England in 1906 and the first case to appear in the medical literature
was reported by Cooke in 192li (McVittie 1965). By 1930 Merewether and
Price had reported to the government that asbestos posed a major problem
in the asbestos textile trade and it was realised that in any occupation
where workers suffered prolonged exposure to respirable sized asbestos,
then a proportion would develop pulmonary fibrosis (Wright 1969).
Since then epidemiological evidence has accumulated linking all
asbestos types (Cooper 1978) and asbestos usage in many industries,
with the development of asbestosis; for example shipyard workers (Harries
1968); insulation workers (Hammond et al 1979); brake repair and
maintenance workers (Lorimer et al 1976) (for a more complete list of
occupations at risk see Becklake 1976).
Such a risk necessitated government control of airborne asbestos in
the workplace and in 1933 regulations were introduced rendering death
from uncomplicated asbestosis a rarity (Elmes 1981); there are suggestions
however that these regulations have not always been stringently enforced
(Wright 1969).
Clearly in determining a safe hygiene standard for airborne asbestos
in workplaces, information is required on the dose response relationship
between exposure to airborne asbestos and development of pulmonary fibrosis.
As extensively discussed by Becklake (1976) it is determination of asbestos
dose over a lifetime of occupational (and non-occupational) exposure to
asbestos which presents the major problem in epidemiological studies into
dose response and asbestos disease. However, using several criteria
for assessment of dose such as years of exposure, years since first
exposure, occupation, occupation and duration and cumulative dust
exposure, Becklake cites 1U studies showing a dose response relationship
between asbestos exposure and development of lung fibrosis. In a recent
well controlled longitudinal study within one factory (Berry and Lewinsohn
1979) the dust levels at various points of the asbestos treatment process
were monitored over 20 years and the length of time individual employees
worked at these various locations in the factory were taken into account
in calculating cumulative dose. The study revealed a clear dose
response relationship between cumulative dose and "probable" asbestosis
(as judged by X-ray and lung function changes and pulmonary rales).
1.5.2 Carcinoma of the lung
The lung cancer associated with asbestos exposure is bronchogenic
carcinoma with the adenocarcinoma cell type predominating with tumours
typically located in the lower lobes (Whitwell et al 197U; Preger 1978).
The first identification of a relationship between asbestos exposure
and bronchogenic carcinoma is attributed to Gloyne, or Lynch and Smith in
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1935 but it was not until Merewether's discovery in 19U7 of 13% incidence
of bronchogenic cancer in autopsies of employees frcm the asbestos textile
trade that the possibility was seriously considered (Wright 1969). The
classical epidemiological work of Doll (1955) confirmed the relationship
and indicated a tenfold increase in the expected incidence of broncho¬
genic cancer in textile workers with at least 20 years of exposure.
KLmes (1 981 ) points out that the 1933 regulations, which led to dust
control and the virtual elimination of uncomplicated asbestosis as a
primary cause of death, resulted in increased longevity of asbestos
workers and the appearance of lung cancer. Thus by 1960 over half of
men classified as having asbestosis had lung cancer at autopsy (Buchanan
1965).
Once again Becklake (1976) in her review has comprehensively examined
the literature with regard to dose response and cites 16 papers showing a
clear dose response relationship between asbestos exposure and lung cancer
incidence; dose was once again estimated by the various criteria
mentioned above (1.5.1).
With regard to the relative risk of development of lung cancer
with exposure to individual fibre types, there is epidemiological evidence
that there is a gradation of risk as follows;- amosite)anthophyllite)
chrysotile with no data available for crocidolite (Acheson and Gardner 1979a).
Clear evidence for a synergistic association between cigarette
smoking and asbestos exposure in development of bronchogenic carcinoma
has been demonstrated by extensive epidemiological studies of insulation
workers (Hammond et al 1979) and shipyard workers (ELmes 1981).
1.5.3 Mesothelioma
Mesothelioma is a tumour of variable morphology (Davis 197U a)
originating apparently from the mesothelial cells of the pleural lining
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of the lungs and chest cavity and from the mesothelial lining of the
peritoneal cavity. Mesothelioma is a rare tumour in the general
population being estimated at 1 (Becklake 1976) or 2-3 per 10^ per
annum (Preger 1978).
The relationship between exposure to asbestos and development of
mesothelioma was established in the classical paper by Wagner et al
(i960) showing 33 cases of mesothelioma associated with the Asbestos Hills
of the South African Cape crocidolite fields. The relationship was
confirmed by Newhouse and Thomson (1965) who also implicated domestic
and neighbourhood (of an asbestos factory) exposure. Many epidemio¬
logical studies have since confirmed the relationship between meso¬
thelioma and asbestos exposure (for more complete reviews see Acheson
and Gardner 1979a; Preger 1979; Kannerstein et al 1978).
Of the 3 major diseases associated with asbestos exposure meso¬
thelioma is the one which has the least clear cut dose response
relationship (Becklake 1976; Acheson and Gardner 1979 a) since the
associated doses have been claimed to be very small, acquired in non¬
occupational situations and with very long latent periods. In his
model however peto (1979) finds a dose response relationship between
duration of asbestos exposure and risk of death from mesothelioma.
The possibility of fibre transport within the body is suggested
by the finding of 27/83 mesotheliomas which originated in the peritoneal
cavity in Newhouse and Thomson's (1965) study. A consistent level of
peritoneal mesotheliomas have been reported in subsequent epidemio¬
logical studies (for example Enticknap and Smither 1961;; McEwen et al
1970).
Unlike asbestos associated lung cancer, mesothelioma development is
not synergistic with smoking (Whitwell and Radcliffe 1971); the intriguing
possibility that chrysotile and the amphiboles could be synergistic in
mesothelioma induction has^ however, recently been raised (Acheson and
Gardner 1979 b).
1.5>.U Other diseases associated with asbestos exposure
Besides the 3 major lung diseases associated with asbestos exposure,
asbestos has been postulated to be involved in several other diseases.
Gastrointestinal carcinoma Epidemiological evidence has accumulated
implicating asbestos exposure with increased levels of gastrointestinal
tract carcinoma (for review see Schneidermann 197U) and this now represents
the second greatest mortality risk in asbestos workers after lung cancer
(Becklake 1976). The site of this excess gastrointestinal cancer
include the oesophagus, stomach and colon/rectum (Selikoff et al 1973).
The gut, as a site for asbestos carcinogenesis, may reflect the gastro¬
intestinal ingestion of asbestos inherent in the normal pulmonary
clearance mechanism.
Laryngeal carcinoma Several studies have suggested an association
between cancer of the larynx and asbestos (for example Stell and McGill
1973).
Haemopoetic system neoplasia Gerber (1970) and Kagan (1980) have
reported cancer' of the haemopoetic system in asbestos exposed individuals
but Selikoff and Lee (1978) point out that this is not in accord with
their extensive experience in asbestos related mortality at Mount Sinai,
New Tork.
Pleural change This is a category which includes benign, possibly pre-
malignant, thickened, hyaline and calcified pleural plaques. This group
of associated lesions, present in the parietal pleura, are found in
association with asbestos exposure (Preger 1978). The lesions are a
result of local connective tissue proliferation and the mesothelial
-13-
covering may also undergo metaplasia (Lewinsohn 197U) suggesting that
this may be the origin of sites of mesothelioma. Benign pleural
effusion is often an accompanying phenomenon to these types of pleural
change (Becklake 1976).
Asbestos bodies Asbestos bodies are not a disease state but they
represent a phenomenon which does not fit easily into any categorisation
of the biological effects of asbestos.
Asbestos bodies are fibres which have attained a conspicuous protein
coating by residence usually in lung tissue although they are found in
other sites (Selikoff and Lee 1978). Asbestos bodies appear to be
formed by the laying down of mucopolysaccharide followed by ferritin,
around fibres ingested by macrophages with final release of the asbestos
body (Davis 1965, 1970).
Such bodies are frequently found in the lungs of asbestos exposed
persons (Ashcroft and Heppleston 1973) and city dwellers (Oldham 1973).
The exact relationship between asbestos body concentration in the lungs,
and fibrosis, is not a simple dose response one (Ashcroft and Heppleston
1973) which is not surprising since the ratio of coated to uncoated
fibres may be as low as 1:11,000 (Davis and Gross 1973). Asbestos
bodies seem therefore to represent a partial defence reaction of the
body to inactivate foreign mineral fibres; this may operate successfully
for a low number of inhaled fibres but the mechanism cannot apparently
cope with greater challenge and lung damage ensues.
1.6 Asbestos related disturbance to the immune system
Disturbance of the normal immune profile is not a disease state
but the central role of the immune system in disease processes demands
consideration of immune parameters to fully understand the aetiology
-1li-
and development of any disease. Epidemiological evidence for the role
of altered immune status in the development of asbestos related disease
was scanty up to 1973 when the Report of the Advisory Committee on
Asbestos Cancer to the Director of the International Agency for Research
on Cancer (Report 1973) recommended enquiring into the immunocompetence
of asbestotic3 with regard to the role of immunity in the subsequent
development of neoplasms. Since then there have been several epidemio¬
logical studies indicating definite alterations in the immune profiles
of asbestos workers and patients suffering from asbestos related disease
and these will be reviewed*
1.6.1 Cell mediated immunity
In the simplest approach the number of circulating white cells
have been counted and relative leukopaenia has been reported in asbestos
workers (El Sewefy et al 197U) and asbestos miners and quarriers (Munan
et al 1981).
Further refinement, involving enumeration of circulating T lympho¬
cytes by the E rosetting technique, has suggested that the total T
lymphocyte count is reduced in asbestotics (Kang et al 197U; Kagan et al
1977b)although reports of unchanged levels of T cells in asbestotics
(Gaumer et al 1981 ) and increased T cells in asbestotics who smoked
(Wagner et al 1979) have also been reported.
No reports have been published involving use of the newly available
panels of monoclonal antibodies to T cell subsets to further dissect the
T cell status of asbestos exposed individuals but the use of the "late
rosetting" T cell technique has been used as a marker for T suppressor
cells. In two studies, using this technique, evidence has been obtained
for decreased numbers of suppressor T cells in asbestotics (Wagner et al
1979; Gaumer et al 1981).
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To obtain information on the functional state of the peripheral
blood T cells the mitogenic response to Phytohaemagglutinin (PHA) or
Concanaralin A (Con A) has been utilised in several studies. Using
PHA, uptake of thymidine by T lymphocytes has been found to be decreased
in asbestotics (Kang et al 197U; Kagan et al 1977a; Haslam et al 1978;
Wagner et al 1979). In contrast Gaumer et al (1981) found no difference
in Con A response in 10 asbestotics compared to 10 suitable controls
while Lange's (1980) data on PHA transformation is impossible to interpret
due to variability in the response of asbestotics. Of particular
interest was the finding by Kagan et al (1977a)of an inhibitor of PHA
transformation in the serum of sane asbestotics.
In their extensive study Kagan et al (1977a)measured "lymphocyte
mediated cytotoxicity" and found it also to be significantly decreased
in asbestotics.
As a measure of total cell mediated immunity the ability of asbestos
workers to mount a delayed hypersensitivity response to recall antigens
has been measured in seme studies. In all the studies where this has
been done significantly increased anergy to recall antigens has been
demonstrated (Kagan et al 1977a; Lange et al 1978; Gaumer et al 1981).
In a further refinement Lange (1980) measured the generation of migration
inhibition factor (MXF) following challenge with recall antigens and
found a significant reduction in MIF production by asbestotics compared
to controls.
1.6.2 Humoral immunity
Gaumer et al (1981) have described an increase in the number of
B lymphocytes in asbestotics compared to controls while Kagan et al
(1977 b) found no difference in this parameter. There is, however,
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evidence from several studies, of a stimulation in humoral immunity
manifest as significantly increased levels of serum IgA, IgG, IgM and
IgE in asbestotics (Kagan et al 1977 b; Lange 1980; Huuskonen et al
1978) although not all of these studies found increases in all of the
Ig classes in their experimental groups.
Kagan et al (l977b ) additionally reported increased secretory
(salivary) IgA and El Sewefy and Hassan (1971) reported immunoelectro-
phoretic evidence of increased IgG, IgM and IgA, in asbestotics.
Possibly related to the above reports of elevated circulating Ig
in asbestotics is recurrent evidence of autoimmune disease manifest as
serum anti-nuclear antibody and/or rheumatoid factor (Pernis et al 1965;
Turner»Warwick and Parkes 1970; Kagan et al 1977 b; Lange et al 1978).
There is no organ specificity in these auto-antibodies as typified by
the failure to find any evidence of specific anti-lung activity in the
asbestotics studied by Turner-Warwick and Haslam (1971).
These findings of autoimmunity in asbestotics taken together with
the results of a study by Toivanen et al (1976) who found no evidence
for increased anti-nuclear antibody or rheumatoid factor in 66 asbestos
workers without asbestosis, and Edge (1976) who failed to demonstrate
increases in these parameters in 160 asbestos workers with pleural plaques
and no asbestosis, supports the view that autoimmunity is a result of
asbestosis rather than a contributory cause. Militating against this
view however is the work of Huuskonen (1978) who found increased auto¬
antibodies in asbestos workers compared to controls but not in asbestotic,
compared to non-asbestotic, asbestos workers. One possible explanation
of the conflicting results of these epidemiological studies is the method
of assessing sub-clinical asbestosis amongst workers in view of the
difficulty in interpretation of X-ray data.
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Additional evidence of inflammation and immunostimulation in
asbestotics is present in the work of Huuskonen (1980) who reported
increased serum CL and C, and ©O anti-trypsin in asbestotics compared
3 u
to non-asbestotic asbestos workers.
The HLA tissue type of individuals has been found to play a role in
susceptibility to seme diseases and Merchant et al (1975) reported increased
incidence of HLA W27 antigen in asbestotics suggesting that HIA W27
individuals had increased susceptibility. In the same study Merchant
et al failed to confirm the suggestion by Badr and EL Sewefy (1971) that
asbestosis was associated with Blood Group '0'. Evans et al (1977)
failed to repeat the findings of Merchant et al with regard to HIA W27
in a group of asbestotics and controls and instead found increased
fibrosis to be linked with HLA B12j they also found that HLA BW5 was
much reduced in asbestotics and interpreted this as HLA BW5 conferring
"protection1* against asbestosis.
Studies on the immunocampetence of asbestos exposed persons who
developed mesothelioma have revealed a decrease in the number of circulating
T cells but no evidence of impaired cell mediated immunity as measured
by antigen recall, or T cell mitogenesis (Ramachandar et al 1975;
Haslam et al 1978).
Epidemiological studies into immune status in asbestos related
disease can be summarised as follows. The presence of asbestosis is
accompanied by impaired T cell function and cellular immunity. Selective
loss of T suppressor cells reported by two groups may have a role in
stimulation of humoral immunity present along with asbestosis and also
possibly in the manifestation of autoimmunity consistently detected in
asbestotics. It is not clear whether asbestosis predisposes to auto¬
immune disease or vice versa and further studies are required to clarify
the conflicting evidence on this point. The reports of lack of
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impairment in T lymphoproliferative status in mesothelioma patients
is in contrast to the findings of decreases in this function reported in maay
studies of cancer patients (Herberman 1978). As such, this particular
finding may provide some insight into the role of the immune response
in development of this unusual tumour.
1.7 Portals of entry
Once epidemiological evidence had demonstrated that asbestos exposure
was associated with defined diseases the subject was accessible to
application of experimental pathology using suitable models. It is
apparent that the lungs represent the major portal of entry and target
organ for the pathological effects of asbestos in view of the ability
of asbestos to become airborne and be inhaled. It is not however the
only target for asbestos disease since asbestos inhaled is asbestos
ingested via the gastrointestinal tract due to the fact that most of
the dust which settles before the terminal airspaces, and much of that
which does, ends up being cleared from the lung via the mucociliary
escalator. This system comprises a continuous blanket of mucus (plus
particles) which is constantly being propelled upwards towards the throat,
through the action of ciliated epithelial lining cells, where it is
normally swallowed.
Additionally asbestos can be ingested directly into the gastro¬
intestinal tract as a contaminant of drinking water (Cunningham and
Pontefract 1971), water filtered through asbestos based filters (Selikoff
and Lee 1978) or in beer, sherry, vermouth or soft drinks (Cunningham and
Pantefract 1971). Asbestos can also be injected as a contaminant of
therapeutic preparations (Selikoff and Lee 1978).
These other portals of entry could be contributory factors in the
extra-pulmonary neoplasia associated with asbestos but the lung remains
-19-
the site of the 3 major asbestos related diseases, pulmonary asbestosis,
bronchial carcinoma and pleural mesothelioma.
1.8 Experimental pathology
Confirmation of the association between an agent and a disease,
which is suspected frcm epidemiological evidence, requires the testing
of the suspected agent in experimental animal models on the assumption
that similar effects will be observed. In addition the use of animal
models allows manipulation of the suspected agent, and the laboratory
animal which can aid in dissecting out the elements of the disease
process. In the following section the evidence gained from experimental
pathology as to the role of asbestos in disease will be reviewed.
1.8.1 Fibrosis
Experiments to determine the fibrogenic effects of asbestos in
animals were begun almost as soon as asbestos was suspected as a pathogenic
agent through the report of Cooke in 192ii. Thus Wagner (1963) records
that Mavrogordato, in 1925, dusted guinea pigs with chrysotile for 2 hours
a day for $0 days and that one animal died with pulmonary fibrosis and
asbestos bodies. Wagner (1963) also reviews the extended study of
Gardner and Cummings which began in 1928 and which reported peri¬
bronchiolar fibrosis in guinea pigs dusted with chrysotile for 600 days.
In these experiments only chrysotile was used but by 1951 Vorwald et al
had reported instillation of crocidolite, chrysotile and amosite into
the lungs of rats and similar lesions were produced by all asbestos types.
Holt et al (1965) found similar levels of fibrosis and type of lesion
following inhalation of crocidolite, chrysotile, amosite and anthophyllite
in guinea pigs. It was not until 197U however that an attempt was made
using UICC samples to accurately assess the two major parameters, i.e. level
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of dust exposure and degree of fibrosis. Thus Wagner et al (197U)
maintained their dust level at 10 mg/m and assessed the degree of
fibrosis blind on a scale from 1-8; these workers reported that
chrysotile was significantly more fibrogenic in rats than amosite and
that crocidolite was intermediate. Asbestosis was found to be
progressive after cessation of dusting. In the study of Davis et al
(1978) UICC samples were applied in clouds of equal fibre number or
equal mass and in this study, mass for mass, chrysotile was found to be
twice as fibrogenic as the amphiboles.
Once the essential fibrogenic activity of asbestos was confirmed in
animals the properties of fibres which imbued them with their fibrogenic
potential was investigated. Thus King et al (19^6) showed that short
fibre chrysotile (< 2.5 pm) produced a lesser reaction than a long fibre
sample (> 15 ;um) and Klosterkotter (1968) reported that both crocidolite
and chrysotile lost their fibrogenic potential when ground to less than
5 /m. Timbrell and Skidmore (1968) obtained a greater pulmonary reaction
to inhaled long fibre amosite than to a short fibre amosite produced by
"further grinding" of the long sample; the clouds were of equal mass.
Davis (1972a) reported that a variety of dusts including chrysotile,
injected into the murine peritoneal cavity, were more fibrogenic as long
fibre samples than as samples ultrasonicated or ground and sieved to
remove the long fibre fraction. Wright and Kdschner (1977) instilled
into the lungs of rats, well characterised long and short fibre samples
of crocidolite and found extensive fibrosis with the long fibres and no
fibrosis with the short fibre sample.
While long fibres seem to be the most active in fibrogenesis by
asbestos there are isolated reports of short fibre samples causing
extensive fibrosis (for example Holt et al 1965).
A few studies hare investigated the role of the asbestos fibre
surface in fibrogenesis; polyvinyl-pyridine-n-oari.de, which produces
protection against silica fibrosis by masking the surface OH groups,
was found to have no effect on the in vivo fibrogenicity of asbestos
(Davis 1972b). Heating chrysotile to above l4.00°C and then injecting
it into the peritoneal cavity resulted in a decrease in fibrogenicity
as measured by size of fibrous granulomas (Davis and Coniam 1973); the
authors concluded that, the loss of the fibrous structure may have been
as important as direct effects of heat on the chrysotile surface.
1.8.2 Carcinogenicity - asbestos alone
Following his pioneering study revealing increased incidence of
mesothelioma in the Cape asbestos fields, Wagner (1962) injected asbestos
intrapleurally into rats and produced pleural mesotheliomas. Wagner
and Berry (1969) went on to report mesothelioma induction by crocidolite,
chrysotile, amosite, anthophyllite and brucite administered in the same
way. Once again, having confirmed that animal experimentation
mimmicked the human situation, in terms of mesothelial reactivity,
experiments were carried out aimed at elucidating the main parameters
of the fibre involved in carcinogenesis.
Stanton and Wrench (1972) carried out a study on the role of fibre
geometry on mesothelioma production by fibrous dusts. Using an unusual
system of applying fibre directly to the pleural surface in a gelatin
base on glass fibre pledgets, a method that appears to only have been
used by Stanton's group, these workers found that crocidolite, chrysotile
and amosite all produced mesotheliomas and that milling to shorter
length reduced the tumourigenic potency of crocidolite. In subsequent
studies Stanton and co-workers (1977, 1978) went on to show that, in
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their system, fibres <0.25 jam diameter and > 8 ^im in length were the
most potentially tumourigenie. Wagner et al (1970) confirmed the
increased potency of long thin fibres, compared to short thick fibres,
in their intrapleural injection studies.
Inhalation of asbestos has been used to generate tumours in
experimental animals but since even in occupationally exposed human
populations the incidence of lung tumours is low (particularly when
the synergistic effect of smoking is absent), this is an inefficient
way of producing tumours, albeit the most realistic way.
Gross et al (1967) produced lung carcinomas and a single mesothelioma
in rats inhaling chrysotile while Reeves et al (1 97JU) reported the same
neoplasms in rats exposed to clouds of chrysotile, crocidolite and
amosite. Wagner et al (197U) exposed rats to clouds of UICC asbestos
of all types and produced lung carcinomas and mesotheliomas. Davis
et al (1978) reported a study where rats were exposed to equal masses
and equal fibre numbers of UICC crocidolite, chrysotile and amosite;
compared on this basis chrysotile was the most carcinogenic producing
lung carcinomas and mesotheliomas. In this study crocidolite produced
no carcinomas and one mesothelioma.
Several studies have been carried out in an attempt to dissect out
the major factor(s) in fibre responsible for the carcinogenicity.
Morgan et al (1977) showed that extensive acid leaching of chrysotile
reduced its tumourigenic potential by approximately andfwhile the
authors claim that this treatment did not affect the tendency of the
chrysotile to fragment,there is evidence that such treatment increases
the fragility of chrysotile (Selikoff and Lee 1978). Monchaux et al
(1981) have also reported virtual abolition of tumourigenic potency of
chrysotile with acid leaching. Early suggestions that polycyclic
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hydrocapbons contaminating fibres could be involved in asbestos carcino¬
genesis (Harington 1965) were ruled out when vigorous extraction of
contaminating and natural oils failed to alter asbestos carcinogenicity
(Wagner et al (1970). The possibility that naturally occurring or
contaminating carcinogenic metals such as nickel and cobalt could be a
factor in carcinogenesis was studied by Stanton's group; nickel,
chromium and other carcinogenic metals were attached to non-fibrous
particles of appropriate size and this failed to render the particles
carcinogenic (Stanton and Layard 1978).
Immunobiology of mesothelioma
In recent years the Wagners and others have carried out studies into
the immunobiology of mesothelioma in rats. Berry and Wagner (1976)
reported that age at asbestos inoculation had a significant effect on
rate of mesothelioma induction; rats injected at 10 months of age had
a significantly increased mesothelioma incidence compared to those
injected at 2 months. The age related difference in susceptibility
was reported by the authors to be in keeping with similar studies using
other experimental carcinogens. Wagner (1979) thymectomized and sham-
thymectomized rats and measured crocidolite induced mesothelioma
production. This study revealed that sham-thymectomy was the major
effect in reducing mesothelioma rate and that sham-thymectcmy was
significantly more effective than thymectomy in reducing mesothelioma
production. Wagner advanced several explanations for these results,
the most likely being that surgery caused T cell dependent macrophage
activation to cytotoxicity which was abrogated by thymectomy. Wagner
et al (1980) also reported that BCG, silica and talc given by intra¬
pleural injection following intrapleural crocidolite had no effect on
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mesothelioma incidence while similarly applied carageenan caused a
threefold increase in mesothelioma incidence. The authors point out
that carageenan kills macrophages and that such toxicity, or altered
macrophage function, could hare contributed to mesothelioma development.
In a recent study carageenan, injected intraperitoneally, has been
shown to potentiate growth of a concomitant experimental peritoneal
ascitic lymphoma (Pugh-Humphreys et a1 1977).
Brown et al (1980) studied rat mesothelioma tumour lines, maintained
through 20 transplant generations by subcutaneous trochar implantation.
Rats immunised by excision of subcutaneous tumours, or implanted with
irradiated tumour fragments, plus suitable controls, were challenged with
tumour fragments; no protection was conferred by these treatments thus
failing to demonstrate tumour associated transplant antigens in asbestos
induced mesothelioma. Using a different index of immunogenicity for
rat mesotheliomas, Stevens et al (1981) failed to detect antibody
dependent cell mediated cytotoxicity mediating activity in serum from
mesothelioma bearing rats using bowel adenocarcinoma cells as targets
and normal peripheral blood lymphocytes as effectors.
In the same assay system serum from chemically induced tumour
bearing rats was positive (approximately 1U^ cytotoxicity). These
studies demonstrate that experimental asbestos mesotheliomas do not
elicit cell mediated immune responses as manifest by tumour rejection
following immunisation and challenge, or humoral immune response which
can mediate antibody dependent cell mediated cytotoxicity.
In a study into the uses of carcinoembryonic antigen (CEA) phenotype
in tumour diagnosis Whitaker and Shilkin (1981) reported absence of CEA
in U0 human mesotheliomas and its presence in carcinomas; while of value
in diagnosing suspect tumours this finding also underlines the mesenchymal
origin of mesotheliomas since CEA is a marker of epithelial neoplasms
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(Goldenberg et al 1978). Gormley et al (1980b) provided further
evidence for the mesenchymal origin of experimental asbestos meso¬
theliomas when cell lines from mesotheliomas of variable histological
type tended to adopt a fibroblastic appearance on culture suggesting
a common mesenchymal heritage.
1.8.3 Carcinogenicity - co-carcinogenic effects
The synergistic, or co-carcinogenic interaction of asbestos and
cigarette smoking in the genesis of bronchial carcinoma which was
demonstrated by epidemiological methods prompted Wehner et al (1975) to
expose hamsters to (i) cigarette smoke, (ii) chrysotile or
(iii) chrysotile plus cigarette smoke. Due to excessive fibrosis in
the asbestos exposed group, however, dusting had to be discontinued
early and, possibly due to conflicting mortality from asbestosis,
the group receiving smoke and asbestos had significantly fewer lung
tumours than the "cigarette smoke only" group. In another poorly
controlled study (Humphrey et al 1981 ) 9 dogs received intratracheal
instillations of crocidolite for up to 3 years; 7/9 of these dogs
smoked U5 cigarettes per week for 6 years. Since the two dogs which
received asbestos alone produced mesotheliomas this rather confounded
the exercise as a study in synergism. However, h/7 of dogs receiving
asbestos only and 3/7 of dogs receiving asbestos and smoke, developed
bronchial carcinomas.
Several studies have investigated co-carcinogenic interaction of
asbestos with conventional laboratory carcinogens. Pylev and Shabad
(1973) produced 0% tumours in rats receiving intratracheal chrysotile
(2mg) and 0% tumours in rats receiving 5 mg Benxo (<*) pyrene, the major
hydrocarbon in cigarette smoke. Rats receiving 2 mg chrysotile with
Benxo («*) pyrene adsorbed onto the surface produced 29% with tumours,
while rats receiving 2 mg chrysotile plus 5 mg benxo («<) pyrene
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developed 59% tumours. Using tracheal transplants exposed to various
non-tumourigenic doses of dimethylbenzanthracene in pellet form,
followed by a non-tumourigenic dose of chrysotile in a gelatin pellet,
Topping and Nettesheim (1980) demonstrated up to 23% incidence of
tracheal carcinomas. These authors present their results as evidence
for a promoting effect of asbestos as the second step to initiation by
dimethylbenxanthracene and point out that the temporal sequence of
application used in these experiments precludes a "carrier effect" of
asbestos in targetting the dimethylbenzanthracene to susceptible cells.
In an attempt to demonstrate a synergistic role for asbestos in
gastrointestinal carcinogenesis Ward et al (1980) utilised the rat
model whereby subcutaneous azoxyraethane produces intestinal tumours in
rats. Intra-gastric instillation of UICC chrysotile was given con¬
currently with subcutaneous azoxymethane, but no significant excess of
tumour was found in the group over and above the level found in the
group receiving azoxymethane alone.
Kanazawa et al (1979), prompted by the report of Chabot et al (1970)
on viral induction of mesothelioma in fowl, undertook a series of
experiments to ascertain whether asbestos could potentiate viral onco¬
genesis. Mice given 5 Jig UICC chrysotile produced no tumours (0/60);
1/59 of mice receiving Moloney sarcoma virus only produced a single
tumour (which regressed); I4i/61 of mice receiving 5 pg chrysotile plus
virus (at the same dose as the controls) produced tumours and 22 died
within 100 days. It was notable that quartz and carbon administered
along with virus produced a low level of tumours:- quartz 12/62 - 2
lethal; carbon 8/62 - 1 lethal.
Experiments into asbestos co-carcinogenesis with polycyclic aromatic
hydrocarbons, which do not fit easily into experimental pathology or
cell studies, include those using liver cell microsomal fractions to
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study carcinogen metabolism. Thomson et al (1978) found that ferric
ions (a major component of asbestos) at low concentrations caused a
20$ increase in the binding of benzopyrene to DNA and made the rather
tenuous association that ferric ions leaching from asbestos could be
synergistic to benzopyrene carcinogenesis. Although Thomson et al
did not actually test asbestos in their system, Kandaswami and O'Brien
(198O) reported that bensopyrene adsorbed onto asbestos was dispersed
in microsomal lipid fraction to a greater degree than bensopyrene alone;
this finding lent support to a similar observation by Lakowicz and
Hylden (1978) using artificial membranes. Kandaswami and O'Brien also
reported that all It main types of asbestos, with bensopyrene adsorbed,
inhibited aryl hydrocarbon hydroxylase in rat liver microsomal fraction.
Since this ensyme is responsible for metabolism of bensopyrene, then its
suppression could enhance the retention time of adsorbed benzopyrene so
increasing the carcinogenic potential. Since Naseem et al (1978) have
reported increased inducibility of aryl hydrocarbon hydroxylase in the
lymphocytes of asbestos workers, and implicated this in asbestos carcino¬
genesis, it appears that both induction and suppression of this enzyme
is being blamed for asbestos carcinogenesis.
Asbestos has therefore been shown experimentally to act as a co-
carcinogen, probably a promoter, with some common polycyclic hydrocarbons
as initiators. There is evidence that the asbestos could act at several
levels:- (i) as a carrier for the polycyclic hydrocarbons; (ii) as an
aid to dispersion of hydrocarbon in the lipid phase; (iii) through
modulating the expression of aryl hydrocarbon hydroxylase. Asbestos
apparently can also act synergistically with oncogenic virus in producing
tumours. These findings have important ramifications for occupational
hygiene and experimental asbestos carcinogenesis. Thus, although
contaminating hydrocarbons appear not to be involved in UICC asbestos
carcinogenesis (Wagner and Berry 1969) the possibility of contamination of
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asbestos in occupational situations, or concomitant exposure, must be a
possibility. The presence of virus infection in men and animals is
also an unknown quantity and the possibility that asbestos affects onco¬
genic virus expression remains a possibility.
1.9 Cytotoxicity
The ability of asbestos to kill cells was the major in vitro
effect of asbestos which was reported up to the middle seventies.
The exact role of asbestos cytotoxicity in vitro to the development of
asbestos associated disease remained obscure but a large body of
research was carried out measuring the different parameters associated
with the ability of asbestos to kill and disrupt cells.
1.9.1 Haemolysis
McNab and Harington (1967) described the haemolytic effect of
chrysotile asbestos on erythrocytes and the rather lesser haemolytic
activity of the amphiboles (Harington et al 1971). It was suggested
that the haemolytic activity of chrysotile was due to its positively
charged, magnesium rich surface which interacts with the negatively
charged sialic acid residues of the erythrocyte membrane causing glyco¬
protein clustering and osmotic disruption (Harington et al 1975).
This theory of the haemolytic action of chrysotile has recently gained
support from the work of Sykes et al (1980). Asbestos haemolysis
occurs only in serum free conditions since fibres rapidly become protein
coated, and the active surface masked in protein solution. Abolition
of haemolysis by serum (Allison 1973), cell fragments (Ottery and
Gormley 1978) and lipids (Jaurand et al 1979) makes it unlikely that
haemolysis has any direct relevance to the in vivo situation. The
directly disruptive action of asbestos on membrane has, however, been
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allocated a role in macrophage cytotoxicity by chrysotile.
1.9.2 Cytotoxicity to macrophages
Harington et al (l97U) reviewed studies on the cytotoxic effects
of asbestos on macrophages in culture between 1968 and 1973. They
showed that in 11 studies using rat, mouse, guinea pig and hamster
macrophages exposed to doses of asbestos frcm 20-1,000 ^pg/10^ cells,
remarkably consistent results were obtained. Thus chrysotile was
shown to have marked rapid toxicity in serum free conditions and
delayed cytotoxicity in the presence of serum. In 5/6 of the studies
where the comparison was made, chrysotile was more cytotoxic than
amphiboles. According to Allison (1971, 1973) and Harington (1976)
the early toxicity in serum free conditions is analogous to haemolysis
and the late cytotoxicity in serum conditions is due to the membranolytic
effect of intralysoscmal chrysotile on the lysosomal membrane causing
leakage of lytic enzymes into the cytoplasm and cell death. This theory
of asbestos toxicity was based on Allison's theory of silica toxicity
to macrophages and his statement of 1971 sums up the importance then
placed on asbestos cytotoxicity and the rather vague association
between alveolar macrophage toxicity and fibrosiss-
"The slowly progressive damage to macrophages so produced
may be an important factor in the fibrotic reaction to asbestos."
(Allison 1971)
Harington could also write in 197U with apparent confidence that -
"the death of the macrophage is a pre-requisite to the
subsequent fibrogenesis although the biochemical steps between
the two major processes have not yet been worked out."
(Harington 197U)
It is notable that Allison's lysosomal rupture theory of silica
induced cell death has been comprehensively tested recently (Kane et al
1980) and shown to be deficient in its major premise and that lysosomal
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rupture can be dissociated from cell death. These authors suggest that
the target for silica toxicity, even in the presence of serum, is the
cell membrane and that lysosomal rupture is not the major factor in
silica induced macrophage killing. This suggests that the mechanism
ft
of chrysotile cytotoxicity to macrophages in vitro must be similarly
re-examined.
In 197U Davies et al showed that macrophages could be stimulated
by asbestos to release lysosomal enzymes in the absence of cell death
and this effect has been confirmed (Morgan et al 1978; Morgan and
Allison 1980; Jaurand et al 1980). Since the central role of
stimulated or activated macrophages in chronic inflammation and immuno¬
logical function had been fully recognised during the early seventies,
followed by the recognition that normal living macrophages could release
fibroblast stimulating factors, there has been a shift away from macrophage
death to stimulatory effects of asbestos. This tendency to emphasise
the stimulatory effects of asbestos on macrophages has been led by
Miller and co-workers (1976, 1977» 1980) who, in contrast to Allison,
emphasised the differences between silica and asbestos (Miller 1979)
and the resulting differences in macrophage response in immunity; and
by Hamilton and co-workers (1976, 1980, 1981) who highlighted the
potential role of asbestos activated macrophages in chronic inflammation.
Studies on the cytotoxic effects of asbestos have continued,
however, but with a tendency to use permanent macrophage-like cell lines
(see papers in Brown et al Eds. 1980) and using cytotoxicity as a
potential predictor of fibrogenicity in the screening of potentially
hazardous dusts. The dangers of such a predictive test, if used alone,
were succinctly expressed by Harington et al (1973>):-
"all cytotoxic types (of asbestos) are fibrogenic but
not all fibrogenic types are cytotoxic"
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the dangers of correlating cytotoxicity with fibrogenicity have been more
recently emphasised by Le Bouffant et al (1980).
1.9.3 Asbestos toxicity to other cell types
Asbestos has been reported to be cytotoxic to several other cell
types such as fibroblasts (Allison 1973; Chamberlain and Brown 1978),
mesothelial cells (Allison 1973; Kaplan et al 1980a)and epithelial
cell lines (Neugut et al 1978; Craighead et al 1980).
1.9.U Cytotoxicity and carcinogenicity testing
The simplicity and cheapness of an in vitro system for detecting
potential carcinogenic activity of mineral dusts has resulted in research
into the feasibility of using cytotoxicity, to suitable targets, as a
possible correlate of tumourigenic potential. Chamberlain and Brown
(1978) used a panel of dusts against a hamster lung epithelial cell
line and an alveolar type II lung epithelial cell line. These workers
reported that quartz, a non-carcinogenic but highly cytotoxic dust to
macrophages, was not cytotoxic but that UICC asbestos samples were very
cytotoxic. This work was extended (Brown et al 1978) to show that
the best correlate of cytotoxicity in 3 UICC amphiboles was the number
of fibres longer than 6.3 Jim. This figure comes quite close to the
length cited by Stanton and his co-workers to be most carcinogenic in
animal studies, i.e. longer than 8 pm. On this basis these workers
suggested that, in their cell system, activity correlated with the
tumourigenicity of fibrous minerals rather than their fibrogenic activity.
Similar claims have been made for the macrophage-like cell line
P388D1 with regard to cytotoxic discrimination between Dawsonite samples
of varying aspect ratio (Wade et al 1980). It should be noted, however,
that another study (Gormley et al (I980a)urged caution in correlating
cytotoxicity in P388D1 cells with tumourigenic potential of some asbestos
types.
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It seems reasonable that, as suggested in the concluding remarks
to a recent conference (Brown et al Eds. 1980) that before making any
claims that a cell line can discriminate, on the grounds of its cyto¬
toxic response, between tumourigenic dusts, it should be tested, in
several centres, against a panel of non-pathogenic, fibrogenic, non-
carcinogenic and carcinogenic dusts.
1.9.5 Survival versus cytotoxicity in asbestos induced fibrosis
and carcinogenesis
In in vitro studies into the effects of asbestos on defined cell
populations, much emphasis has been placed on the ability of asbestos
to kill cells. It seems logical, however, that the surviving cells
are an important population in disorders of cell growth control such
as fibrosis and cancer.
With regard to fibrosis a role for macrophage cytotoxicity is often
implied but the weight of evidence is that asbestos, even chrysotile,
is not toxic to macrophages in vivo (Miller 1978) while in vitro the
A
amphiboles are only weakly cytotoxic and chrysotile cytotoxicity may
be a transient phenomenon decreasing with magnesium leaching. It is
also possible that over dose effects, compared to the in vivo situation,
can be misleading in in vitro experiments. It is notable that many of
the rtharmfuln mediators traditionally seen as being released from daad
or dying macrophages - elastase, collagenase, lysosomal hydrolases,
oxygen radicals, fibrogenic factors, etc. (Brain 1980) are in fact
released in increased amounts by activated macrophages (Davies and
Bonney 1980; Pabst and Johnson 1980; Wahl et al 198C&).
In asbestos carcinogenesis, direct cytotoxicity to relevant target
cells (epithelial cells, mesothelial cells) may be important in inducing
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repair and proliferation which could lead to transformation (Kakunaga
1975). It has however been suggested that cytotoxic agents can create
selective pressure in favour of "initiated" cells (Solt and Farber 1976)
and so the cells which survive asbestos treatment, but are changed such
that they go on to form tumours, are obvious targets for study.
Similarly macrophages surviving asbestos challenge (or simply present
in dusted animals) in view of the cell growth regulatory role of the
macrophage (Keller 1981) deserve attention as-to any possible alterations
in this function which could play a role in asbestos carcinogenesis
and fibrosis.
Thus, while some cells in the lung may die following asbestos
deposition, and in the peritoneal cavity following asbestos injection,
it is a central argument of this thesis that the living cells can be
considered to be as important as the dead ones in bringing about
subsequent disease.
1.10 Potential targets for asbestos in the lung
Given that the major locus for the pathological effects of asbestos
is the lung, it is possible to list the cell populations and systems
in the lung which, on encountering asbestos, could be altered in such a
way as to result in disease. This then allows studies to be carried out
on relevant isolated systems or homogeneous cell populations to further
dissect out the effects of asbestos. These effects could be directly
on fibroblasts to produce fibrosis, directly on epithelium to produce
carcinoma, or directly on mesothelium to produce mesothelioma. Asbestos
could also act indirectly via the cells and humoral elements of the
major body defence systems, the immune and inflammatory systems, to
bring about overall changes in the growth control of the above mentioned
target cells.
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In the following sections it is intended to (i) review the
evidence for direct effects of asbestos on these target cells with
regard to changes which could be relevant to fibrosis or carcinogenesis;
(ii) review the role of the macrophage in inflammation and immunity
with emphasis on the known effects of asbestos on macrophage function;
(iii) review the tumour cell modulating effects of macrophages.
1.10.1 Direct effects - fibroblasts
Using rabbit lung fibroblasts in vitro Richards et al (1971) and
Richards and Morris (1973) have shown that, following an initial cyto¬
toxic effect, 3 weeks of culture with chrysotile results in increased
collagen secretion by these cells. This group also grew fibroblasts
for 8-9 months in the presence of chrysotile and this gave rise to a
strain of fibroblasts which produced greater amounts of collagen than
control fibroblasts maintained in parallel for the same length of time
(Hext et al 1977). The early cytotoxic effect of chrysotile in this
system was examined closely (Richards and Jacoby 1976) and the recovery of
the cultures was seen to be typified by gross changes in the pattern
of collagen deposition from an even distribution in controls, to short
thick clusters in the long term chrysotile treated cultures. The
authors suggest that such altered collagen may contribute to fibrosis
by being more stable to normal turnover than conventional collagen.
Richards et al (l977) went on to postulate a mechanism for chrysotile
induced fibroblast stimulation involving entry of chrysotile into
fibroblasts in both membrane bound (lysosomal) and non-membrane bound
forms. Adsorption of RNA by the free chrysotile is envisaged as
depleting the cytoplasmic RNA pool and causing stimulation to produce
more RNA and hence increased protein synthesis; this is coupled with
removal of lysosomal degradative enzymes by adsorption to lysosomal
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chrysotile so inhibiting the normal collagen degradative process.
While rather mechanistic this model could operate and is open to experi¬
mental verification; it is however tempting to speculate that the
many fibroblast membrane receptors which have been recently described
(Pastan and Willingham 1981) are targets for direct effects of asbestos
on fibroblasts.
In a different approach to the direct effects of asbestos on
fibroblasts Maroudas et al (1973) utilised the fact that normal fibro¬
blasts require a solid support in order to undergo proliferation, i.e.
they are anchorage dependent; these authors then examined the threshold
length of asbestos which would provide sufficient anchorage for fibro¬
blast proliferation in semi-solid agar. The authors found that only
asbestos samples with fibres more than 20 ^um long supplied sufficient
anchorage for fibroblast proliferation. While these authors compared
these results with their findings on the increased ability of longer
fibres to cause mesotheliomas, it seems as likely that such a mechanism
could operate in fibrosis.
Several studies have shown chromosomal alteration following
treatment of fibroblastic cells (Chinese hamster ovary cells) with
asbestos in vitro; thus chromosomal structural changes and aberrations
were found with low doses (lO^g/ml) of both chrysotile and crocidolite
( Lavappa et al 1975; Sincock and Seabright 1975) while only crocidolite
(10 ^ig/ml) was found to cause significant increases in sister chromatid
exchange compared to controls in the study of Livingston et al (1980).
In support of these reports of chromosomal effects of asbestos on
fibroblasts is the report of Huang (1979) that crocidolite, chrysotile
and amosite are all weakly positive in a fibroblast mutagenesis assay;
this contrasts with the study of Chamberlain and Tarmy (1977) who found
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chrysotile, superfine chrysotile, crocidolite, amosite and anthophyllite,
to be negative in Ames type bacterial mutation tests.
Daniel et al (1980) reported that asbestos treatment of foreskin
fibroblasts in culture enhanced the binding of polycyclic aromatic
hydrocarbons to the fibroblast DNA, an effect which the authors noted
had been reported to have a clear relationship with carcinogenic
potential.
Biochemical evidence that asbestos alone can produce transformational
type changes in fibroblastic cells was provided by Neumann et al (1980).
This group reported that Syrian hamster embryo cells treated with asbestos
showed simplification of cell surface glycoproteins and glycolipids in
a manner reminiscent of the changes following alteration from the normal
to the transformed phenotype induced by conventional agents in many
previous studies.
Tejwani et al (1980) reported inconclusive results as to the effect
of asbestos on the cyclic nucleotide balance of fibroblasts; chemical
carcinogens decrease this ratio but asbestos, while lowering the ratio
initially, caused doubling of the ratio on longer incubation. The
authors noted that this pattern of change was found with some tumour
promoters.
1.10.2 Direct effects - epithelial cells
Adding asbestos to an epithelial cell line (monkey kidney) in vitro
Hahon and Eckert (197^) showed that all asbestos types, at doses
insufficient to impair viability could depress viral interferon
induction by up to 90%. A corollary of this was that more rapid viral
replication was noted in asbestos treated cells. The important role of
viruses in animal carcinogenesis and its postulated but unproven role
in human tumours (Pitot 1978) make this finding particularly interesting.
Mossman et al (1980) added chrysotile at very low levels {0.S jig/ml)
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and crocidolite (5 jxg/mL) to an epithelial cell line derived from
trachea and found increased levels of UNA, presumed to reflect increased
proliferation of the epithelial cells.
Hamster trachea organ culture has been utilised (Mossman et al
1977j Frank 1980) and it has been shown to undergo increased basal cell
hyperplasia on treatment with asbestos. This is particularly inter¬
esting in view of the. fact that basal cell hyperplasia has been
characterised as a pre-malignant state.
1.10.3 Direct effects - mesothelial cells
In 1972 Rajan et al used explants of human lung to study the effect
of crocidolite asbestos on the pleural mesothelium in vitro and found
that culturing lung fragments in the presence of crocidolite caused
proliferation of the mesothelial cells of the visceral pleura, from a
monolayer to 5 or 6 cells thick. This was accompanied by "invasion"
by these cells of the underlying lung and increased nuclear size;
identical pieces of lung from the same donor grown in the absence of
asbestos showed a normal mesothelial monolayer.
It was not until 1978 however that Bignon and co-workers managed
to grow a homogeneous mesothelial cell line from scrapes of rat parietal
pleura (Thiollet et al 1978) and they were then able to examine the
effects of asbestos on this pure population.
This group reported that cultures of mesothelial cells phagocytosed
UICC chrysotile with subsequent formation of secondary lysosomes
(Jaurand et al 1979h)and that sub-lethal doses of chrysotile caused
vacuolation in the cells which eventually recovered but with an increased
doubling time, possibly suggesting some damage to the synthetic machinery
of the cell (Kaplan et al 1980 a). In their system there was a failure
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to demonstrate any difference in rate of sister chromatid exchange
between untreated mesothelial cells and those treated with chrysotile
(Kaplan et al 1980 b). Bignon and co-workers are in the midst of a
conprehensive study of the effects of asbestos on their mesothelial
cell line with regard to long term asbestos treatment and mutagenesis
testing of asbestos alone and in association with other substances
(Kaplan et al 1980 b) and the results of these studies are awaited
with interest.
1.10.Li OrerTiew
It is clear from these studies that both the fibrogenic and carcino¬
genic properties of asbestos can be manifest in experiments on the
direct effects of asbestos on fibroblasts, epithelial cells and meso¬
thelial cells in culture. Thus fibroblasts can be induced to proliferate
excessively and lay down abnormal collagen in response to asbestos
treatment; asbestos above a certain length can also provide a sufficient
substratum for anchorage dependent growth. In terms of carcinogenic
response chromosomal damage, sister chromatid exchange, biochemical
evidence of transformation and increased DNA binding of polycyclic
aromatic hydrocarbons have all been reported following asbestos treatment.
It is notable that fibroblasts, while obvious candidates for fibrogenic
effects, are not traditionally seen as candidates for the carcinogenic
effects of asbestos. It can be assumed that their selection as target
cells in seme of the above studies detecting carcinogenic type effects
are a matter of convenience or routine in the assays used. However,
asbestos has been detected by electron microscopy in the lung inter-
stitium 2h hours after a 1 hour inhalation exposure to chrysotile in rats
(Brody and Hill 1981); close interactions between asbestos and inter-
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stitial fibroblasts could therefore be an early sequel to inhalation.
Many mesotheliomas are described as fibrosarcoraatous and are manifestly
fibroblastic in appearance and it seems possible that at least seme
"mesotheliomas'1 are actually fibroblastic in origin although the common
mesenchymal heritage of both fibroblasts and mesothelial cells makes a
judgment on the stem cell of such a tumour difficult.
Evidence that asbestos can directly affect epithelial cells in ways
consistent with carcinogenesis is present in the evidence that asbestos
inhibits interferon induction and also causes increased proliferation
of epithelial cells in a small number of studies. Asbestos can be taken
up by Type I alveolar epithelial cells within 1 hour of commencement
of inhalation (Brody and Hill 1981) and so the possibility for prolonged
interaction exists.
There is little evidence for direct "carcinogenic type" effects of
asbestos on mesothelial cells in culture except for data reporting
mesothelial proliferation in organ culture and which does not appear to
have been repeated by other groups.
1.11 Possible effects of asbestos jn fibrosis through its immune
and inflammatory effects
The most likely candidates for the indirect effects of asbestos on
fibroblasts are the body's major defence systems, the inflammatory and
immune systems. These highly complex systems interconnect and overlap
so that the response to an inflammatory or immunogenic agent can bring
in aspects of both systems. The "final" common pathway of both systems
can be fibroblast proliferation as in the case of scar formation when
the stimulus is purely inflammatory, e.g. a sterile cut; and in the
case of fibroplasia in granulomatous disease of immunological origin,
e.g. tuberculosis. In view of the current evidence as to the central
role of the macrophage in immune response, inflammatory response and
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regulation of fibroblast proliferation (see later) the macrophage
appears as, the most likely cell to arbitrate between the inflammatory
and immune systems and in the final resolution of the reaction by
fibroblast proliferation. The major role of the alveolar macrophage
in phagocytosis and clearance of inhaled asbestos (Miller 1978) and
other fibrogenic dust make it additionally likely that the macrophage
could have a major role in the development of pulmonary fibrosis.
It is proposed to review relevant aspects of macrophage function
with particular reference to inflammation, immunity and control of cell
proliferation and discuss where asbestos might have its effects. Where
appropriate other aspects of host defence will be discussed along with
the known effects of asbestos.
1.11.1 Macrophage function
1.11.1.1 Macrophages - nomenclature
The term mononuclear phagocyte was introduced to describe the cells
of the monocyte/macrophage series (van Furth et al 1972) but the term
macrophage will be used here to describe the adherent mononuclear cells
of the peritoneal cavity, alveolar spaces and other sites.
Macrophages are present in the mammalian body as 56.h% in the liver
(Kupfer cells), lU.9^ in the lungs, 7.6% in the peritoneal cavity and
21.1% in other tissue sites (van Furth et al 1980).
1.11.1.2 Ontogeny
The origin of macrophages at various sites has been elucidated in
recent years principally through the work of van Furth and his co¬
workers using mice and rabbits (for example review by van Furth et al
1980). All cells of the macrophage lineage arise from primitive
monoblast precursors in the bone marrow, through monoblast, promonocyte
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to monocyte. Monocytes enter the peripheral blood where they remain on
average for 1 day (Bainton 1980); they then leave the peripheral blood
to become tissue macrophages at one of the above mentioned sites.
The large number of monocytes in the blood and the fact that they only
remain there on average for one day means that macrophages at tissue
sites are a constantly renewing population from incoming monocytes.
During an inflammatory response in the murine peritoneal cavity,
when there is increased recruitment to that site, a specific factor is
present in the serum which induces monocytopoesis (Sluiter et al 1980);
towards the end of the acute inflammatory phase this is replaced by a
factor inhibiting monocytopoesis. These factors appear to be released
by macrophages themselves at the site of inflammation and feed back to
the bone marrow acting at the level of monoblast or promonocyte division
(van Waarde 1978). Although the bulk of evidence is that turnover of
tissue macrophages is met by replacement from blood monocytes there is
evidence that local macrophage division may have a role in normal
turnover and an increased role at inflammatory foci in the peritoneal
cavity (Stewart et al 1975) and lung (Evans et al 1973). Thus up to
"\0% mitotic macrophages were present in the alveoli of NO^ exposed lung
(Evans et al 1973) and up to 10^ of macrophages at an adjuvant induced
inflammatory site were synthesising DNA (Spector 1977).
1.11.1.3 Function
The functions of macrophages are now known to be so extensive,
and their activities and secretions so numerous, that a complete review
is not appropriate here. The functions of macrophages have been
extensively reviewed elsewhere with regard to their role in inflammation
(Allison et al 1978; Edelson 1980; Davies and Bonney 1980); in the sensory
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and effector arms of the immune system (Nelson 1976; Unanue and
Rosenthal 1980); modulatory effects on tumour cells (Fink1976; James
et al 1977; Keller 1981), and in phagocytosis (Stossel 1976; Walters
and Papadimitriou 1978). That one cell can apparently carry out this
multiplicity of functions may be explained in part by heterogeneity
and activation as discussed below.
1.11.1.It Heterogeneity
The site related heterogeneity of macrophages is well documented
particularly with regard to differences between alveolar and peritoneal
macrophages due to the ease of obtaining these populations for comparison
(Hopper et al 1979; Walker 1976; Stuart 1977). As well as functional
differences there are also differences in expression of specific antigens
between alveolar and peritoneal macrophages (Walker 1976) and recently
monoclonal antibodies have been used extensively to detect macrophage
subsets (see papers in Forster and Landy Ed?. 1981). The fact that the
vast majority of macrophages at any site are derived from blood monocytes
makes it likely that local, environmentally produced differentiation
signals are responsible for site specific variation in macrophage
phenotype.
As well as showing site specific heterogeneity the population of
macrophages at any one site display heterogeneity with regard to the
expression of various structural and functional properties. Thus
peritoneal macrophages display a range of Fc receptor activities with
some cells having high avidity receptors and some having low avidity
receptors, as measured by specific rosetting techniques (Rhodes 1975).
Similarly the proportion of any macrophage population reacting to anti-
macrophage sera shows considerable variation suggesting heterogeneity
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in expression of macrophage membrane antigens (Hopper et al 1979;
papers in Forster and Landy Eds. 1981). There is also heterogeneity
in size within any macrophage population and different sized sub-
populations hare been shown to possess different functional properties
with, for instance, the large macrophage sub-population possessing
the most effective anti-tumour potential (Lee 1980).
The multitude of functions and secretions now attributed to macro¬
phages makes this property of heterogeneity within macrophage sub-
populations less surprising since only specialisation or the presence
of macrophages at different stages of differentiation (activation)
could reasonably account for this bewildering spectrum of activity
(Hopper et al 1979).
1.11.1.5 Activation
One of the most studied manifestations of normal macrophage function,
and one which probably underlies much of the evidence for heterogeneity
in macrophage populations, is the change from resting to activated
macrophages. The term macrophage activation was first used by Mackaness
approximately 20 years ago (for example Mackaness 196ii) who described
the increased bactericidal activity of macrophages from infected animals.
Although initially thought to be a specific response of the macrophage
it was later shown that such activated macrophages could kill a variety
of microbes. In 1972 Simon and Sheagren demonstrated that control
macrophages incubated with sensitized lymphocytes plus antigen attained
increased bactericidal potential so demonstrating that the specificity
of the response resided in lymphocytes which transferred this non¬
specific protective function to macrophages. It was also established
that lymphokine capable of activating macrophages was generated by
lymphocytes responding to allogeneic cells, T cell mitogens and B cell
mitogens (North 1981). The fact that animals bearing chronic infection
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were resistant to tumour cell inoculation led KLbbs (1972) and others
to test whether this resistance was macrophage mediated. When macro¬
phages were found to possess tumouricidal potential, the natural
corollary, that macrophages in culture could be activated to the
tumouricidal state by lymphokine treatment, was also demonstrated (for
example Piessens et al 1975). Macrophages activated with lymphokine
have many properties which differ from resting macrophages including
altered secretions and altered functions (Morahan 1980) and these will
be discussed in detail with regard to the role of the activated macro¬
phage in inflammation, immunity and control of cell proliferation, in
later sections.
It has been shown that some, but not all, of the properties of
lymphokine activated macrophages are also shared by inflammatory
macrophages elicited by inflammatory stimuli in the peritoneal cavity
(Karnovsky and Lazdins 1978; Cohn 1978). Such macrophages have been
referred to as "non-specifically activated", "non-immunologically
activated", stimulated or inflammatory macrophages to distinguish them
from lymphokine activated macrophages (Morahan 1980). The most quoted
difference between the two types of activation is that inflammatory
macrophages are not tumour cell cytotoxic while lymphokine activated
macrophages are (Cohn 1978). This is not, however, a hard and fast
rule since treatment of macrophages with C3b, a complement cleavage
product released during inflammation, renders them tumouricidal
(Schorlemmer et al 1977a)and macrophages collected on subcutaneously
implanted coverslips, a purely inflammatory stimulus, have been reported
to show tumour cell cytotoxicity (Poste 1979). Macrophages activated
by both immunological and non-immunological stimuli have many properties
in common and this has led Cohn (1978) to postulate a temporal sequence
of adoption of properties during activation. The adoption of same of
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the early properties in the sequence are seen as pre-requisite in
priming the macrophage for the lymphokine signal which raises it to
the full tumouricidal state; this is supported by in vitro studies
on differentiation signals in activation (Russell et al 1977; Poste
1979; KLbbs et al 1980).
1.11.2 Macrophages and Inflammation
Inflammation is one of the most important hcmeostatic mechanisms
in mammalian functioning and ever since the pioneering work of
Metchnikoff (1893) the central role of phagocytic cells in the process
has been emphasised. Local tissue injury, due to any invading substance
or trauma elicits changes in the microvasculature which culminate in a
cellular infiltrate of macrophages, neutrophils and other cells to the
inflammatory focus; these act to eliminate the damaging agent by
phagocytosis and lead to resolution. The humoral and cellular arms of
the immune system may be brought into play in the case of an immunogenic
agent and humoral responses may lead to complement mediated lysis or
opsonization of micro-organisms which aids in their clearance. The
cellular arm of the immune system acts in the case of viruses, parasites
and fungi to eliminate altered cells. These specific effectors are
joined by the complement, clotting and kinin cascades and other cellular
elements in a complex network of interactions which generate a full
inflammatory reaction. This may continue as chronic inflammation,
or may resolve, depending on the nature of the inflammatory agent.
Macrophages and other cells accumulate at inflammatory foci by
chemotaxis, in response to a variety of chemotaxins released at the
site of acute inflammation; these include bacterial products, complement
components, Hageman factor (Factor XII) and lymphokines (Sainton 1980).
Macrophages which accumulate at the inflammatory site become activated
and release a large number of inflammatory mediators including acid
-U6-
hydrolases and neutral proteases, complement components, interferon,
endogenous pyrogen, tissue thromboplastin and prostaglandin (Allison
et al (1978). It has been noted (Schorlemmer et al 1977b) that many
agents which elicit chronic inflammation also activate complement by
the alternative pathway to yieldC3b which is a potent macrophage activating
agent (Schorlemmer et al 1976). Activated macrophages in turn secrete
C3b, C3 and proteases which cleave C3 to C3b and C3a. Thus local
alternative pathway activation could initiate an "autostimulatory loop"
of C3b mediated macrophage activation. Such activation is non-
immunological since it is not T cell mediated. Another example of
non-immunological activation occurs when macrophages are activated by
agents in decomplemented serum or serum free conditions. In these
cases local direct activation of the alternative pathway cannot occur
so C3b from this source cannot be a contributory factor to activation.
There is however now evidence that agents which can activate under these
circumstances (e.g. zymosan, polyanions) can induce macrophages to
release C3b which then activates local macrophages to release C3b
resulting in a cascade of macrophage activation (Schorlemmer et al 1981).
Additionally it has been suggested that binding of some agents to the
macrophage membrane, such as lipopolysaccharide (LPS) or Corynebacterium
parvum (C. parvum) might cause an increase in turnover of membrane
phosphatidylinositol which could cause sufficient perturbation to
potentiate the membrane to further stimulation (Weir and Ogmundsdottir
1980; Ogmundsdottir and Weir 1980).
During inflammation due to an immunogenic agent macrophage activation
will also occur via lymphokine.
1.11.3 Asbestos and inflammation
The first suggestion that macrophage activation might play a role in
asbestos disease was the finding by Davies et al (197U) that treatment
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of macrophages in culture with chrysotile induced release of lysosomal
enzymes into the supernatant without cdll death. Such selective
release of lysosomal enzymes by macrophages is induced by a host of
other macrophage activating agents both immunological and non-immunological
for example, zymosan, dental plaque, streptococcal cell walls, immune
complexes, lymphokine and C3b (Davies and Allison 1976; Schorlemmer
et al 1981). Shortly after this demonstration of chrysotile induced
macrophage activation,Hamilton et al (1976) reported that intra-peritoneal
chrysotile and chrysotile treatment of peritoneal macrophages in vitro,
both caused increased release of the neutral protease plasminogen
activator. The neutral proteases are a group of inducible enzymes
whose substrates include the major connective tissue components and so
these enzymes may be particularly important in fibrosis and other
disorders where cells proliferate beyond their normal confines
necessitating remodelling of the connective tissue stroma. Apart from
plasminogen activator the neutral proteases include elastase, collagenase
and proteoglycan degrading enzyme (Davies and Bonney 1980) and it seems
possible that the neutral protease could be particularly important in
the chronic inflammation and fibrosis associated with asbestos exposure.
Plasminogen activator is an important macrophage secretion since as well
as being active in connective tissue destruction by activating collagenase,
it also mediates inflammatory processes such as complement activation
and the clotting and kinin cascades (Hamilton 1980). Release of
neutral proteases can be induced by a large number of macrophage
activating agents including thioglycollate, endotoxin, zymosan,
Concanavalin A, phorbol ester and lymphokine (Davies and Bonney 1980).
Wilson et al (1977) reported that asbestos could activate complement
directly via the alternative pathway when added to cell free, fresh
serum; complement cleavage products (probably C7a and C3a)
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with chemotactic activity for peripheral blood leukocytes, were also
generated. This placed asbestos alongside the other "alternative
complement pathway activating" inducers of inflammation discussed
above. The ability of asbestos to directly activate the alternative
pathway has now been amply confirmed (Hasselbacher 1979; Saint-Remy
and Cole 1 980) and all 5 UICC samples have been found to have this
potential. In addition Saint-Remy and Cole (1980) reported that
magnesium leached chrysotile still retained this activity suggesting
that chrysotile might reside for a long time in tissue and still retain
inflammation generating activity.
The complement system is intricately connected with the other
plasma-borne inflammation regulating pathways - the clotting, fibrinolytic
and kinin systems, to form a network of interrelated pathways of
inflammatory mediation which has been called a "tangled web" (Ryan and
Majno 1977). The activation of any of these systems leads to mobilisation
of the full inflammatory response. In this regard it is interesting
to note that Hamilton et al (1981) have lately shown the amphiboles to be
potent activators of Hagemann factor in serum which leads in the first
instance to initiation of the kinin cascade. The ability of the
amphiboles to activate Hagemann factor places them alongside other
negatively charged surfaces such as collagen, articular cartilage,
renal basement membrane, sodium urate crystals of gout, pyrophosphate
crystals of pseudo-gout, glass and kaolin, which also have this effect
(Spragg 197i*; Ryan and Majno 1977). The final product of the kinin
cascade is kinin (bradykinin) which is a highly potent inflammatory
mediator causing smooth muscle contraction, blood vessel dilatation and
increased vascular permeability. Other products of the kinin cascade
include:- plasmin, which activates the alternative pathway of complement
through its C3 cleaving activity; kallikrein,which is a chemoattractant
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and which, due to its Hagemann factor activating activity produces a kinin
activating "loop"; and plasminogen activator,with the multiple activities
discussed above. Hamilton et al (1981) also reported that amphiboles
could induce the clotting cascade although this is very likely a direct
consequence of their Hagemann factor activating potency.
Prostaglandins represent another group of important inflammatory
mediators which have been found to be produced in increased amounts
by macrophages treated with asbestos in vitro (Humes et al 1977;
Sirois et al 1980). Prostaglandins mediate inflanmation in a ccmplex
way (Zurier 197U) and while they are almost certainly important in
macrophage activation their exact role is not understood (Barlin et al
1981; Bonney et al 1981).
It is clear frcm the above studies in the cell biology of inflammation
and the effects of asbestos,that asbestos is capable of activating
the camplement/clotting/kinin/fibrinolytic system of plasma in a direct
way, possibly mainly through Hagemann factor activation. Asbestos is
also capable of generating inflammatory mediators through direct effects
and possibly indirect effects (via complement) on macrophages to
stimulate the release of lysosomal hydrolases, plasminogen activator
and prostaglandin. These experiments, mostly reported in the last 8
years, provide a cellular/molecular basis for the inflammatory generating
effects of asbestos which have been realised for many years.
Epithelial damage and inflammation
This discussion of asbestos and inflammation has been limited to
the effects of asbestos on the cellular and humoral inflammatory
mediators. It is however important to point out that direct epithelial
or endothelial damage by asbestos could result in exposure of basement
membrane and altered vascular permeability and thereby also lead to
inflammation (Pickrell 1981).
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1.11.1* Immune responses and macrophages
Macrophages are central cells in the functioning of the immune
system in both the sensory and effector arms of both humoral and cell
mediated immunity. The immune functions of macrophages will be reviewed
with particular reference to macrophage activation, in view of the
previously discussed evidence for the macrophage activating potential
of asbestos.
1.11.lw1 Antigen presentation
Macrophages take up antigen and process it through their vacuolar
system before re-expressing it on their surface membrane as highly
immunogenic fragments which are recognised by T and B lymphocytes
leading to initiation of immune responses (Pierce and Kapp 1978).
This presentation function of macrophages is an absolute requirement
for induction of T helper cells in vitro (Erb and Feldmann 1975) and
antigen presented in this way can be 1,000-10,000 times more immuno¬
genic than antigen in the soluble form (Mitchison 1969). Antigen is
displayed on the macrophage surface in association with la antigens
which are Ir gene products of the major histocompatibility complex.
Simultaneous display of la antigen has been found to be mandatory
for antigen presentation by macrophages for initiation of the following
immune responses:- presentation to B cells for antibody production
(Niederhuber et al 1979); antigen presentation to T cells for antigen
specific proliferation (Braendstrop et al 1979); generation of cyto¬
toxic T cells to syngeneic tumours (Woodward et al 1979). Requirement
for la expression results in genetic restriction with regard to T cell/
macrophage (Rosenthal and Shevach 1973) and B cell/macrophage (Howie and
Feldmann (1978) interaction for induction of immune responses. Ia phenotype
is not a stable characteristic in macrophages and reversal of la" to
Ia+ can be elicited by lymphokine treatment in vitro (Steinman et al
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1980). Ia expression seems to be a transient event, however, which,
once lost by mature macrophages cannot be regained (Beller and Unanue
1981).
A soluble factor released by macrophages which acts on a I cell sub-
population to amplify T helper induction has been found to be la bound
to a fragment of antigen (Erb and Feldmann 1976) and has been designated
Genetically Restricted Factor.
1.11.1*. 2 Macrophage secretion in immune response
Macrophages secrete a variety of immunomodulatory molecules which
have potential to both activate and inhibit lymphocyte function,
(i) Immunostimulatory activity The secretion of non-specific
lymphocyte stimulation factors are a major factor in the absolute
requirement for macrophages in lymphocyte proliferation in response to
antigens, mitogens and heterologous lymphocytes (Wing and Remington 1980).
The most studied lymphostimulatory molecule secreted by macrophages is
Lymphocyte Activating Factor (Gery et al 1972) also called Mitogenic
Protein (Unanue 1978a)and latterly Interleukin 1. Interleukin 1
(IL1) has potent stimulating activity for thymocytes and to a lesser
extent T and B cells (Unanue 1978b)and is generated in large amounts
when immune T cells, macrophages and antigen are co-cultured (Unanue
et al 1976). The fact that non-stimulated and peptone induced macro¬
phages release increased amounts of IL1 following phagocytosis, while
thioglycollate induced macrophages are very poor secretors following
phagocytosis (Unanue et al 1976), suggests that level of activation
exerts a very fine degree of control over"synthesis or secretion of
the molecule.
Macrophages also release a factor which induces thymocytes to
differentiate to the mature T cell phenotype (Beller et al 1978).
Macrophages can secrete activity which enhances B cell function in
-52-
mice (Calderon et al 1975); this activity causes differentiation
of antigen pulsed B cells into antibody producing cells and is T cell
independent (Hoffmann et al 1979). A polyclonal B cell activator
has also been reported to be released by rabbit macrophages. By
contrast this factor acts on T cells to release a soluble product
which induces polyclonal immunoglobulin synthesis by primed lymph node
lymphocytes (Waldrep and Reese 1981).
(ii) Suppressor activity
Macrophages also release molecules which have potential to inhibit
lymphocyte function. Allison (1978) lists 8 products of macrophages
which could non-specifically inhibit lymphocyte responses in vitro;
these are thymidine, arginase, polyamine oxidase, complement cleavage
products, prostaglandins, cAMP and interferon. Most of these substances
are present, or are released, in increased amounts by activated macro¬
phages and this goes some way to explaining the substantial literature
reporting inhibitory or suppressor effects of macrophages on lymphocytes
(reviewed by Nelson et al 1976). Evidence that suppression is increased
where macrophages are activated comes from graft versus host disease
(Sjoberg 1972), adjuvant stimulation (Idimpel and Henney 1978), infection
(Wadee and Rabson 1981) and tumour growth (Herberman et al 1980). A
typical example is found in the report of Warner et al (1981) that
resting peritoneal exudate macrophages were not appreciably suppressive
to PHA mitogenesis of lymphocytes while peptone induced macrophages were.
While suppression may be non-specific and mediated by well
characterised cell modulating factors originating from macrophages, such
as prostaglandin, it has also been shown that macrophage suppression
may be specifically mediated through the agency of soluble factor(s),
so far uncharacterised, which activate suppressor T cells (Wadee and
Rabson 1981). Xn contrast Holt et al (1981) using alveolar macrophages,
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have reported evidence for a T cell which responds to mitogen by
releasing a "suppressor signal" translated by adjacent activated macro¬
phages into a lymphostatic response.
It seems likely that functional heterogeneity particularly in
activation level within macrophage populations, could explain the
contradictions present in apparently opposing reports of macrophage
stimulatory and suppressor activity in vitro discussed above. Thus
Holt (1979) has reported functional heterogeneity in rat alveolar
macrophage populations where a weakly adherent population supported
lymphocyte function and a strongly adherent population suppressed it.
Similarly Nelson et al (1976) describes a dialysable inhibitor and a
non-dialysable potentiator of lymphocyte mitogenic response, in macro¬
phage supernatants. Differences in experimental technique can also
be important in these types of experiment, since ratio of macrophage
to lymphocytes (Pennline and Herscowitz 1981) and time in culture
before testing for lymphomodulatory activity (Wing and Remington 1980)
have both been shown to profoundly affect the expression of suppressor
activity by alveolar and peritoneal macrophages.
1.11.5 Experimental studies on asbestos and immune response
Experimental studies on the effects of asbestos on elements of the
immune response have been carried out mostly in animal models but
human cells have also been used.
1.11.5.1 Cell mediated immunity
Using rats Miller and Kagan (1976) were the first to emphasise
the possible effects of asbestos on the immunological role of the
alveolar macrophage and to present data suggesting that asbestos exposure
in vivo could result in macrophage activation. In early studies
altered characteristics of in vivo asbestos exposed macrophages were
reported including altered membrane morphology, increased Fc receptor
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activity and general activated appearance (Miller and Kagan 1976;
Miller et al 1978; Miller 1978); the non-toxic nature of crocidolite,
as reflected in the lack of obvious toxic effects on alveolar macro¬
phages from rats inhaling crocidolite, was emphasised, as well as the
immunological consequences (Miller 1980). Further studies into the
functional potential of asbestos activated alveolar macrophages from
rats inhaling crocidolite showed that such macrophages, when cultured
with lymphocytes, underwent a close physical interaction with the
lymphocytes followed by two separate kinds of lymphocyte proliferation,
one of which resembled antigen specific T cell proliferation (Miller
et al 1979; Miller and Kagan 1981). This and a previous finding of
increased complement mediated immune adherence to these macrophages
(Miller and Kagan 1977) was interpreted by the authors as evidence of
antigen specific T cell proliferation in response to a putative asbestos
related macrophage membrane neo-antigen recognised by sensitised T
cells present in dusted rats.
On the basis of their interpretation of these results, the
epidemiological data on immune disturbance in asbestotics and sporadic
reports of asbestos related lymphoproliferative neoplasms (Lieben)i 966;
Robinson et al 1979) Kagan and Miller have gone on to suggest a unifying
role for uncontrolled lymphocyte proliferation in response to asbestos
induced altered macrophage membrane antigenicity, in the pathogenesis
of asbestos related disease (Kagan 1980; Kagan and Miller 1981).
Using in vitro asbestos treatment of normal human peripheral
blood mononuclear cells (PBMC) Kagamimori et al (1980) reported that
chrysotile was not toxic to the lymphocyte fraction but toxic to the
monocyte fraction. Decreased PHA blastogenesis of the PBMC was therefore
attributed to loss of monocyte co-operation in PHA mitogenesis. The
fact that 2-mercapto-ethanol, which substitutes for macrophages in
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in vitro lymphocyte responses (Opitz et al 1978), did not appear to be
included in their culture fluid supports this explanation. Addition
of chrysotile directly into assays of macrophage mediated antibody
dependent cell mediated cytotoxicity against target Chang cells resulted
in inhibition of this function; as suggested by Kagamimori et al
this was probably due to mechanical interference with macrophage/
target interaction.
Rola-Plesczcynski et al (1981) used sheep which had been given
intratracheal dases of asbestos and found that unfractionated free
airway cells showed increased responsiveness to the mitogens Con A,
PHA, Pokeweed mitogen and staphylococcal lysate. The effect was in
general dose dependent from 1-16 mg of asbestos. The use of unseparated
bronchoalveolar cells present problems of interpretation as to the
origin of the stimulus for increased thymidine uptake since the mitogen
could act (i) directly in lymphocytes to stimulate them; (ii) on
macrophages to cause them to release IL1 which stimulates lymphocytes;
(iii) on a T cell sub-population to release macrophage activating
lymphokine causing macrophages to act as in (ii). Therefore, while
this study shows that there is something different about the free
airway cells from dusted sheep lungs compared to controls, it is not
clear exactly what the difference is. Further fractionation and
characterisation of the free airway cells is required to gain useful
information on pulmonary response.
1.11.5*2 Humoral immunity
Virtually no work has been carried out into the role of asbestos in
humoral immunity. The disturbance to humoral immunity in asbestotic3
which has been reviewed previously (1.6.2) is, in general, attributed
to disturbances of B cell immunoregulation mediated through altered
macrophages and T cells. In one study, however, attempts were made
-56-
to raise a rabbit anti-serum to asbestos and asbestos coated with BSA.
While the author obtained some qualitative evidence in support of the
presence of anti-BSA antibody in appropriate anti-serum, even qualitative
data in support of specific anti-asbestos activity was unconvincing
(Lukens 1978).
1.11.6 Experimental evidence for the role of the macrophage and
immune system in control of fibroblast proliferation
It is proposed to review the literature concerning cellular inter¬
action in fibrogenesis with particular reference to the macrophage;
this includes both non-immunological production of macrophage derived
factors and also production of such factors by immunocompetent cells
such as activated macrophages and lymphocytes.
While early workers in experimental pneumoconiosis emphasised the
cytotoxic effect of silica or asbestos on macrophages (Allison et al
1966) and even declared cell death to be mandatory for fibrogenesis
(Harington 197k) it is now clear that fibroblast accumulation and
increased division can occur in response to secretions from live cells.
Thus while factors may well be produced from killed macrophages
which stimulate fibroblasts in vitro (as discussed below) it remains to
be shown that cell death is a necessary prelude to fibrogenesis in vivo.
Early work showing that an in vitro macrophage cytotoxic particle
(quartz) could induce release of a diffusible factor which stimulated
fibroblasts to secrete hydroxy-proline was carried out by Heppleston
and Styles (1967). This active fraction was produced by treating
alveolar macrophages with quartz in vitro, disintegrating them, and
collecting the supernatant which was added to fibroblast cultures.
This effect of quartz was confirmed by others (see review by Heppleston
1982). Kulonen and co-workers have further characterised this quartz
induced fibroblast stimulating factor which apparently acts by inhibiting
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RN-ase, so allowing collagen protein specific RNA to persist and be
expressed as excess collagen synthesis (Kulonen et al 1980). While
much valuable information has been gained using this system, as mentioned
above, this approach may have limited relevance to the in vivo fibrogenesis
produced either solely by immunological phenomena (Boros 1981) or by
non-toxic (in vivo) particulates such as the amphiboles (Miller 1978).
There is however an accumulation of literature suggesting that fibroblast
stimulating factors are also released by lymphoreticular cells during
normal functioning.
The suggestion that living macrophages could be mandatory for
fibroblast proliferation came from Leibovich and Ross (1975) who
reported that guinea pigs depleted of macrophages with hydrocortisone
and anti-macrophage serum had diminished ability to repair wounds.
Leibovich and Danon (1980) carried out the converse of this experiment
and reported that topical application of the macrophage activating
agent glucan caused increased macrophage reaction to a wound and
resulted in increased fibroplasia. Leibovich and Ross (1976) also
reported that fibroblasts growing very slowly in vitro in medium
deficient in platelet derived growth factor (platelet poor plasma
serum - PPPS) could be stimulated to divide by the addition of super-
natants from macrophages cultured in PPPS. The stimulation of division
was greater than that produced by addition of appropriate amounts of
PPPS. It was particularly noticeable that macrophages killed by
freeze-thawing were only about one half as effective in producing
fibroblast stimulating activity and that macrophages induced with oil
produced slightly more activity than resting macrophages. Leibovich
(1978) further characterised this activity and reported two functionally
separate activities - one which caused fibroblasts to divide and another
which inhibited tritiated thymidine uptake. The complex nature of
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the activating phenomenon was revealed by the fact that only macro¬
phages cultured in PPPS released the fibroblast division stimulating
activity while macrophages cultured in PPPS, Foetal Calf Serum, blood
serum or bovine serum albumen all released increased amounts of the
tritiated thymidine uptake inhibiting activity.
The fact that monocytes are recruited into sites of acute inflammation
has prompted investigation into these cells as potential sources of
fibroblast stimulating activity. Thus De Lustro et al (1980) detected
fibroblast stimulating activity in supernatants from peripheral blood
monocytes. Glenn and Ross (1981), using platelet depleted plasma
derived serum, failed to detect release of fibroblast stimulating
activity from cultured monocytes$ however treatment with the potent
macrophage activating agents, endotoxin, Con A and zymosan could induce
substantial release of fibroblast stimulating activity. It was
interesting to note that phagocytosis of SRBC's, opsonized SRBC's,
latex beads, or treatment with muramyl dipeptide or n-formyl methionyl
peptide failed to induce release of the factor.
The growth factor described by Glenn and Ross also showed activity
against smooth muscle cells and is described by the authors as a
"mesenchymal cell mitogen". Stimulation of mesenchymal cell proliferation
has also been ascribed to a macrophage derived growth factor described
by Martin et al (1981)$ in this study peptone elicited macrophages,
following phagocytosis of latex, showed a greater than 6 fold increase
in-release of the growth factor while treatment with LPS and the tumour
promoter phorbol myristate acetate produced U and 3.5 fold increases
respectively. Wahl et al (198(h) has also reported large increases in
thymidine uptake and collagen protein secretion by fibroblasts treated
with supernatants from endotoxin activated macrophages.
It is clear frcm the above that normal macrophages and monocytes
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can be found to be releasing fibroblast stimulating activity and that
activation can cause a considerable increase in this release. Thus
during cell mediated immune responses, activation of macrophages at
sites where T lymphocytes are secreting lymphokine (MAF) could lead
to release of fibroblast activating factors; in confirmation of this
are reports that lymphokine synthesis can be detected in
immunological granulomas (Boros 1981). It is, however, also apparent
that non-immunological activation, e.g. latex phagocytosis and zymosan,
can cause increased release of fibroblast stimulating factor(s).
While the macrophage can be seen as the effector of fibroblast
proliferation in response to immunological stimuli, lymphocytes
themselves have also been reported to release fibroblast modulating
activity. Postlethwaite et al (1976) showed that lymphokine generated
in response to antigen or mitogen were chemotactic for fibroblasts while
Johnson and Ziff (1976) reported that lymphokine added to fibroblast
initiated cell division and collagen production. This was confirmed
by Wahl et al (1980b) who reported that antigen specific T cell proliferation
generated factor(s) which increased tritiated thymidine uptake by
fibroblasts.
The cell mediated immunity to collagen found in some fibrotic lung
disease (Kravis et al 1976) would appear to be the ideal condition
for persistent lymphokine generation by sensitised T cells and persistent
macrophage activation by the lymphokine produced by these T cells;
both lymphokine and monokine could combine to produce local concentrations
of potent fibroblast stimulating activity. Support for this sequence
in some types of pulmonary fibrosis comes, in part, from a study on
the functional state of alveolar macrophages obtained by lavage from
patients with a variety of inflammatory lung conditions including
idiopathic pulmonary fibrosis and sarcoidosis (Allen and Doe 1981).
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In this small study the macrophages from the lungs of such patients
were highly activated by the criteria of lysosomal enzyme secretion,
plasminogen activator release, f>' nucleotidase levels and phagocytosis,
compared to controls; activation indices decreased with anti-inflammatory
steroid treatment.
Further evidence for immunoregulation of fibroblast activity comes
from studies into the disease Progressive Systemic Sclerosis (PSS),
a connective tissue disorder typified by widespread fibrosis, auto-immunity
and the presence of T lymphocytes sensitised to collagen, amongst other
endogenous substances. Using a crossed one way mixed lymphocyte
culture of peripheral blood mononuclears from PSS patients and normal
subjectSjCathcart and Krakauer (1980) reported a large increase in
fibroblast stimulating lymphokine in the supernatants where PSS patients
were the responders compared to cultures where normal lymphocytes were
the responders. This increased activity was manifest as a 6 times
increase in hydroxyproline incorporation in the targets and it was
interesting to note that supernatants obtained from cultures where
both PSS and normals were the responders had equal amounts of factor
which stimulated fibroblast proliferation as measured by thymidine
uptake. Thus activated lymphocytes from PSS patients produced lympho¬
kine which caused fibroblasts to produce more collagen in the absence
of fibroblast proliferation.
The above mentioned macrophage and lymphocyte derived factors
which stimulate fibroblasts are largely uncharacterised but there are
well characterised endogenous mitogenic agents - the proteases.
Considerable evidence now exists that proteases can stimulate cell
division and differentiation in a variety of cells (review by James
1980). Fibroblasts, in particular, have been shown to be capable of
stimulation to divide and lose contact inhibition, by treatment with
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low doses of protease (Burger 1970; Noonan 1976). Rokosova and
Bentley (1980) have reported increased division of fibroblasts following
treatment with macrophage lysosomal enzymes at lew concentration and
in view of the above mentioned association between macrophage activation
and protease secretion this finding may be of particular relevance.
1.11.7 Experimental evidence that asbestos can affect fibroblast
growth via lymphoreticular cells
The evidence that asbestos can cause macrophages to release fibro¬
blast stimulating activity is mostly indirect and concerns evidence,
reviewed above, that asbestos can activate macrophages. Similarly,
the evidence that asbestos inhalation results in cell mediated immune
responses in the lung, and thereby accumulation of fibroblast activating
lymphokine, is circumstantial.
Macrophages Allison et al (1977) and Bateman et al (1980) used diffusion
chambers to enclose asbestos alone, or asbestos plus macrophages, behind
a membrane which only allowed molecules smaller than the pore size
of the enclosing membrane to pass out. On implantation in animals
both of these studies revealed increased fibrosis around the chamber in
the case of asbestos plus macrophages than with either asbestos or
macrophages alone; this suggested that interaction between asbestos
and macrophages led to release of a diffusible fibroblast stimulating
factor. Recently, however, more direct information has been published
(Bitterman et al 1981) in abstract showing that guinea pig alveolar
macrophages treated with chrysotile for U hours in the presence of serum
(a time course unlikely to result in cell death in the presence of serum)
released fibroblast stimulating activity into the supernatant. Super-
natants from control untreated alveolar macrophages had no effect on
fibroblast proliferation but no phagocytosis controls were reported.
Lymphocytes The only indirect evidence that lymphokine, possibly
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capable of stimulating fibroblast growth as found by Postlethwaite
et al (1976), might be present in the lungs of individuals exposed
to asbestos has come from the work of Miller et al (1979). Alveolar
macrophage activation was present and the release of immunomodulatory
molecules by activated macrophages, as discussed above, could lead to
lymphokine generation. The studies of Miller did not, however,
involve studying lung lymphocytes or lung lymph node associated
lymphocytes for lymphokine production. Based on their studies
Miller (l980) suggested that splenic T cells from dusted animals were
sensitized to asbestos related membrane neo-antigens in alveolar macro¬
phages exposed to asbestos and that these sensitized lymphocytes
underwent antigen specific T cell proliferation on encountering the
neo-antigen bearing macrophages. If this occurs in the lungs of
asbestos exposed individuals then the fibroblast stimulating activity
described by Wahl et al (1980b), in supernatants from cultures of antigen
specific T cell proliferation, could be released. 1
1.12 Effects of macrophages on the growth of tumour cells
The cell modulating effects of asbestos so far described have
concerned enhancement and suppression of normal cells, i.e. lymphocytes
and mesenchymal cells; however macrophages can, tinder certain conditions,
also kill, inhibit or promote the growth of tumour cells. As pointed out
by Keller (1981) there has been a marked emphasis on the inhibiting
effects of macrophages in tumour cells due, no doubt, to the currency
during the seventies of the "Theory of Immunosurveillance" concerning
host defence against tumours (Pitot 1978). In this model, macrophages
and certain other cells are envisaged as recognising new clones of
transformed cells in tissue and killing them (Adams and Snyderman 1979).
The growth promoting effects of macrophages on tumour cells have received
little attention (Keller 1981).
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1.12.1 Inhibitory effects
The evidence that macrophages can inhibit tumour cells has cane
from both in vivo and in vitro studies. The in vivo evidence has been
listed as:- (i) macrophages constitute a significant proportion of
cells in tumours undergoing rejection; (ii) agents that depress or
deplete macrophages prolong tumour survival; (iii) agents that stimulate
macrophage function promote tumour destruction; (iv) macrophages
are obligatory for the destruction of some tumours (Adams and Snyderman
1979).
The in vitro evidence that macrophages can kill tumour cells is
now overwhelming and has been extensively reviewed (for example Fink 1976;
James et al 1977; Keller 1981). A low level of spontaneous cyto¬
toxicity is evident in resting unstimulated macrophages from mice
(Pels and den Otter 1979) and in rats (Keller 1978); activation of
macrophages however, results in a dramatic increase in their cytostatic
s
and cytocidal capability against tumour cells. This activation can be
induced in vivo by injection of immune adjuvants such as Freunds, or
bacterial endotoxin, by injection of heat killed bacteria such as
Corynebacterium parvum or Bacille Calmette Guerin and by infection with
protozoa such as Toxoplasma gondii. A similar activation is achieved
in vitro by exposure of macrophages to lymphokine (Piessens et al 1975).
Lymphokine containing the active principal (Macrophage Activating Factor)Kniep
et al 1981) is generated by sensitized lymphocytes on exposure to
antigen (David et al 1976), in mixed lymphocyte culture (Dimitriou et al 1975)
and by lymphocyte mitogenesis (Mantovani et al 1980). Other arbiters
of the immune response such as immunoglobulin (as aggregates and complexes)
(Evans and Alexander 1976) and complement components (Ferluga et al
1978) can also activate macrophages to non-specific tumour cell cyto¬
toxicity.
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A rather heterologous group of non-immunological agents including
double standard RNA, endotoxin, pyran co-polymer, Concanavalin A and
streptococcal cell walls can activate macrophages in a lymphocyte
independent manner; sane of these are thought to act via the C3b
autostimulatory loop (Ferluga et al 1978; Schorlemmer et al 1981)
and/or interferon induction (Schultz et al 1977).
Macrophages obtained by all such means are non-specificaily tumour
cell cytotoxic and exhibit toxicity against a range of tumour cell
targets (Keller 1976).
The attainment of the non-specific tumouricidal state has been found
not to be an all or none event but apparently requires a sequence of
differentiation signals inducing stepwise expression of properties which
may culminate in expression of the fully tumouricidal/microbicidal
phenotype (Cohn 1978). Evidence for this comes from the work of
Russell et al (1977) and Hibbs et al (1980) who identified h activational
states, presumably representing a continuum, using inflammatory eliciting
agents, lymphokine and LPS responsiveness. It can be assumed that
local environmental signals generated by the immune and inflammatory
systems directly or indirectly modulate the activational state and
tumouricidal function of macrophages in in vivo (Meltzer et al 1979).
In addition to non-specific tumour cell cytotoxic activation of
macrophages, specific "arming" of macrophages against particular tumour
cell lines has also been reported (Evans and Alexander 1976). Arming
requires that lymphocytes, sensitized to tumour cells, interact with
normal macrophages; specific growth inhibition of the immunizing
tumour cells then occurs on incubation of the armed macrophages with
the specific targets with no anti-tumour activity shown against irrelevant
tumour lines (Evans and Alexander 1972). A non-lymphokine Specific
Macrophage Arming Factor could be detected in the supernatant of co-
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cultures of tumour cells, macrophages and tumour antigen inmune lymphocytes;
specific anti-tumour activity was conferred on control macrophages by
treatment with this factor which the authors postulated was a T lympho¬
cyte derived cytophilic antibody-like molecule (Evans et al 1972).
The sequence of biochemical events leading to macrophage killing
of tumour cells are not well understood but for full tumouricidal
function both binding to target cells and release of cytotoxic agents
have been seen as obligatory (Adams et al 1981) although there have
been reports of tumour cell killing mediated by soluble products of
activated macrophages (Sharma et al 1980). In the case of cytostasis
both cell contact and diffusible macrophage products have been reported
as inhibitory to tumour cell proliferation (Keller 1981). Undoubtedly,
when tumour cells and cytotoxically activated macrophages are co-cultured
they undergo close physical interaction (Hanna et al 1976) and suggestions
as to the nature of the cytocidal effector molecules include transferred
lysosomal contents (particularly proteases ) (Hibbs 19710, complement
components (principally C3a) (Ferluga et al 1978), hydrogen peroxide
(Nathan and Cohn 1981) and arginase (Farran and Nelson 1980). The
variation in response of different target tumour cell lines to the
same cytotoxically activated macrophages (Hibbs and Granger 1981;
Keller 1981) and the heterogeneity in macrophage phenotype in any
population, make it possible that several, or all, of these mechanisms
could apply depending on the exact nature of the participating cells.
There are no published studies on the effects of asbestos on the
tumouricidal function of macrophages.
1.12.2 Growth promoting effects
While the anti-tumour function of macrophages is more frequently
described, there is also evidence that macrophages can enhance the
growth of neoplastic cells in vivo and in vitro and that the activational
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state of the macrophages could be a major factor in determining which
effector capacity is expressed (Keller 1977).
By studying the kinetics of host cell infiltrate into experimental
tumours Evans (1979) postulated that the presence of host cells, including
macrophages, were mandatory for tumour growth. Evans (1976) also demon¬
strated that tumour cells growing in depleted culture medium to reduce
their proliferation increased their rate of proliferation when tumour
derived macrophage supernatant was added and that this increase was
greater than that produced by adding the same volume of new medium.
Keller (1975, 1978) using in vitro assays has shown that, depending
on the tumour cell target, either inhibition or enhancement of prolif¬
eration can be produced by incubation with macrophages. In vivo
derived evidence that macrophages can, under some circumstances, enhance
tumour growth comes from occasional reports of tumour growth enhancement
in animals treated with well documented macrophage activating agents
such as C. parvum (Peters et al 1978) and BCG (Piessens et al 1970).
Using Winn assays Gabison and Trainin (1980) found that thioglycollate
induced macrophages and freshly excised chemically induced fibrosarcoma
cells, at a ratio of U0:1, produced tumours in a significantly shorter
time than the appropriate number of tumour cells alone; the final
incidence of tumours was the same.
The concept that macrophage derived growth factors, which enhance
tumour cell proliferation might have a role in two stage carcinogenesis
has been propounded by Salmon and Hamburger (1978). These workers
reported that treatment of mice with oil "promoter" resulted in splenic
macrophages which released factor(s) promoting tumour cell growth and
colony formation in soft agar. This work was extended by Currie (1981 )
who used FS6 tumour cells which are platelet derived growth factor
(PDGF) dependent for normal proliferation and which do not form colonies
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in soft agar. Currie found that FS6 tumour derived macrophage super¬
natant could replace PDGF for FS6 cell proliferation and that presence
of the supernatant also induced FS6 cells to form colonies in soft
agar. It was notable that proteose peptone elicited macrophages were
as effective in bringing about these effects as FS6 tumour derived
macrophages and that the tumour promoter 12-tetradecanoyl-phorbol-13
acetate, present in the anchorage independent growth assay, could
induce colony formation in soft agar by FS6 tumour cells. These
experiments are of interest when taken with the findings of Frantz
et al (1979) who reported that fibroblasts were more responsive to
the proliferation enhancing effects of growth factor following treatment
with phorbol ester promoter.
The conclusion that can be drawn from these studies is that macro¬
phages could be responsible for the growth of sane tumours in vivo
through the secretion of growth factor-like molecules and that macro¬
phages could be involved as promoters, via the same molecules, in two
stage carcinogenesis. There is evidence that phorbol ester tumour
promoters can induce some degree of macrophage activation as measured
by spreading and phagocytosis (phaire-Washington et al 1980; Laskin et al
1980) but that they can block lymphokine mediated activation to the
tumouricidal state in vitro (Keller et al 1982). It is tempting on
the basis of these results to postulate that tumour promoters could
operate at (at least) two levels in bringing about promotion;-
(a) macrophages are activated by the promoter sufficiently to release
increased amounts of the endogenous macrophage derived growth factor
but with blockage of the capacity to become tumouricidally activated;
(b) fibroblasts are affected by the promoter to proliferate excessively
in response to the macrophage derived growth factors.
The proven tumour promoting effects of asbestos described earlier
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and the obvious fibroblast stimulating effects of asbestos manifest in
fibrosis, make these findings of particular relevance in asbestos
related neoplasia.
1.13 Central role of the macrophage membrane
1.13.1 Cell membrane structure
Up until the early nineteen-sixties the cell membrane was envisaged
as a rather rigid tri-laminar sheath which functioned mainly as a semi¬
permeable barrier to the extra-cellular environment. On the basis of
evolving evidence as to the fluidity of biological membranes and the
lateral movement (translational mobility) of membrane proteins Singer
and Nicolson (1972) advanced the "fluid mosaic" model of membrane
structure. The concept of membrane fluidity and its consequences
have been a major force in cell biology and has led directly to the
current concept of the cell membrane as a dynamic entity functioning
as the principal sensor and effector organelle in cellular control
of growth, division, development, communication, differentiation and
death (Nicolson 1976). The implications of the fluid mosaic model
have been extensively reviewed elsewhere with regard to cells in general
(Nicolson 1976a)and with regard to macrophages in particular (Oliver
and Berlin 1976). A major tenet of this model is that sane of the
integral membrane proteins span a membrane lipid bi-layer with a fluidity
similar to light machine oil (Nicolson 1976). These trans-membrane
glycoproteins have carbohydrate containing moieties displayed at the
outer face which may function as specific receptors by virtue of their
chemistry and three dimensional shape while at the inner face the protein
has the capacity to interact with the contractile proteins of the
cytoskeleton (Nicolson and Poste 1976). When this occurs the integral
protein may have its free diffusion in the fluid bi-layer affected and
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be immobilised, or it may be redistributed in the plane of the membrane
in an energy dependent way.
The macrophage, in view of its central position in the immune
system and inflammatory system and its endocytic activity, might be
predicted to have a particularly highly evolved cell membrane in order
to fulfil its multiple functions and indeed the macrophage has been
found to have a large complement of receptors and specialised membrane
functions.
1.13.2 Phagocytosis
Phagocytosis is a major membrane related process which is carried
out by only a few cells and is a particular function of macrophages.
Phagocytosis is a complex process involving uptake of a particle following
non-specific or specific (receptor mediated) interaction between the
particle and the macrophage membrane; this results in local mobilisation
of cytoskeletal elements leading to internalization of the particle into
a phagosome "pinched off" from the cell membrane. Phagocytosis is an
important function of macrophages and is carried out at sites of
inflammation where bacteria and cell debris are removed leading to
resolution of the inflammatory focus.
Phagocytosis can be seen as a particularly important function of
alveolar macrophages since the lung is constantly challenged with organic
and inorganic particulates, although a large proportion of this inhaled
dust is cleared by the mucociliary escalator, never reaching the alveolar
macrophages.
Phagocytosis can be Fc or C3 receptor mediated via immunoglobulin
or complement opsonins on the surface of the particles (Michl and
Silverstein 1978). Phagocytosis can also be mediated by non-specific
receptors for particles such as latex beads, silica or asbestos, which
are readily ingested; in these cases phagocytosis is thought to be
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mediated by adhesion forces, between the particle and the macrophage
membrane glycoproteins, such as electrostatic forces, van der Waal's
forces and co-valent bonding (Jones 1975). Once initiated phagocytosis
proceeds, in keeping with the "zipper" model, by the membrane interacting
sequentially with ligands on the particle surface until the particle
is eventually surrounded by membrane and is effectively internalized
(Griffin et al 1975a). While the exact nature of the transmembrane
signal following contact between the particle and the membrane, which
initiates the cytoskeletal mobilisation associated with phagocytosis,
is not understood, a general model has been put forward (Michl and
Silverstein 1978). In this model interaction between the particle
and the membrane receptor results in activation of a "receptor coupling
factor" which combines with the cytoskeletal contractile proteins
leading to pseudopodal extension and phagocytosis. It is notable that
whether the particle attaches via a specific receptor or non-specifically
interacts with the membrane the final pathway of cytoskeletal mobil¬
isation, leading to phagocytosis, is the same.
There is evidence with regard to phagocytosis that the macrophage
membrane is a mosaic with specialised membrane domains which selectively
internalize and discriminate for certain particles via receptor mediated
recognition (Griffin and Silverstein 197U); there is also evidence
that specialised "transport" areas of the membrane are never internalized
at phagocytosis but are selectively excluded (Tsan and Berlin 1971).
1.13.3 Macrophage membrane receptors
1.13.3.1 Non-specific receptors
Macrophages bind a variety of particles via different non-specific
binding mechanisms as shown in the study of Benoliel et al (1980),
who altered the degree of binding of various particles by altering
the physicochemical conditions of binding; this study also revealed
that binding in some cases triggered phagocytosis and in some cases did
not. There is also evidence that lectin-like receptors are present
in macrophage membranes which play a role in recognising micro-organisms
and binding them via their cell wall carbohydrates prior to phagocytosis
(Weir and Ogmundsdottir 1977); it is suggested by these authors that
this represents an evolutionary primitive recognition system predating
the immune system and specific opsonization.
Lectins are plant proteins with high specific binding activity
for certain sugar groups and they have been used extensively to study
the cell surface oligosaccharides which comprise the carbohydrate
moiety of the integral and peripheral membrane glycoproteins. Lectins
have been used as probes to study different aspects of membrane structure
and function (Nicolson 1976b)as well as tools to induce transmembrane
signals such as mitogenesis (see for example Oppenheim and Rosenstreich
T976). Several lectins have been used as probes of macrophage membrane
including Concanavalin A (Oliver and Berlin 1976); Lotus tetragonolobus
lectin (Homma et al 1981); wheat germ agglutinin (Hadley et al 1977);
Phytohaemagglutinin and Pokeweed mitogen (Loor and Roelants 197U).
The Concanavalin A receptor which recognizes «Dglycosyl residues has
been particularly used in studies on macrophages with regard to the
effect of spreading and phagocytosis (Lutton 1973), ligand induced
capping (Williams et al 1979) and transmembrane organization (Adachi
et al 1980).
As well as possessing these non-specific receptors macrophages
also possess specific membrane receptors for key molecules.
1.13.3.2 Fc receptor
The macrophage receptor for the Fc portion of immunoglobulin is
important in the immune phagocytosis of opsonized particles and immune
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complexes. Receptors displaying Ig class and subclass specificity
have been described. Mouse macrophages possess a trypsin sensitive
receptor for aggregated or monomeric IgG2a and a tryspin insensitive
receptor for IgG1 and IgG2 in monomeric or aggregated farm (Zuckerman
and Douglas 1979). Although rats have been described as having an
IgE receptor (Boltz-Nitelescu and Spiegelberg 1981) this has not been
t
described in mouse macrophages. The rabbit alveolar macrophage has been
calculated to have 10^ receptors for IgG in the resting state and
2x10^ in the activated state (Arend and Mannik 1973). Increased
numbers of Fc receptors, as measured by rosetting techniques, have
also been described in activated peritoneal macrophages compared to
resting peritoneal macrophages (Rhodes 1975). As well as having a
role in recognizing opsonized particles the macrophage Fc receptor
can also mediate target cell cytolysis and may also aid in lymphocyte
macrophage interactions (Zuckerman and Douglas 1979).
1.13.3.3 C3 receptor
Macrophages possess two classes of receptor which recognize C3
cleavage fragments;- type CR1 which recognizes C3b, Cl;b and C5b
components and CR3 receptors which react with C3b1 (Ross 1981). C3
and Fc receptors apparently act in a co-operative manner to mediate
immune phagocytosis of opsonized particles since less antibody is
required for internalization in the presence of complement (Griffin
et al 1975b). Conversely, studies with mouse peritoneal macrophages
have revealed that in resting macrophages the C3 receptor mediates
binding but not phagocytosis of a C3 opsonized particle; addition of
a small amount of specific Ig then results in ingestion (Mantovani et al




Macrophages possess a trypsin sensitive receptor for migration
inhibition factor (David and Remold 1976).
1.13.3.5 Chemotactic factor receptor
Macrophages possess a specific membrane receptor for the synthetic
chemotactic agent f.Met-Leu-Phe; the numbers of these receptors are
not increased in inflammatory (activated ) macrophages (Snyderman and
Fudman 1980).
1.13.3.6 Receptor mediated endocytosis
A number of physiologically important molecules are internalized
by the process of receptor mediated endocytosis including <*-2 macroglobulin,
lysosomal enzymes, low density lipoprotein, transcobalamin and hormones
such as epidermal growth factor (Stahl et al 1980). Receptor mediated
endocytosis involves binding of molecules to specific receptors which
are aggregated in specialized membrane areas called coated pits;
following internalization of these areas as coated vesicles the receptors
may be re-cycled to the membrane (Goldstein et al 1979).
1.13.1; Macrophage membrane associated cytoskeletal components
Cytoskeletal components which are associated with the macrophage
membrane integral glycoproteins have been shown to be organised, at
areas of macrophage attachment to the substratum, as a web of micro¬
filaments adjacent to the plasma membrane while next to this area a
zone of microtubules which occasionally extended into the body of the
cell; the same pattern was seen in regions of membrane in contact with
phagocytosable particles (Reaven and Axline 1973). Evidence that these
cytoskeletal conponents are indeed important in macrophage membrane
related functions, as predicted from the fluid mosaic model, ccmes from
the use of cy-toskeleton disrupting drugs; these have been found to
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affect locomotion and spreading (Cheung et al 1978); chemotaxis
(Rinehart and Boulivare 1977); pinocytosis and phagocytosis (Axline
and Reaven 197ii); Fc receptor function (Atkinson and Parker 1977)
and lectin receptor mobility (Pick and Wilner 1979).
1.13.5 Membrane fusion
A particular property of macrophage membranes is that macrophages
can fuse together to form multi-nucleate giant cells or macrophage
polykarya under particular conditions. This occurs at inflammatory
sites such as granulomas due to chronic infection by bacteria, fungal
pathogens, viruses and at sites of foreign body implantation (papadimitriou
and Walters 1979). Immunological factors appear to play a role in
membrane fusion as shown by the findings that lymphokine from antigen
stimulated sensitized lymph node cells (Galindo et al 197U) and lung
washings from animals undergoing immune response to BCG (Parks and
Weiser 1975) are able to promote macrophage fusion. Of particular
interest here are reports of multinucleate giant cell formation in
response to asbestos (Davis 1970b; Sethi et al 1971; Miller 1978).
The foregoing introduction has been aimed at reviewing evidence for
a causal relationship between asbestos exposure and lung disease.
Experimental evidence that asbestos can directly affect relevant target
cells has also been reviewed but emphasis has been placed on the possible
key role of the macrophage due to its position in dealing with inhaled
particles and its multiple effector functions. In reviewing evidence for
the importance of macrophage activation and the central role of the macro¬
phage membrane in macrophage responses, it is hoped that a study of the
effects of asbestos on macrophage activation, with special reference to
the membrane, is therefore justified.
AIMS AND SCOPE 0 F THE STUDY
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Aims and scope of the study
The foregoing literature review has shown that from the middle
1970's there has been a small number of publications with emphasis
away from the lethal effects of asbestos on macrophages; previous
studies of asbestos/macrophage interaction had concentrated almost
exclusively on the ability of asbestos to kill macrophages. The
general aim of this present study, begun in 1979, was to confirm and
extend these studies of Hamilton et al (1976) and Miller (review 1978) which
first emphasised the non-toxic effects of asbestos in vivo and the
possible consequences of asbestos induced modulation of macrophage
function in the aetiology of asbestos related disease.
An intraperitoneal asbestos injection model in CBA/Ca mice was
chosen and parameters of the induced macrophage population were studied
with appropriate controls.
The aims of the study were, in the first instance -
(a) to determine whether ip asbestos injection resulted in the induction
into the peritoneal cavity of a macrophage population altered in
ways suggestive of macrophage activation,
(b) to determine whether activation to the fully activated tumoricidal
state was attained.
Following on from these initial studies which revealed the
asbestos induced macrophages to be activated but not tumoricidally
activated in an in vitro assay, the study then proceeded along three
separate lines.
(a) an examination of the possible consequences of asbestos induced
macrophage activation for tumour growth in vivo and in vitro and
for immune response in vitro as measured by lymphocyte mitogenesis.
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(b) the use of the lectin Concanavalin A as a probe to study asbestos/
macrophage interaction and their consequences for macrophage
membrane.
(c) an investigation into the possible expression of a membrane neo-
antigen in asbestos activated peritoneal macrophages and its
possible consequences in terms of autoimmune humoral response.
Separately from the main macrophage study the biology of tumours
derived from the peritoneal cavity of long term asbestos bearing mice
was studied to a limited degree.
Through these studies it was hoped to confirm the macrophage
activating potential of asbestos for peritoneal macrophages. It was
also hoped to gain some information on the possible consequences of
such activation for systems in which macrophages are important factors,
i.e. tumour growth and lymphocyte function, and which are relevant to




Choice of a model for studying the effects of asbestos on macrophages.
The principal aim of this study was to examine the effects of asbestos on
macrophages with special reference to changes induced in the cell membrane.
There are several strategies which can be adopted in such a study:-
1. Macrophages can be cultivated, asbestos added and the effects
measured.
2. experimental animals can be exposed to clouds of airborne
asbestos by inhalation; the alveolar macrophages can then be
harvested and studied.
3. experimental animals can have asbestos in solution instilled,
via the trachea, into the lungs; the induced macrophages can
then be harvested and studied.
U. asbestos can be introduced into the peritoneal cavity of
experimental aminals and the induced macrophages harvested and
studied.
Strategy 1 carries with it all the drawbacks present in studies where
cells are treated am vitro with an agent and the effects measured. This
problem is particularly severe with macrophages which are intimately
involved in the major body defence system, i.e. the inflammatory and
immune systems. It is perilous therefore to make generalisations from
such studies with regard to the effect of an agent on macrophages
deprived of the multitude of cellular and humoral factors with which they
interact in vivo. Strategy 2 is technically and financially beyond the
means of this study but is the ideal strategy. Strategy 3 requires the
use of rats if non-surgical intratracheal instillation of asbestos is to
be carried out. In mice there is a surgical procedure but it carries with
it the risk of infection. Strategy U was adopted in this study for the
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following reasons.
(1) the peritoneal macrophages encounter asbestos in the body
where the normal cell and tissue interactive processes can occur.
(2) in particular the process of cell recruitment, replacement
and turnover are operative, thus cells recruited into the peritoneal
cavity as part of the overall response will also be harvested and studied.
(3) administration to mice by intraperitoneal injection is simple
and straightforward for one person as is harvesting of the peritoneal
macrophage population.
The major drawback of this model is the well documented difference
between peritoneal and alveolar macrophages with regard to some properties
(see later). There are, however, many similarities in structure and
function and both are derived from monocytes.
2.1.1 Choice of asbestos types
Asbestos can be divided, on the basis of mineralogical differences,
into two distinct types (see previous), (a) serpentine (b) amphibole.
Chrysotile is the only serpentine asbestos type and so this was used in
the study; chrysotile is also the major industrially utilised asbestos
type. There are 5 amphibole types with crocidolite as the most
industrially important and so crocidolite was also used. In both cases
the standard UICC samples were used as these have been prepared to enable
cross-laboratory comparison of studies on asbestos. Fig. 2.1 shows the light
and electron microscopic appearance of the UICC samples of crocidolite and
chrysotile with the latex control particulate for comparison.
2.1.2 Choice of asbestos dose
The choice of a dose for injection into the mouse peritoneum was
based on the study by Wirth (197?) who injected UICC asbestos intra-
peritoneally into mice. Wirth injected 5 mg of asbestos and reported
-78a-
UICC chrysotile (middle) and 0.81
diameter latex by scanning electron
microscopy and high power light
microscopy.
Marker line U ^um
Inset Mag. x 8U0
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fibrotic nodules and a mesothelioma-like tumour developing within 12
months. This dose was therefore used in some early experiments and
macrophage activation was found; the dose was arbitrarily halved and
macrophage activation was still present so this dose of 2.5 mg was used
thereafter. As discussed later a dose of 2.9 mg in the CBA/Ca mice used
in this study, proved to be capable of inducing a fibrotic and carcinogenic
response.
2.1.3 Choice of controls
Throughout this study three controls have been used -
(a) Dulbecco A Since asbestos was, of necessity, injected into the
peritoneal cavity as a solution in sterile Dulbecco A, then sterile Dul A
alone was included as a control.
(b) Latex spheres The lung is exposed continuously to inhaled
particulates from the environment and the alveolar macrophages constantly
phagocytose these particles; the majority of these particles are non-
fibrous being of vegetable origin (pollen etc.) or amorphous dust. As a
control for any effects on the peritoneal macrophage of a sudden challenge
of phagocytosable particles in the peritoneal cavity, spherical, non-toxic
latex particles were utilised.
(c) Corynebacterium parvum (C. parvum) The preliminary work in this
study indicated that the macrophages induced by intraperitoneal injection
of asbestos were activated in some way. C. parvum is a well documented
macrophage activating agent in vivo and so 5 day £. parvum induced
macrophages were often included as a positively activated macrophage
population for comparison with the asbestos activated macrophages.
2.2 Mice
CBA/Ca male mice, originally obtained from the MRC Breeding Unit
Carshalton and inbred at the Department of Surgery, University of Edinburgh
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and 12-16 weeks old at the time of injection were used throughout this
study. They were housed, before and after treatment, in plastic cages
with wood shaving bedding. They were fed laboratory mouse diet (McGregor)
and tap water ad libitum. The animal house was conventionally ventilated
and illuminated on a 10 hour photoperiod at an average temperature of 22°C.
2.3 Intraperitoneal (ip) injection
For ip injection the UICC asbestos samples were prepared at 2.3 nig/
0.3 ml in sterile Dul A and shaken vigourously prior to injection; latex
(1$) (Bacto-latex 0.81 ^tm diameter Difco) was made up in sterile Dul A;
sterile Dul A was also used. Animals were injected with 0.3 ml in the
mid-peritoneal cavity beneath the line of the liver and above the bladder.
Mice therefore received (i) 0.3 ml Dul A/2.3 mg UICC crocidolite or
chrysotile; (ii) 0.3 ml Dul A/1^ latex spheres; (iii) 0.3 ml Dul A.
In experiments where C. parvum activated macrophages were required 0.2 ml
(l.li mg) of heat killed C. parvum (Wellcome) were injected.
Deaths in the few days following injection and presumed to be due to
mis-injection were very rare.
2.U Harvesting of peritoneal exudate cells (PEC)
When required, mice were killed by ether overdose and the PEC harvested.
Three consecutive 2 ml volumes of cold sterile RPMI 16U0 containing 10 U/ml
Heparin (Pularin) were injected. After each injection the cavity was
massaged gently before withdrawing the fluid; invariably 3 ml of fluid
plus PEC were retrieved in total from each mouse. - The peritoneal
washouts from separate mice, containing the macrophages to be studied, were
at all times held in separate 10 ml glass conical tubes which were
siliconised with 2 coats of Sigmacote (Sigma). Where large numbers of
mice were to be harvested, and the PEC could be pooled, the peritoneal
washout fluids were collected in siliconised glass universals.
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PBC were then centrifuged and washed 3 times with Dulbecco A before
being brought into 1-3 ml volumes of complete RPMI 16U0 (cRPMI) (RPMI 16U0)
(Gibco) containing 10$ Foetal Calf Serum (Gibco); 1 mM L-glutamine; 30 U/ml
penicillin and streptomycin (Gibco) and 23 mM Hepes buffer. PEC were then
counted by suitable dilutions in a 0.03$ solution of Nigrosin dye in a
haemocytometer; viability as shown by dye exclusion was always >90$.
PEC were then diluted appropriately in cRPMI for subsequent use in assays.
2.3 Effect of ip asbestos on sane properties of the induced macrophage
population in the short, medium and long term
2.3.1 Background
In order to gain initial information on the effect of ip asbestos on
the induced peritoneal macrophage population, groups of 3 mice were injected
ip with asbestos or control solutions and kept for 3, 18 or 70 days before
being killed and some characteristics of the peritoneal macrophages
determined. These time points were arbitrarily chosen to represent short,
medium and long term response. The experiments were carried out twice and
the results pooled.
2.3.2 Coverslip culture
All subsequent assays, except for 3' nucleotidase, were carried out on
macrophage coverslip cultures prepared in the following manner. One hundred
microlitres of PEC at 1x10^/ml in cHPMI (obtained as given in 2.h) were
pipetted as a drop on to chemically clean, distilled water rinsed, 6x22 mm
glass coverslips (Chance Propper) on specially made racks. The coverslips
were then incubated in sealed plastic boxes, gassed with 5$ C0^ for 1 hour
to allow the macrophages to adhere, then washed vigorously in phosphate
buffered saline (PBS) to remove the non-adherent cells.
The following assays were carried out either immediately after the 1 hour
incubation, as in the case of spreading assays, or within h hours during which
time the macrophage coverslip cultures were maintained at 37°C in 3$ CO^.
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2.^.3 Phagocytosis assay
Macrophage coverslip cultures had 100 pi of 1 % latex spheres (Bacto-
latex 0.81 diameter Difco) in cRPMI added and incubated at 37°C in 5%
C02 for 1.5 hours. Coverslips were then washed vigorously to remove the
non-phagocytosed latex particles and inverted on a microscope slide on a
drop of toluidine blue. Macrophages with more than 1 internalised latex
particle, as revealed by a xLiO objective lens, were scored as phagocytosis
positive and the percentage of phagocytosis positive macrophages in 200
cells was expressed as a percentage for each coverslip culture.
2.5.14. Spreading assay
Immediately the 1 hour of incubation to allow adherence was over,
coverslip cultures were washed vigorously in PBS and immersed in May-
Grurrwald solution and a May-Grunwald Giemsa stain carried out. The
percentage of spread macrophages in 200 cells was assessed for each cover-
slipj an unspread macrophage was scored as one where no rim of cytoplasm
could be clearly seen. Fig.3.7 shows examples of spread and unspread
macrophages.
2.5.5 Fc receptor avidity assay
(i) Sheep red blood cells (SRBC's) SRBC's (Oxoid) were washed 3
times with Dulbecco A and adjusted to 5£ packed cell volume.
(ii) Rabbit anti-serum to SRBC's Anti-SRBC serum which had been
raised in New Zealand White rabbits by hyperimmunization and stored at
-20°C was used. In preliminary experiments anti-SRBC was prepared at 1/10,
1/100, 1/1000 and 1/10,000 dilutions in RPMI. Similar dilutions of normal
rabbit serum (NRS) were included as controls for spontaneous rosette
formation.
(iii) Coating of SRBC's with anti-SRBC 0.5 ml of 5^ washed SRBC
and 0.5 ml of the various dilutions of anti-serum and NRS were incubated
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at 37°C fer 30 minutes, washed 3 times with PBS and adjusted to 1^ in RPMI.
(iv) Fc rosette assay Coverslip cultures had 100 ^il of coated SRBC
added and left at room temperature for 20 minutes. Coverslips were then
washed according to a strictly adhered-to wash procedure and inverted on a
drop of toluidine blue. Two or more adherent SRBC's was taken to
constitute a rosette and the percentage of rosette forming cells in 200
macrophages was assessed for each dilution of sensitising anti-SRBC and
for URS controls.
(v) Preliminary experiments
Control, 3 day saline, 3 day chrysotile and 5 day C. parvum induced
macrophages were tested for percentage rosette forming cells against the panel
of variously sensitized SRBC's. Fig.2.2shows that C. parvum and
chrysotile induced macrophages had greatly increased Fc receptor avidity as
shown by their increased ability to form rosettes at 1/100 and 1/1000
dilutions of sensitizing antibody. It was evident that low dilutions of
sensitizing antibody could detect differences in affinity of Fc receptors
between saline induced and both crocidolite and C. parvum activated
macrophages. This effect was consistently obtained in preliminary
experiments and so rosette forming ability with SRBC's coated with 1/1000
dilution of anti-SRBC serum was taken as a marker for high avidity Fc
receptor bearing cells.
Thereafter coverslip cultures for each condition at each time point
were treated with 1/10 sensitized SRBC's to detect total rosette forming
cells, and 1/1000 sensitized SRBC's to detect cells with high avidity
receptors.
Spontaneous rosette formation detected with SRBC's coated with various











FIGURE 2.2 Mean percentage of macrophages forming rosettes with
1/10 - 1/10,000 dilutions of anti-sheep red blood
cell serum. Macrophages induced with saline,
crocidolite and C. parvum.
Bars denote - one standard deviation.





Coriments on the Fc receptor avidity assay
It was noted that consistent results could only be obtained in this
assay if a standardised washing procedure was rigidly adhered to. During
washing, coverslips may be particularly prone to shear force which can
dislodge Fc receptor bound SRBC's; whatever the reason, the adoption of
a standard washing method was a necessity in order to obtain reproducible
results.
The source of SRBC's was. also a potentially confounding factor in
this assay. On one occasion, freshly obtained (same day) SRBC's were
used due to failure of the usual source; such SRBC's yielded results
entirely different to those routinely obtained with Oxoid SRBC's up to
h weeks old. The major effect was an approximate 5-fold increase in the
apparent avidity of control macrophage Fc receptors; this effect was
never obtained with any of the Oxoid SRBC's.
2.5.6 Electron microscopy
In order to obtain information on the morphology of macrophages,
transmission and scanning electron microscopy of PEC was carried out.
Occasionally electron microscopy was used to study other cells and the
procedure was essentially the same as for PEC.
(i) Transmission electron microscopy (TIM)
PEC were washed, centrifuged and resuspended in h% glutaraldehyde
in 0.2 M cacodylate buffer pH 7.2. After 1 hour the cells were centri¬
fuged again and washed 3 times with cacodylate buffer before immersion
for 1 hour in 1% osmium tetroxide in 0.1 M cacodylate buffer pH 7.2.
Cells were then washed a further 3 times with buffer and processed through
graded alcohols before embedding in araldite. Sections were cut on an
ultramicrotome (Reichert), mounted on copper grids and stained with
uranyl acetate and lead citrate. Sections were viewed and photographed
in a Cora (Kratos) electron microscope.
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(ii) Scanning electron microscopy (SEM)
PEC were allowed to adhere to 6x22mm glass coverslips for 1 hour
before being washed to remove non-adherent cells. Coverslips were then
immersed in h% glutaraldehyde in 0.1 M cacodylate buffer pH 7.2 for 1 hour
followed by washing in buffer. The cultures were fixed for 1 hour in
osmium tetroxide in 0.1 M cacodylate buffer pH 7.2 and then washed 3 times
with buffer prior to critical point drying.
Critical point drying was carried out in a Polaran critical point
drying apparatus according to the maker*s instructions. Coverslips were
brought to absolute acetone by placing in 30^ aqueous acetone in a glass
tube which was then sealed in a bell jar containing $00 ml of absolute
acetone and a beaker of anhydrous calcium chloride; after 2-3 days the
30$ acetone was replaced by absolute acetone and the water was taken up
by the calcium chloride. Coverslips were then placed in the special
"boat** in absolute acetone and placed inside the critical point drier,
pressure and temperature were then increased, in accordance with the
maker*s instructions, until the critical point was reached and then
returned to atmospheric pressure. Coverslips were coated with gold in a
Polaron sputter coater before viewing and photographing in a Cambridge
600B scanning electron microscope.
2.5.7 Macrophage plasma membrane 5* nucleotidase and lysosomal acid
phosphatase assays.
The method used to measure the ecto-enzyme 5* nucleotidase was
essentially that of Raz et al (1977).
(i) Enzyme substrate incubation
PEC was adjusted to 10^/ml in Dul A, 1 ml placed in wells of 2k well
plates (Falcon 3008) and allowed to adhere for 1 hour. Wells were then
washed 3 times with 1 ml of Dul A and 0.6 ml of distilled water was added;
plates were then frozen at -20°C overnight. After thawing 0.6 ml of each
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of the following substrates was added to triplicate wells -
(i) 30 mg/ml p glycerophosphate (Sigma) in O-U M sodium acetate
buffer pH 5.0.
(ii) 30 mg/ml p> glycerophosphate in 0.2 M Tris/HCl buffer pH 8.5
plus 20 mM MgGl^.
(iii) 7 mg/ml 5' adenosine monophosphate (5* AMP) (Sigma) in 0.2 M
Tris/HCl buffer pH 8.5 plus 20 mM MgCl2.
Triplicate wells containing p glycerophosphate and 5' AMP only were
included as a control for spontaneous substrate hydrolysis; triplicate
wells containing cells only were used to ascertain endogenous phosphate
and for protein assay.
Plates were incubated at 37°C for 2 hours and the reaction terminated
by the addition of O.h ml of cold trichloracetic acid (20$). Plates were
then spun at 1,000 rpm for 5 minutes in the plate carrying head of a
Mistral (MSE) centrifuge and 0.5 ml of supernatant removed from each well
and assayed for inorganic phosphate.
(ii) Inorganic phosphate assay
The assay was essentially that of Chen et al (1956). Colour reagent
was prepared by dissolving 0.5 g of ascorbic acid (Sigma) in 15 ml of
distilled water to which was added 5 ml of 2.5$ ammonium molybdate (Sigma)
and 5 ml of 3 M H^SO^. To 0.5 ml of colour reagent was added 0.5 ml of
supernatant from wells and this mixture was incubated for 1 hour at 37°C.
The colour change was read against a blank of 0.5 ml colour reagent plus
0.5 ml of distilled water in a spectrophotometer (Pye SP500) at 820 njn.
Doubling dilutions of a phosphate standard from 100-0.8 jug phosphate/ml
were used to construct a standard curve; total phosphate per well was
calculated from the standard curve.
(iii) Protein estimation
Triplicate wells were assayed for protein content by the method of
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Lowry et al (1951). Six hundred raicrolitres of 8 M urea were added to
washed adherent cells to solubilize them and their protein content was
assessed as follows. Alkaline copper reagent was prepared by adding
UO g Na^CO^, 1 g of sodium tartrate and 8 g of NaOH to 2 L of distilled
water. Copper sulphate (0.1 $£) was added to alkaline copper reagent in
a ratio of 1 :10 to yield Lowry's first reagent. Two hundred microlitres
of sample was added to 2.9 ml of Lowry first reagent and incubated for 20
minutes at room temperature. One hundred microlitres of Folin Ciocalteau
reagent (BDH) were then added, mixed immediately and incubated at room
temperature in the dark for 1 hour. Colour change was read in a
spectrophotometer at 750 nm compared to a blank of colour reagent plus
200 /il of 8 M urea. Protein concentration of samples was obtained from
a standard curve constructed from bovine serum albumin (BSA) standards
(5-200jug/ml).
(iv) Expression of results
Enzyme levels were expressed as moles of inorganic phosphate/mg
protein/hour for nucleotidase and phosphatase. Endogenous phosphate,
spontaneous substrate hydrolysis and non-specific alkaline phosphatase
activity were subtracted appropriately to yield the final activity of
acid phosphatase and 5' nucleotidase.
2.6 Macrophage cytotoxicity to tumour cells
The assay system used to measure the ability of macrophages to kill
tumour cells was essentially the thymidine release assay of Mantovani et
al (1980) with the modification of Poste (1979) whereby the counts
remaining in the pre-labelled tumour cells at the end of the incubation
period, were measured.
2.6.1 Tumour cell targets
Cultured CCH^ fibrosarcoma cells, produced originally from a
methylcholanthrene induced sarcoma in CBA/Ca mice and maintained in long
term culture were used throughout (Woodruff et al 1972).
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2.6.2 Tumour cell labelling
For use as targets in the assay CCH^ cells were cultured in 20 ml
of cRPMI with 30 ^iCi (2 Ci/mmol) of tritiated thymidine (Amersham
International) in 75 ml flasks (Corning 2^110). Maintained in this
way CCH^ cells took up label rapidly in a linear fashion until day 6
(Fig2.3) when uptake reached a plateau at approximately 2,000 cpm/10^
CCH.J cells in this experiment. In practice, throughout the thirty
experiments carried out, the labelling varied between 1200 and 2^00 cpm/
<
10 CCH.J cells with no obvious reason for the variation.
2.6.3 Spontaneous loss of label
Labelled CCH^ cells maintained in culture for the duration of the
assay period lost label spontaneously at a rate of approximately 10$
per day (Fig. 2.2a) .
2.6.1± Preliminary experiments
Once CCH^ cells were found to be reliably labelled with tritiated
thymidine various methods of measuring nucleotide release were tried. A
microtitre plate assay was first tried but the small number of cells used
provided too few counts so 2h well plates (Falcon 3008) were used where
10^ target cells could be used in each well. Attempts were made at first
to measure the appearance of counts in the supernatant as an index of
cytotoxicity but, while this was sometimes satisfactory, occasional wells
had inexplicably high levels of supernatant counts which completely
confounded statistical comparisons. Finally the method of Poste (1979)
was adopted where the radioactivity associated with the tumour cells at





FIGURE 2.3 Uptake of "^H thymidine by CCH^ tumour cells
in culture.










FIGURE 2.It Spontaneous loss of label by thymidine labelled CCH^
tumour cells maintained in culture for 3 days.
Symbols denote mean - one standard deviation
of triplicate wells.^repres. exp^
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2.6.5 Positive control
Throughout the use of this assay, 5 day C. parvum activated macro¬
phages were included in every experiment as positive controls since they
are known to be highly cytotoxic to tumour cells in vitro.
2.6.6 Method
6 5 5
PEC were harvested, washed and adjusted to 10 , 5x10 , 10 and
5x10^ cells/ml in cRPMI. One millilitre of each concentration was added
to triplicate wells of 2h well plates and after 1 hour of incubation at
37°C in $% CO^# the non-adherent cells were removed by washing with Dul A.
Labelled target cells, washed 3 times with Dul A and adjusted to 10^/ml
in cRPMI, were added as 1 ml to each well yielding original PEC to target
ratios of 10:1, 5:1. 1:1 amd 0.5si 5 1 ml of CCH^ cells alone was added
to empty wells to determine spontaneous loss of label. Plates were
incubated at 37°C in a 5^ C0^ atmosphere for 2 days. The supernatants
were then carefully removed and replaced with 1 ml of Q.2% ethylene
diamine tetra-acetic acid (EDTA BDH) and left for 5 minutes at room
temperature; the EDTA was pipetted up and down to further aid release of
tumour cells. The 1 ml of EDTA plus tumour cells was then transferred
to plastic tubes for harvesting onto glass fibre paper in a cell harvester
(Skatron). The glass fibre papeis with cell bound radioactivity were
placed in scintillation vials (Kartell) and allowed to dry at 37°C
overnight before adding 6 ml of scintillation cocktail (Burroughs).
Tritium was then assessed in a ^scintillation counter (Tricarb).
Background counts were below 30 cpm.
2.6.7 Expression of results
Since asbestos was always injected in saline suspension and saline
alone was found to induce a small amount of tumour cell cytotoxicity in
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the induced macrophage population, n% specific toxicity" due to asbestos
was calculated as follows, for each ratio:-
% specific toxicity* 100
Tumour cell bound counts following culture
with asbestos induced macrophages x100
Tumour cell bound counts following culture
with saline induced macrophages
2.6.8 Time course of cytotoxicity
Fig. 2.5 shows the tritiated thymidine counts associated with CCH^ cells
following incubation of 10^ labelled CCH^ cells for up to 3 days with
C. parrum and saline induced macrophages at a ratio of 10:1. It is clear
that even after 1 day there is accelerated loss of label from target cells
incubated with C. par-rum macrophages while by 2 days (the end of a normal
assay) the radioactivity remaining in targets incubated with C. parvum
macrophages is only $0% of that present in tumour cells incubated with
saline induced macrophages. Toxicity at day 3 was also measured and it is
clear that the C. parvum toxic effect was levelling out. The counts
associated with CCM^ cells alone on day 2 show that even saline induced
macrophages have seme cytotoxicity against tumour cells at 10:1 ratio.
2.6.9 Validation of assay
As a validation of the assay system positively cytotoxic C. parvum
macrophages plus crocidolite induced and saline induced macrophages were
set up in an assay and the following two corollaries of cytotoxicity,
which should accompany loss of tumour cell bound counts in the C. parvum
macrophage wells, were measured
(i) reduction in the actual number of tumour cells, compared to
controls, as assessed by counting in a haemocytometer.
(ii) increased appearance of counts in the supernatant (although as
measured previously this was not a consistently reliable measure).
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~ 3FIGURE 2.5 H Thymidine counts in tumour cells incubated at a
ratio of 10:1 with saline macrophages or C. parvum
macrophages for up to 3 days.
Symbols denote x - one standard deviation.
triplicate wells (repr. exp* j
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Fig.2.6 shews that both of these conditions were satisfied and that,
accompanying the decrease in tumour cell bound counts in the C. parvum
macrophage wells, there was a decrease in the number of tumour cells and
an increase in the supernatant counts, compared to the other two conditions.
2.6.10 Elimination of tritiated thymidine uptake by macrophages as a
potential confusing factor
Other experiments in this study have shown that macrophages can take
up tritiated thymidine in considerable amounts and this, allied to the
likelihood that some macrophages would be released by EDTA, necessitated
that this potentially confusing factor in the assay be checked. In order
to check this the maximum number of macrophages (i.e. derived from 10^
3 day saline, 5 day C. parvum, 3 day crocidolite and chrysotile PEC) were
plated into wells, washed and incubated in 2,500 cpm tritiated thymidine;
this dose represented more than the maximum of counts which could be
released by a 50% kill of well labelled CCH^ cells. These macrophage
cultures were then EDTA treated and harvested in the usual manner.
Table 2.1 shows the results of the experiment showing that only background
counts were harvested. Uptake of tritiated thymidine by macrophages
and their possible release by EDTA amongst the tumour cells was therefore
ruled out.
2.6.31 Elimination of the possible confusing effect of tumour cells not
being killed but merely floating off
In order to check that viable tumour cells were not being discarded
with the supernatant before EDTA was added at harvesting, the following
was carried out. A typical C. parvum macrophage kill was set up
including a dose response and the supematants were retained, at the end
of the incubation period and, instead of being discarded, they were



























SAL. C. porvum CROC.
FIGURE 2.6 Figure demonstrating that reduction of counts in
EDTA released tumour cells (top) following
incubation with C. parvum is correlated with a
decrease in the number of tumour cells which can
be counted visually (middle) and an increase in
the supernatant counts (bottom).
Symbols denote x - one standard deviation.
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TABLE 2.1 Harvestable counts obtained from macrophages
(derived from 10^ PEC) induced by various
agents and incubated with 2,500 cpm tritiated
thymidine for 2 days.
Macrophage Source Harvestable Counts
3 day saline 25 - 1U
3 day crocidolite 17-9
3 day chrysotile i+ o

















FIGURE 2.7 Harvestable EDTA released cell bound counts and
supernatant counts at various effector target ratios
with C. parvum induced macrophages.
x^sd of triplicate wells (repr*6 expl)
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response in the killing as measured by decreased counts in the EDTA
released tumour cells while the harvestable counts in the supernatant
remained at the same low level throughout the dose response. The
absence of harvestable counts in the supernatant showed that "floating off"
of labelled tumour cells did not contribute to the loss of tumour cell
bound counts during a C. parvum activated macrophage mediated tumour cell
kill.
2.7 Assay for the effect of macrophage supernatants, asbestos and asbestos
leached medium on CCH^ tumour cell proliferation
2.7.1 Macrophage supernatants
PEC harvested 3 days after ip saline, chrysotile or crocidolite, or
5 days after ip C. parvum were cultured in 75 ml flasks (Corning 25110)
(6.0x10^/flask) in cRFMI for 1 hour then washed to remove non-adherent cells.
The macrophages remaining were then incubated for a further 2h hours in
15 ml cEPMI after which the supernatants were harvested, centrifuged,
aliquoted and frozen at -20°C until use.
2.7.2 Asbestos
Crocidolite and chrysotile were prepared at 5 mg/ml in cRPMI and
incubated at 37°C for 1 hour then diluted in cRFMI to yield 0.01, 0.1, 1,
10 and 100 jag/lOO jil.
2.7.3 Leachate(medium in which asbestos has been incubated)
Crocidolite and chrysotile asbestos at 5 mg/ml in cRPMI were incubated
for 3 days at 37°C with daily mixing. The suspension was then spun at
3,500 g for 50 minutes and the asbestos free supernatant Millipore
filtered (0.2 pn) to sterility.
2.7.i|. Preliminary experiments
Since it had been decided to utilise a microtitre plate assay,
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experiments were undertaken to decide the best inoculating dose of GGH^
cells to use in each well. Various concentrationf of CCH^ cells were
prepared such that 100 /a yielded 10^, 2x1o\ 5x1o\ 10^ and 10^ cells;
after 2h hours 0.25 pCi of tritiated thymidine were added to each well;
wells were harvested after a further 2li hours. Uptake of tritiated
thymidine (measured as in 2.6.6) was seen to peak in cultures containing
5x10^ - 10** CCH^ cells (Fig.2.8) so 5x10^ was routinely used in subsequent
assays.
2..?.5 Method
CCH.J cells were harvested from culture, washed and adjusted to
5x10*Vml; 100 ^jul of this suspension were added to the wells of microtitre
plates (Sterilin M29 ARTL). Depending on the agent whose effect was
sought the following were then added to triplicate wellsj-
(i) macrophage superaatants at 5, 25 and 50^ of the total volume
(200 jil).
(ii) asbestos at 0.01, 0.1, 1, 10 or 100 pg in 100 jal of cHPMI.
(iii) asbestos leachate as 5, 25 and 50^ of the total volume.
Plates were incubated at 37°C in 5^ CO^ for 2h hours at which point
0.25 JiCi of tritiated thymidine were added to each well; wells were
harvested after a further 21; hours and the cell bound tritium assessed as
described previously^2.6.6). Microscopic examination of wells before and
after harvesting revealed that virtually all tumour cells were harvested
from wells.
2.8 In vivo assays to measure the effect of asbestos on growth of
subcutaneous CCH^ tumours
2.8.1 Subcutaneous tumour growth
CCH^ tumour cells were harvested frcm culture, washed 3 times with
Dul A and adjusted in Dul A so that 0.1 ml gave the required inoculating
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TUMOUR CELLS/WELL
FIGURE 2.8 Effect of number of inoculating CCH, tumour cells
3
on subsequent uptake of H thymidine.
xtsd of triplicate wells (repreexf£)
-9k-
6 2
dose of 10 or 5x10 cells. Mice were prepared in groups of 10 and
received 0.1 ml of tumour cell suspension subcutaneously in the exterior
lateral aspect of the right hind leg; in this position the growth of the
tumour could be monitored using a caliper calibrated to 0.5 mm.
2.8.2 Asbestos injection
Asbestos was injected ip within 3 days before or after tumour cell
inoculation. Crocidolite or chrysotile asbestos was used at 2.5, 5 or
20 mg in 0.5 ml Dul A; Dul A alone and 0.2 ml (1.1; mg) of C. parvum were
also injected as controls.
2.8.3 Winn type assays
In this assay PEC induced by asbestos or saline were mixed at 10:1
or 100t1 with CCH^ cells and injected subcutaneously in 0.1 ml volume
[t f\ o
containing 10 CCH^ cells plus 10 PEC (10:1) or 5x10 CCEj cells plus
5x10^ PEC (100:1); controls consisting of the appropriate number of CCH^
cells alone were also used.
2.8.1; Effect on tumour growth of mixing crocidolite with the inoculating
tumour cells
CCH^ cells were harvested, adjusted to the required concentration and
divided into h aliquots. To separate aliquots were added 5, 50, 500 or
0 ^ig crocidolite as a constant volume (10 pi) of cRPMI. The crocidolite
had been pre-incubated with cRFMI for 1 hour at 37°C before dilution.
Mice were injected subcutaneously with 0.1 ml containing 500 CCH^ cells
plus 0, 5, 50 or 500 pg of crocidolite. The growth of the tumours was
monitored.
2.8.5 Effect on tumour growth of having grown the inoculating tumour cells
in vitro in the presence of crocidolite
2.5 jhg of crocidolite asbestos was pre-incubated in cRPMI for 1 hour
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then added to a culture flask newly seeded with 0.5x10^ CCH^ cells which
were then incubated for U days. CC^ cells were then harvested, adjusted
to 500 CC^/0.1 ml and 0.1 ml injected subcutaneously into 10 mice; 10
mice received the same dose of CCH^ cells grown in parallel, but untreated,
culture. Tumour growth was monitored.
2-9 Use of Concanavalin A to study the effect of asbestos on macro¬
phage membranes
2.9.1 Visualisation of Concanavalin A receptors in macrophages
during interaction with asbestos in vitro - light microscopy
Concanavalin A (Con A) conjugated to fluorescein isothiocyanate
(FITC-Con A) (Sigma) was dissolved in Dul A at 20 )ig/ml. Control
macrophage cultures were prepared as previously indicated (2.5.2) and
100^1 of chrysotile asbestos (50 )ig/ml) in RPMI (with or without 10$
foetal calf serum) was added to each corerslip. Cultures were then
incubated at 37°C in 5$ CO^ for 10, 30 or 60 minutes to allow for
chrysotile/macrophage membrane interaction. Coverslips were then washed
in Dul A and incubated in FITC-Con A for 20 minutes at room temperature
after which they were washed in Dul A, fixed in ethanol for 5 minutes
and mounted in Dul A/Glycerol 1:1. Coverslips were viewed and photographed
in an American Optical Company, Phase Star light microscope with an
ultraviolet light source and photographic attachment. All photographs
were exposed on Tri I Pan film (Kodak).
2.9.2 Electron microscopy
The demonstration of Con A binding sites by the peroxidase method
was taken from Garrido et al (197U). Control macrophage cultures were
prepared in plastic petri-dishes (50 mm Sterilin 122) and chrysotile
asbestos (50^pg/ml) was added in RPMI with or without 10$ foetal calf
serum; plates we.re incubated for 5, 10, 30 or 60 minutes. Only
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chrysotile could be used since this is the only asbestos type which is
readily cut by ultramicrotomy.
At appropriate time points monolayers were washed and fixed by the
addition of glutaraldehyde in cacodylate buffer (see section 2.5.6) for
5 minutes. Cultures were then washed a further 3 times and incubated
with Con A (Taab laboratories) (50 /ig/ml Dul A) for 15 minutes at U°C,
after which time the cultures were washed 3 times and incubated with
peroxidase (Taab * laboratories) (50 ^ig/ml Dul A) for 15 minutes at room
temperature. The substrate for the demonstration of peroxidase was
prepared immediately before use by adding 1 drop of 30^ (Taab
laboratories) per 5 ml of 3.3 diaminobenzidine (Taab laboratories)
(0.5 mg/ml in 0.1 M Tris buffer pH 7.U). This substrate was added to
the culture plates and incubated for 15 minutes in the dark at room
temperature. Cultures were then washed 3 times with PBS and fixed in
OsO^ fixative (see 2.5.6). The cells were then harvested with a rubber
policeman and processed to araldite. Unstained sections were viewed in
the electron microscope where Con A/peroxidase sites were evident as
black reaction product at the cell surface. Control cells processed
for endogenous peroxidase showed very occasional pale intracellular
staining with no cell membrane staining.
2.9.3 Con A induced capping of macrophages
PEC induced by various stimuli were set up as coverslip cultures,
allowed to adhere and the non-adherent cells removed by washing.
Coverslips were then placed on racks and 200 ;il of FITC-Con A (Sigma)
(20 jig/ml Dul A) were added and the coverslips incubated for 20 minutes
at 37°C; occasionally shorter or longer periods of incubation were used.
Coverslips were then washed with PBS, fixed in ethanol for 5 minutes and
mounted in Dul A/glycerol 1:1. The coverslips were finally examined
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in a UV microscope and the percentage of capping macrophages in 200 cells
was determined for each coverslip.
(i) Specificity of FITC-Con A binding To check the specificity of
FITC-Con A binding to the macrophage surface, macrophages werej-
(a) pre-incubated in non-fluoresceinated Con A followed by
FITC-Con A treatment for 20 minutes.
(b) treated with FITC-Con A in the presence of $0 mM methyl
mannoside.
With both of these treatments membrane fluorescence of macrophages
was abolished and pinocytic uptake of FITC-Con A was seen to be minimal.
(ii) Temperature requirement for capping The percentage of capping
macrophages was determined for C. parrum and chrysotile activated
macrophages treated with FITC-Con A at room temperature or 37°C for 20
minutes.
(iii) Time course of capping C. parvum and chrysotile activated
macrophages were incubated at 37°C for various times and the percentage
of capping cells determined.
(iv) Pharmacological modification of capping In experiments to assess
the role of microtubules and microfilaments in Con A induced capping of
activated macrophages the following pre-treatments were given;-
1. colchicine (Sigma) 10"^M.
2. cytochalasin B (Sigma) 10~Sl.
_2
3. lignocaine hydrochloride (Phoenix Pharmaceuticals) 10 M
all given as 100 jil of a Dul A solution for 1 hour at 37°C followed by
incubation with FITC-Con A for 20 minutes at 37°C; percentage of caps
in 200 randomly counted cells was assessed. Since cytochalasin B was
dissolved initially in dimethyl sulphoxide (BMS0) (BDH), a suitable
dilution of DMS0 was also used to pretreat macrophages to preclude any
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effect of DMSO alone on capping.
(v) Dose response of capping in chrysotile induced macrophages Mice
were injected with 0.005, 0.05, 0.125, 0.5, 1.25 and 2.5 rag of chrysotile
asbestos in 0.5 nil Dul A, and the percentage of capping macrophages in
the 3 day induced macrophages ascertained.
(vi) Re-expression of Con A receptors after capping Three day saline and
chrysotile induced macrophage cultures were treated with non-fluoresceinated
Con A (20/ug/ml) at 37°C for 20 minutes then incubated in cRPMI for up to
h hours to allow re-expression of Con A receptor sites. At 0, 15 minutes,
30 minutes, 1 hour, 2 hours, 3 hours and U hours the macrophage cultures
were treated with FITC-Con A at 37°C for 20 minutes and then scored for
brightness of fluorescence and proportion of caps.
2.9.1a Assessment of number of macrophage membrane Con A binding sites
by Pgj Con A binding
(i) Iodination of Con A The method used was essentially that of Hunter
(1978). Con A (Pharmacia) and Na (Amersham International)were used.
One ml of Con A (10 mg/ml Dul A) was placed in an ice cooled bijou cont¬
aining a small magnetic stirrer; 100 ^il of 0.5 M phosphate buffer pH7.5
and 10 ^il of Na (lii.1 mCi/^ug iodine: 100 mCi/ml) were then added.
To start the iodination reaction 100 ^ul of chloramine T (BDH) (20 mg/ml
Dul A) were added and the reaction allowed to continue for 30 seconds.
To stop the reaction 100 ^il of sodium metabisulphate (U0 mg/ml Dul A) were
added. The stopped reaction mixture was passed down a Sephadex G25
column which had been pre-coated with 300 jil of Bovine Serum Albumin
(Pentex) (20% W/V) and equilibrated with PBS; 10x3 ml fractions were
eluted with PBS into glass tubes. Ten microlitre samples from each
fraction were placed in 5 ral glass tubes and counted in a gamma counter
(LKB); 100 yul of 5% foetal calf serum was then added to each tube
followed by ii ml of 20^ trichloracetic acid (TCA) and each tube was
capped and vortexed. The TCA precipitate was sedimented by centri-
fugation, the supernatant discarded and the TCA precipitable counts assessed.
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A graph showing the results of a typical iodination is shown as Fig. 2.9
The TCA precipitable counts were 9h% of the total counts in the l|th and.
5th fractions which were pooled for use in assays. The P^lj Con A,
«n of which was assumed to hare been eluted, was made up to 10 ml (1 mg/ml)
aliquoted and frozen until use.
(ii) Stability of P^l] Con A A batch of P^l] Con A was assessed
for stability one month after iodination and, as shown in Table 2.2
Pi 25
dissociation was found to be less than 5% per month. [ Ij Con A was
only kept for 2 months maximum.
(iii) Choice of an assay system for measurement of P^lj Con A binding
to macrophages Several assay systems were considered for measuring the
binding of [1 Con A to macrophage surfaces. The methods used were
essentially the same as for the coverslip method eventually adopted.
Normal PEC (5x10*) were added to glass or plastic tubes pre-treated, or not,
with 5% BSA (Pentex) for T hour at 37°C. In the case of the microtitre
plate assay 5x10^ PEC were added to each well. An arbitrary 1/10
dilution of P^ll Con A was used. After washing to remove non-adherents,
macrophages were treated with P ^i) Con A for 15 minutes at room temp¬
erature then washed extensively. The counts in tubes and control tubes
with no cells were assessed in a gamma counter. In the case of the micro¬
titre plate assay the washed wells were separated with a hot wire before
gamma counting. In the case of the sodium dodecyl sulphate (SDS)
[125,technique the test tubes had the Con A labelled cells solubilized
in 2 ml of SDS (20$) for 10 minutes with mixing; the counts in the SDS
solubilized macrophages and SDS washes of
tubes were then assessed.
(,25i) Con A treated control
of the
Fig. 2.10 shows the amount of non-specific binding, due to adsorption
125, Con A to the surfaces of the tubes and wells tried. It is
clear that microtitre plates, plastic and glass tubes uncoated and coated
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FIGURE 2.9 Result of a typical Con A iodination.
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TABLE 2.2 Change in percentage of TCA precipitable
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with BSA and SDS solubilization all resulted in very high background
counts. The glass coverslip method therefore proved to be the best system
with regard to non-specific binding and was adopted for use.
fl25>
(iv) Coverslip method of measuring I IJ Con A binding to macrophages
The method used was essentially the method of Lutton (l973)• In
preliminary experiments PEC were collected, washed and the percentage of
adherent cells was assessed for 3 day saline, 3 day chrysotile and 5 day
C. parvum PEC. This was done by plating 10^ PEC onto plastic petri-
dishes (f>0 mm Sterilin 122) in cRPMI and incubating for 1 hour at 37°C
in 5% CO,,; the non-adherents were then removed with 3 consecutive Dul A
washes and the washes kept and pooled. The pooled washes were centrifuged,
brought into a small volume and counted in a haemocytometer to yield the
percentage non-adherents. The percentage of macrophages (100 - % non¬
adherents) was:- saline lh.2%', chrysotile h9.3%; C. parvum 65.6%.
The PEC were adjusted to yield H.5x10^ adherent cells/ml in each case and
100 jil of suspension were pipetted on to 6x22mm coverslips (Chance-Propper).
The coverslips had been washed in Decon and extensively rinsed in tap and
distilled water. Coverslips on racks were incubated for 1 hour at 37°C
in 5% CO^ to allow for macrophage adherence then washed vigorously in PBS
to remove non-adherents. To each coverslip was added 100^.1 of [^^ij
Con A and the coverslips incubated for 15 minutes at room temperature.
[
, 125
The / I Con A was drained off and the coverslips washed, using forceps,
in 5 large volumes of PBS before placing in plastic tubes and assessing the
bound L ^ij counts.
(v) Concentration of Con A Binding to control macrophages (h»5xl0^)
was found to have plateaued by 200 ug/ml (Fig. 2.11) so this concentration
*125, ~of Con A was used routinely.
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FIGURE 2.11 Effect of l ^Ij Con A concentration on binding to
control macrophages.
x of duplicate coverslips
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(vi) Number of target macrophages Increasing the number of target
macrophages/coverslip caused a linear increase in the amount of
binding (Fig. 2.12).
(rii) Time course off^l] Con A binding Binding of [1^lJ Con A to
macrophages was found to hare reached a plateau by 15 minutes at roan
temperature (Fig. 2.13).
(▼iii) Specificity of (1 ^1 Con A binding In order to test the
specificity of [1 ^i] Con A binding the binding was carried out in the
presence of $0 mM methyl mannoside; binding was reduced to background
by this procedure (Table 2.3).
(ix) Elimination of endocytosis of f1^l] Con A as a potential confusing
factor To test whether endocytic uptake of [1^l]con A could contribute
significantly to binding levels, the binding of [1^l] Con A was carried
out in the presence of 2 inhibitors of endocytosis - 2 mM sodium azide
and 1 mM sodium iodoacetate. No significant effect on binding was
produced by inhibiting endocytosis (Table 2.1i).
(x) Latex phagocytosis To measure the effect of latex phagocytosis on
[,25i] Con A binding, control macrophage cultures were prepared and 100 pi
of 1% latex (Bacto latex 0.81 pm diameter, Difco) in cRPMI were added and
incubated for 1 hour at 37°C in CO^. ^on ^ binding to latex
treated macrophages and control macrophages was then carried out as normal.
(xi) Asbestos phagocytosis In seme experiments control macrophages
were incubated for 1 hour at 37°C with 100 pi of chrysotile (50 pg/ml) in
cRPMI and [l^l] Con A binding assessed.
(xii) Antibody coated SRBC phagocytosis Antibody coated SRBC's (Ab SRBC's)
were prepared with 1:50 dilution of anti-SRBC serum (as given in 2.5.5)
and 100 pi were added to control macrophage cultures which were incubated
at 37°C for 1 hour. Control and Ab SRBC treated cultures were then
treated with 100 pi of red blood cell lytic buffer for 2 minutes before
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FIGURE 2.12 Effect onj^^i] Con A binding of increasing the number of
target cells.
x of duplicate c/slips
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FIGURE 2.13 Time course ofjj^l] Con A binding to macrophages.
x of duplicate c/slips
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TABLE 2.3 Effect of carrying out L ^Ij Con A binding
in the presence of 50 mM methyl mannoside.
Condition [12^l] Con A Bound
(cp 30 seconds)
Blank coverslip 5,367 - 23h
Macrophages +
[12%] Con A 1*1,326 - 10,073
Macrophages +
[125l] Con A +
Methyl mannoside
U,7U2 - 707
TABLE 2.it Effect of the endocytic inhibitors
iodoacetate and azide on
binding.
c125n Con A
Treatment [l25l] Con A Bound
(cp 30 seconds)
Saline 67,957 - 10,07U
Iodoacetate 6U,356 - 5,352
Azide 56,863 - 12,727
Blank 8,357 - 1051
f
t xtsd of 3 separate exp*
washing in 3 volumes of PBS.
-102-
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IJ Con A binding was then measured.
Con A(xiii) Trypsin releasability of bound ft 2^l] Con A A normal
binding experiment was carried out and the counts released by enzyme
treatment assessed according to the method of Marques (1978). Coverslips
were placed in tubes containing 2 ml trypsin (1 mg/ml Dul A) (Difco) or,
in initial experiments in pronase (2.5 mg/ml Dul A) (Calbiochem Behring).
Coverslips were left in enzyme for 15 minutes at room temperature, agitated
in enzyme solution with forceps then transferred to another tube.
Enzyme released and coverslip retained counts were then determined;
enzyme released counts were expressed as a percentage of total counts.
2.10 Effects of asbestos induced macrophage supernatants on lymphocyte
mitogenesis
2.10.1 Thymocyte mitogenasis assay
Thymuses were obtained under sterile conditions from 6 week old
CBA/Ca mice and gently disaggregated in a glass homogenizer in Dul A.
The large debris was allowed to settle and the supernatant containing
free thymocytes was decanted; the thymocytes were washed 3 times with
Dul A and adjusted to 5x10^/ml in cRPMI supplemented with 5x10~^M
2 mercapto-ethanol. Aliquots of cell suspension were adjusted to 0, 2,
U and 5 ^ig/ml Concanaralin A (Pharmacia) by adding a small volume of
concentrated Con A in Dul A. One humdred microlitres of cell suspension
were added to the wells of microtitre plates (Sterilin M29 ARTL); 100^il
of test medium, e.g. macrophage supernatant, were then added to triplicate
wells. This produced a final concentration of 0, 1, 2 and U ^ig/ml Con A
in 200 ^il volume. The plates were then incubated at 37°C in 5% C0^ for
U8 hours at which point 0.25 pCl of tritiated thymidine were added to each
well. After a further 2h hours the wells were harvested in a cell
harvester and the cell bound tritiated thymidine determined as described
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previously (2.6.6) by scintillometry. In some preliminary experiments
label was added after 72 hours and the wells harvested at 96 hours.
A typical dose response curve for Con A mitogenesis of thymocytes
is shown in Fig.2.1ii and it is clear that there is an optimal dose above
which tritiated thymidine uptake is inhibited.
2.10.2 Attempts to obtain Interleukin 1 (IL1) activity in supernatants
of macrophages activated in vitro
Normal PEC were seeded into 75 ml flasks (Corning 25110) at 6x10^/
flask in cRPMI and the non-adherents removed after 1 hour. The medium
was replaced with cRPMI containing 50 ^ig/ml bacterial lipopolysaccharide
(LPS) (Difco). Flasks were incubated at 37°C in 5$ CO^ for 2li or 72
hours after which the supernatants were collected, centrifuged, aliquoted
and stored at -20°C.
2.10.3 Attempts to obtain IL1 activity in supernatants of macrophages
activated in vivo
Mice were injected with 0.5 ml proteose peptone (Difco) (10$) or
0.5 ml Con A (Pharmacia) (500 ^ig/0.5 ml) and left for 3 days after which
time the PEC were harvested and the adherent cells incubated in serum-
containing or serum-free RPMI for 2k or U8 hours. The supernatants
were harvested, centrifuged and dialysed overnight against RPMI at U°C.
Supernatants were then filtered to sterility and made up to cHPMI where
appropriate.
2.10.ii Preparation of supernatants with suppressor activity, from
asbestos induced macrophages
Twenty-four hour supernatants were prepared in cHPMI for 3 day
crocidolite, 3 day chrysotile, 3 day latex , 3 day saline, 10 month
crocidolite and 10 month saline induced macrophages. Supernatants
were obtained as described above.
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FIGURE 2.1U Effect of Con A concentration on thymocyte
mitogenesis as measured by thymidine
uptake.
xis.d. of triplicate wells (Yepr^exp)
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2.10.$ Supernatants from macrophages treated with chrysotile in vitro
Adherents obtained from 5x10^ control PEC were incubated in 75 ml
flasks in cRPMI containing 500 pg chrysotile/ml. At the end of 72
hours of incubation more than 70% of macrophages were dead as assessed
by dye exclusion. The 72 hour supernatant was centrifuged at 3,500 G
for 30 minutes, aliquoted and stored at -20°C.
2.10.6 Dialysis
Three day chrysotile macrophage supernatant was dialysed overnight
against RPMI at U°C.
2.10.7 Serum
Serum collected from 3 day saline, 3 day crocidolite and 3 day
chrysotile injected mice was incorporated in the thymocyte mitogenesis
assay at 1 and 10^.
2.10.8 Asbestos
Asbestos was preincubated for 1 hour at 37°C in cRPMI then diluted
so that 100 pi contained 0.001, 0.01, 0.1, 1 or 10 pg; 100 pi of asbestos
solution were incorporated into wells in thymocyte mitogenesis assays.
2.10.9 Effect of supernatants on fibroblast proliferation
An early passage mouse kidney fibroblast cell line kindly provided
by Dr. Jan Boyd was used as a target to test the effect of supernatants
on non-lymphoid cells. The proliferation assay used was essentially
the same as that used for tumour cells (2.7.5) except that the target
cells were incubated for 10 minutes in0.5per cent' trypsin before harvesting.
2.10.10 Preparation of splenic lymphocytes
CBA/Ca mouse spleen cells were obtained under sterile conditions
g
and gently dispersed in a glass homogeniser. Approximately 10 mononuclear
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cells were obtained from one spleen. The cells obtained from one
spleen were suspended in 0.5 ml of cRPMI and applied to a nylon wool
column (Leukopac) prepared in a 10 ml plastic syringe (Sterilin)
according to the method given in Mishell and Shiigi (1980) and
equilibrated with cEPMI at 37°C for 1 hour. The splenocytes were
layered on to the top of the nylon wool and allowed to enter the column;
a further 2 ml of cHPMI were added and the column closed. The column
was incubated at 37°C for 1 hour after which time the non-adherent
cells were eluted with 15 ml of cRPMI.
The cells eluted from the column, and those which could be obtained
by mechanical agitation of the nylon wool after elution of the non¬
adherents, were characterised by surface immunofluorescent staining
with anti-fc (prepared in the Department of Surgery) to detect T lymphocytes
and anti-Ig (Dako) to detect B lymphocytes. As shown in Table 2.5 the
column eluted cells were 80^ T lymphocytes and contaminated with only
2% of B lymphocytes; the remaining cells were presumed to be macrophages.
Similarly the cells which could be obtained by mechanical agitation of
the nylon wool, which would be predicted to be B lymphocytes, were 80%
surface Ig positive and contained only 16% 9 positive cells.
2.11 Attempts to detect differences in surface antigenicity between
saline and asbestos induced macrophages
2.11.1 Raising of anti-sera
Mature New Zealand White (NZW) rabbits bred in the Department of
Surgery were used. On day 0 PEC was collected from mice injected ip
6 days previously with 0.5 nil Dul A or 2.5 mg crocidolite in 0.5 ml
Dul A. The PEC were collected in RPMI 16U0 containing 10 U/ml heparin
(Pularin) and no serum. PEC were washed ij. times with Dul A and adjusted
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TABLE 2.5 Surface staining characteristics of
(a) splenocytes eluted from a nylon
wool column and (b) cells obtained




Anti 9 80 20
Anti Ig 2 98
(a)
+ -
Anti 9 16 Qh




to 5x10 in 0.2 ml Dul A. The PEC were then added to 1.5 ml of
Complete Freunds Adjutant (Difco), placed in a laboratory blender and
mixed for 5 minutes until a drop of the mixture remained stable on a
water surface. This adjuvant mixture was injected subcutaneously into
the left flank. Rabbit 151 received the saline PEC; rabbit 152
received the crocidolite PEC.
This procedure was repeated on day 1 it substituting Incomplete
Freunds Adjuvant (Difco), and injected subcutaneously into the right
flank.
•7
On day 28 5x10 washed PEC in 0.2 ml Dul A were injected into the
ear vein of the appropriate rabbits.
2.11.2 Harvesting and storage of anti-sera
Rabbits were pre-bled from the ear vein on day -2 and were bled from
the ear vein to obtain anti-sera on days lj.2 and 56; on day 70 the
animals were exsanguinated. All blood samples were kept overnight
at U°C in universal containers to allow clotting, then spun at 3,500 G
for 10 minutes. The serum was separated from the clot and spun once
more to remove all blood cells. Sera was then complement de-activated
by incubating in a water bath at 56°C for 30 minutes, aliquoted and
stored at -20°C until use.
2.11.3 Assay of antibody binding to macrophages
The iodination of Protein A and subsequent assay were carried out
essentially as described by Brown et al (1979).
2.11 .It Iodination of Protein A
A bijou, in a beaker of ice, was set up on a small magnetic mixer
and 30 jil of Protein A (1 mg/ml PBS) (Pharmacia) were added. To this
1 ?5
were added 100 ^pl 0.5 M phosphate buffer (pH 7.2), 10 ^al Na I (1U. 1 mCi/
^ig iodine : 10 mCi/ml) (Amersham International) and 10 jul of Chloramine T
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(1 rag/ral PBS) (Sigma); the solution was allowed to mix on ice for 20
minutes. To terminate the reaction 20 jil of sodium metabisulphite
(1 mg/ml PBS) and 20 pi of sodium iodide (20 mg/ml) were added. The
stopped reaction mixture was passed down a 25 cm Sephadex G25> column
pre-coated with 200 pi BSA(50 mg/ml) and equilibrated with PBS; 2.5 ml
fractions were eluted with PBS into glass tubes and the TCA precipitable
counts assessed as described earlier (2.9.U). In the fractions pooled
to obtain the working reagent there were approximately 90% TCA precipit¬
able counts. Fig. 2.15 shows the result of a typical Protein A iodination.
2.11.5 ft Protein A binding assay
Whole PEC PEC were harvested in the usual manner 6 days after ip
injection of 0.5 ml saline or 2.5 mg crodicolite in 0.5 ml saline.
PEC were washed 3 times and adjusted to 5x10^/ml in diluent (5£ FCS in
PBS). Two hundred microlitres of PEC suspension were added to triplicate
wells (Remov-a-well system Klhk Dynatech) in a polystyrene "plate".
As with all other centrifugations in this assay the plates were then
centrifuged in the plate carrying head of an MSE Mistral centrifuge at
1,000 rpm for 5 minutes. The cells were then resuspended by holding
against a whirlimixer and 200 ^il of anti-serum or prebleed serum, suitably
diluted, were added. The plates were incubated on ice for 1 hour.
(*125
Plates were then spun and washed 3 times before adding 100 jil of ( I
Protein A (10^ cpm/100 jil) and leaving to incubate on ice for U5 minutes.
After this incubation 100 pi of diluent were added and the cells spun
and washed a further U times. Wells were then allowed to dry overnight
before counting in a gamma-counter.
The following controls were always included:-
(i) replacing the anti-serum step with diluent to measure non-specific
Protein A adherence.
(ii) prebleed serum was used to check for Fc mediated attachment of
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FRACTION
FIGURE 2.15 Result of a typical Concanavalin A iodination
showing that the vast majority of P^lj in
fractions h and 5 are protein bound.
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antibody and cross reactive antibody which could be present
in normal serum.
Adherent cells In later experiments only adherent cells were used
and allowed to adhere for 1 hour before washing to remove non-adherents.
The assay was otherwise the same as for whole PEC except that centri-
fugation was unnecessary.
2.11.6 Absorption of anti-sera
Absorptions were carried out by mixing 100 yul of anti-serum with
8
up to 10 CBA/Ca thymocytes and incubating on ice for 1 hour.
2.11.7 Immunofluorescenc e
(i) Anti-sera Absorbed anti-serum to 6 day saline or 6 day
crocidolite PEC was used.
(ii) Developing anti-globulin Fluorescein isothiocyanate conjugated
goat anti-rabbit IgG (FITC-OR) (Seward) was used at a dilution
of 1/30 in Dul A to detect binding of anti-serum.
(iii) Method Coverslip cultures of 6 day saline or 6 day crocidolite
macrophages were prepared, washed and 100 jzl of absorbed anti¬
serum (1/10 dilution in Dul A) were placed on them for 30 minutes
at room temperature. Coverslips were then washed and uncubated
with 100 jil of FITC-OR at room temperature for 30 minutes.
Coverslips were then washed 3 times with PBS and mounted on slides
in PBS;glycerol (1:1) and examined in a UV microscope.
(iv) Blocking experiments In experiments designed to detect differences
between anti-sera, with regard to binding to macrophages, coverslip
cultures were treated with a first anti-serum as above followed by un-
labelled CWt; macrophages were then treated with the second anti¬
serum followed by FITC-G<xR. In this way only sites not recog¬
nised by the first anti-serum but recognised by the second were
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revealed. The number of macrophages showing "ring" fluorescence
in 200 cells was expressed as a percentage for each treatment.
2.11.8 Complement mediated lysis
g
Anti-sera absorbed with 10 thymocytes /100 ^il were prepared at
1:10 dilution in 5% BSA in Dul A and guinea pig serum, as a source of
complement, was added as 25% V/V. One hundred microlitres of anti¬
serum and appropriate controls were added to coverslip cultures of 6
day saline and 6 day crocidolite induced macrophages and incubated at
37°C for 2 hours. Coverslips were then washed, 100 pi of 0.05% Nigrosin
added and left at room temperature for 10 minutes before inverting on a
glass slide and counting the percentage of dead cells in 200 macrophages.
The following controls were used in the incubation step:-
(a) Dul A/BSA
(b) anti-sera plus 25% heat inactivated (30 minutes at 36°C) guinea
pig serum.
(c) Dul A/BSA plus 25% guinea pig serum
(d) prebleed serum plus 25% guinea pig serum
(e) to test that the guinea pig serum was working 1/25 dilution of
horse anti-thymocyte serum was used against thymocytes.
2.12 Use of indirect P ^i] Protein A binding to measure autoimmune
deposition of antibody on the surfaces of asbestos induced
macrophages in vivo
Attempts were made -to detect the presence of immunoglobulin on the
surface of asbestos activated macrophages using an indirect D Protein A
binding assay.
2.12.1
PEC were obtained 6 days, 1U days and up to 11 months after ip
injection of 2.5 mg crocidolite, chrysotile or Dul A and adjusted to
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2x10^ PEC/ml in cRPMI. One hundred microlitres of cell suspension
was delivered into Remov-a-wells (Dynatech M7h A) in a well holding
plate and spun for 5 minutes at 1,000 rpm as described above. Plates
were then incubated for 3 hours at 37^C in 5% CO^ to allow for macrophage
adherence. The non-adherent cells were removed with 3 washes with
200 ^il of cold diluent (Dul A containing FCS). Two hundred micro-
litres of various dilutions of rabbit anti-mouse immunoglobulin anti¬
serum (Dako) in diluent were added to triplicate wells and left on ice
for 1 hour. Wells were then washed, incubated with [1^l] Protein A,
washed and the radioactivity associated with each well ascertained as
described for the indirect Protein A assay (2.11.5).
Controls
(a) Dul A/FCS was substituted for anti-serum to measure non-specific
L ^i]Protein A adherence.
(b) To demonstrate that P^l] Protein A was working, anti-sera to PEC
(151/2 unabsorbed) was used at 1/50 dilution.
(c) To demonstrate that rabbit anti-serum to mouse Ig was working and
detecting mouse Ig, spleen cells which had been treated with a
monoclonal mouse anti © (1/50 dilution 1 hour at 0°C) then washed,
were included.
2.13 Long term effects of intraperitoneal asbestos
A number of mice were injected with asbestos and kept for up to 2
years to assess the validity of the CBA/Ca mouse peritoneal cavity as a
model in comparison with the known pathological effects of asbestos.
2.13.1 Histopathology
When mice showed signs of ill health or, in some cases, at pre¬
determined times, they were killed by ether overdose and the peritoneal
viscera resected and fixed in Bouin's solution. Tissue was processed
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to wax then cut and stained with haematoxylin and eosin. Other tissues
including tumours were treated in the same way.
2.13.2 Attempts to passage ascitic tumours by direct transfer
To determine whether the ascites which developed in many long term
asbestos injected mice, was malignant, ascites was removed by syringe
under sterile conditions from freshly killed mice. One millilitre
was injected directly into recipient syngeneic mice which were monitored
for ascites development.
2.13.3 Cell lines from ascites
On two occasions ascites from long term asbestos injected mice
was brought into culture as 5x10^ cells/flask (75 ml Corning 25110) and
maintained in primary culture for up to 6 weeks in cHPMI. If piled up
colonies developed, the flasks were treated with Trypsin/EDTA (Gibco)
for 5 minutes at 37°C and the cells so obtained were subcultured until
a cell line was established.
2.13.U Assay of tumourigenicity of cell lines
Subcutaneous site Cells were removed from culture, washed and adjusted
£
to 10 cells/0.1 ml Dul A and 0.1 ml injected subcutaneously into the
right hind limb of mice. Animals were observed for tumour growth.
Intraperitoneal site Cells were obtained as above and adjusted to
10^ cells/0.5 ml Dul A; 0.5 ml was then injected ip and the mice
observed for tumour development.
Tumours from the subcutaneous sites were occasionally disaggregated
with ensymes by incubating diced tumour with Trypsin (0.1 mg/ml) (Difco),
Pronase (0.25 mg/ml) (Calbiochem Behring), DN ase (0.1 mg/ml) (Calbiochem
Behring) at 37°C for 30 minutes with occasional shaking. Freed cells
were cultured as given above.
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2.13.5 Limited characteri»ation of 13 MC1 Asc cell line
This cell line was chosen to carry out same preliminary character¬
isation due to its ability to produce mesothelioma-like tumours on ip
injection.
(a) Immunogenicity 13 MC1 Asc cells were irradiated with 22,000 RADS
and mice received 10^ irradiated tumour cells ip on day 0. On day 1U
6 5 li 3
they received 10, 10, 10 or 10 normal 13 MC1 Asc ip. Other mice
^ ^ 1 I ^
received no prior immunisation but received 10, 10, 10 or 10
13 MCI Asc. Mice were monitored for tumour development.
(b) plit antigen expression Attempts to detect the "plit" marker
of the transformed phenotype (Bowen and Kulatilake 1979),
were carried out using the Protein A assay for immunoglobulin
binding as described above (2.11.5). Rabbit anti-serum to "pli*" was a
gift from Dr. D. Hannant.
2.1U Statistical analysis
Mean and standard deviation of replicates were calculated on pocket
calculators (TI Programmable 58 Texas Instruments and Cassio fx 3600P),
and the means compared using Student's T test (Bailey 1959).
RESULTS •
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3.1 Validity of the CBA/Ca mouse peritoneal model
A major factor in justifying the use of the mouse peritoneal injection
model to study the biological effects of asbestos is that it reacts
with lesions analogous to those produced in the lung by asbestos ; these pul¬
monary responses have been described extensively in Chapter 1 and are
fibrogenesis and carcinogenesis. Mice were therefore injected intra-
peritoneally with asbestos or control solutions and kept long term to
check the development of pathology. Further details are given in
Section 3.8.
3.1.1 Fibrogenic response
All mice killed more than 10 weeks after asbestos injection had some
degree of fibrosis in the peritoneal cavity and this was evident at
autopsy as binding together of the peritoneal viscera making separation
of the organs very difficult. At light microscopy the reason for this
was seen to be extensive fibrous adhesions binding the gut and visceral
organs together (Fig. 3.1); these fibrotic masses often contained
visible asbestos fibres.
3.1.2 Carcinogenic response
Many mice injected with asbestos and kept for more than a year
developed ascites and when this was transferred intraperitoneally to
syngeneic mice, tumours were produced in a small proportion of cases.
When the primary ascites was cultured, piled up colonies of cells arose
which, on injection, formed fibrosarcomas at subcutaneous sites and
mesothelioma-like tumours on injection into the peritoneal cavity (Fig.
3.2).
In these studies UICC asbestos injected into the peritoneal cavity
of CBA/Ca mice elicited a fibrogenic and carcinogenic response while
saline, latex and C. parvum controls did not.
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FIGURE 3.1 Section of the peritoneal viscera of a
mouse injected with crocidolite 13 months
previously. Large fibrous masses are '
visible binding sections of gut together
Mag. x 60
jar. T-J v -•*
XT • "V -V *****
FIGURE 3.2 Nodular tumour arising in the peritoneal
cavity following intraperitoneal injection
of a cell line (13MC1) derived from




3.2 Effects of intra-peritoneal asbestos on seme properties of the
induced macrophage population in the short, medium and long tern
3.2.1 Number of PEG Fig. 3.3 shows the total number of PEC harvested
from mice at the 3 time points, 3, 18 and 70 days after injection of
saline, latex, crocidolite or chrysotile. The number of PEC induced by
asbestos was significantly (P< 0.05 to P< 0.002 see Fig. 3.3 for details)
greater than that induced by saline on days 3 and 70; there was no
significant difference between saline or asbestos PEC numbers on day 18.
The number of PEC induced by latex injection was never significantly
greater than that induced by saline.
The exact cellular composition of the PEC was not ascertained at
each time point but macrophages averaged between 50 and 70% of the cells
with lymphocytes and neutrophils comprising the remainder; neutrophils
were particularly increased in proportion in the 3 day asbestos induced
populations.
3.2.2 Macrophage phagocytosis
Fig. 3.1; shows that on day 3 both asbestos types had induced macrophages
with a lesser mean proportion of cells able to phagocytose latex particles
than saline induced macrophages. Only crocidolite induced macrophages
however were significantly (?<_ 0.05) less able to phagocytose than saline
induced macrophages. At the two subsequent time points there was no
significant difference with regard to phagocytic ability.
3.2.3 Fc rosettes
Fig. 3.5 shows the percentage of rosette forming macrophages at the
3 time points. The total rosette forming cells were detected with 1/10
dilution of sensitizing antiserum and the high affinity receptor bearing
cells with a 1/1000 dilution of sensitizing antiserum. The mean total






FIGURE 3.3 Mean number of peritoneal exudate cells harvested from
mice 3, 18 or 70 days after injection of 0.5 ml Dul A
2.5 mg crocidolite, 2.5 mg chrysotile or 0.1$ latex.
Significant differences between asbestos and saline
3 days crocidolite P<0.002, chrysotile P<0.01j 70 days
crocidolite P<0.05> chrysotile p<0.01; latex was never
significantly different from saline.















FIGURE 3.4 Mean percentage of variously induced macrophages which
could phagocytose latex particles.
Significant difference between saline and crocidolite
at day 3:- P<0.05.
Bars denote - one standard deviation
£ pooled data from 2 separate experiments
DAYS AFTER INJECTION
-1 llib-






FIGURE 3.5 Mean percentage of macrophages forming Fc rosettes with
SRBC's coated with 1:10 and 1;1,000 dilutions of anti-
SRBC serum. Macrophages induced with various stimuli
as shown. Bars denote - one standard deviation. At
all 3 time points crocidolite and chrysotile induced
macrophages had a statistically significant increase in
the percentage able to form rosettes with lightly sensi¬
tised SRBC's compared to saline induced macrophages.
Levels of significance;- 3 day crocidolite and chrysotile
P<0.01; 18 day crocidolite pc0.05, 18 day chrysotile
P<0.01; 70 day crocidolite and chrysotile P<0.02.
At 3 days latex also produced a significant increase
(P<0.05) in this parameter over saline induced macro¬
phages.
pooled daia from 2 separate exps
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conditions at all time points. High affinity receptor bearing cells
were detected in low proportions in saline and latex induced macrophages
(on average between 5 and 20% of macrophages). The asbestos induced
macrophages always had a significantly greater (P<0.01 to P<0.05 see
Fig. 3.5 for details) percentage of cells able to form rosettes with
lightly sensitized SRBC's compared to saline induced macrophages. The
3 day latex induced macrophages had a small significant (P <0.05) increase
in this parameter over saline induced macrophages.
In addition to forming more rosettes with lightly sensitized SRBC's
the asbestos elicited macrophages also formed rosettes which had a
significantly (P^. 0.001) greater number of SRBC's/rosette than saline
induced macrophages (Table 3.1).
3.2.U Spreading
The percentage of macrophages able to spread on glass within 1 hour
is shown in Fig. 3.6. At all 3 time points asbestos induced macrophages
had a significantly (P^. 0.002 to P<0.01; see Fig. 3.6 for details)
greater proportion of cells which spread rapidly on glass; this population
was greatest at day 3 being more than b0% of all macrophages and lower at
subsequent time points. Saline and latex macrophages had less than 10%
of spreading macrophages at all time points, except for 3 day latex
which, at 15.U£ was slightly elevated.
3.2.5 Membrane 5' nucleotidase and lysosomal acid phosphatase
In addition to the three previous methods of measuring macrophage
activation, a further measure was sought. The levels of the ecto-enzyme
5' nucleotidase and the lysosomal enzyme acid phosphatase are known to
change with macrophage activation so these were measured in 3 day saline
and chrysotile induced macrophages. Table 3.2 shows the results of the
assays including appropriate controls and reveals a 7.U fold drop in 5'
nucleotidase and an 11.8 fold increase in acid phosphatase in chrysotile
-115a.
TABLE 3.1 Number of SRBC's/Rosette of macrophages induced
3 days after ip injection of saline or chrysotile.





3 day saline U.O-2.3*
3 day chrysotile 8.9-6.5
* x * sd of 50 rosette forming cells.
TABLE 3.2 Levels of 5' nucleotidase and acid phosphatase in
3 day saline and 3 day chrysotile induced macrophages.
3 DAY INDUCED MACROPHAGES
REACTION SALINE CHRYSOTILE
1 Nucleotidase 5.3*0.3 * 2.U-0.3
2 Acid phosphatase 1.5*0.1 5.1-0.9
3 Alkaline phosphatase 0.7-0.2 0.7*0.1
h Spontaneous substrate
hydrolysis (1 ) 0.2*0.0 0.2*0.0
5 Spontaneous substrate
hydrolysis (2) 0.U-0.2 0.3*0.0
6 Endogenous phosphate 0.7*0.1 1.0*0.2
7 Nucleotidase minus controls* 5.3-1.6=3.7 2.U-1.9=0.5
8 Acid phosphatase minus controls* 1.5-1.1-0J4. 5.1-O.U-U.7
Units = }i moles phosphate/mg protein/hour.
+
for nucleotidase subtract controls 3, U and 6
for acid phosphatase subtract controls 5 and 6.
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DAYS AFTER INJECTION
FIGURE 3.6 Mean percentage of macrophages spread on glass
after 1 hour incubation at 37°C. Macrophages
induced with various stimuli as shown. Bars
denote 1 one standard deviation. At all three
time points there was a statistically significant
increase in the percent spreading of asbestos
induced macrophages compared to saline. Levels
of significance:- 3 day crocidolite and
chrysotile P<0.01; 18 day crocidolite and
chrysotile P<0.01; 70 day crocidolite P<0.002,
70 day chrysotile P<0.02.
pooled data from 2 separate expf
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induced macrophages compared to saline induced macrophages.
3.2.6 Morphology
The appearance of asbestos induced macrophages at various time points
was compared with saline and latex induced macrophages using light and
electron microscopy.
3.2.6.1 Light microscopy
One hour after being plated on to glass, stained preparations of
macrophages (prepared for the spreading assay) revealed considerable
differences in morphology between those induced with latex or saline and
those induced with asbestos. This was true for all the time points but
was particularly marked at 3 days. May-Grunwald Giemsa staining revealed
saline and latex induced macrophages to be mainly small darkly staining cells
(Fig. 3.7); a frill of cytoplasm indicative of spreading was, in general,
absent although occasional cells were well spread and vacuolated.
Asbestos induced macrophages however were typified by a sub-population,
varying in proportion but always more than in the controls, of large
vacuolated granular cells which had spread extensively after 1 hour on
glass (Fig. 3.7). Many of these cells contained visible asbestos fibres
particlularly in the case of crocidolite. The remainder of cells in the
asbestos induced population were small unspread cells.
After 21; hours in culture in cRPMI there was an increase in the
percentage of spread cells in the saline and latex induced populations
(Fig. 3.8) but even the spread macrophages were strikingly different fran
asbestos induced macrophages cultured for a similar time. After 2b hours
in culture the majority of asbestos induced macrophages had spread and were
granular and had multiple vacuoles (Fig. 3.8).
After 3 days in culture on plastic, as revealed by low power phase
contrast microscopy in Fig. 3.9, the majority of saline induced macrophages






FIGURE 3.7 Light microscope view of preparations made
for the macrophage spreading assay and
therefore representing macrophages incubated
for 1 hour at 37°C on glass.
Upper;- 3 day latex induced macrophages.




FIGURE 3.8 Macrophages incubated for 2k hours.
Upper*- 3 day latex induced macrophages;




FIGURE 3.9 Low power phase contrast view of macrophages





were spread out on the plastic although a small sub-population remained
unspread.
3.2.6.2 Transmission Electron Microscopy (TEM)
The differences between asbestos induced and control macrophages
evident at light microscopy were confirmed by TM. Fig. 3.10 shows
18 day latex induced PEC containing predominantly macrophages compared
to 18 day chrysotiie PEC. In the case of the chrysotile PEC the induced
macrophages are increased in size and have much increased membrane activity
evident as complex infoldings of the surface.
Sections of 3 day chrysotile induced PEC were not, in general of good
quality due to large amounts of chrysotile which interfered with good
sectioning; some sections of acceptable quality were, however,, obtained.
Fig. 3.11 shows a low power view of a 3 day chrysotile induced macrophage
illustrating the convoluted nature of the plasma membrane. Fig. 3.11 also
shows a grazing section of such a cell to emphasise the convoluted nature
of the surface.
Fig. 3.12 shows a 70 day saline induced macrophage which is normal
in appearance compared with a 70 day chrysotile induced macrophage; the
latter has a large number of mitochondria and granules and possesses a
highly developed Golgi/vesicle system. The overall impression of the
chrysotile induced macrophages was, therefore, consistent with the increased
secretory status and metabolism of the activated macrophage.
Fig. 3.13 is a high power view of a 70 day chrysotile induced macro¬
phage with chrysotile fibrils present in a phagolysosome confirming that
the resident macrophages, 2-§ months after injection of asbestos, are
still handling asbestos through their vacuolar system.
Fig. 3.lli is a low power view of a multi-nucleate giant cell from 18
day chrysotile PEC and chrysotile is visible lying free in the cytoplasm
and also membrane bound. Multinucleate giant cells were present in low
-117a-






FIGURE 3.11 3 day chrysotile induced macrophages to
show convolutions of cell membrane.
Upper;- low power view Mag. x 5,000
Lower;- high power grazing section of a
macrophage to show complex nature of
surface infoldings Mag. x 12,000
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FIGURE 3♦12 70 day induced macrophages.
Upper - saline induced;
Lower - chrysotile induced.
Mag. x 7,500
-*17d.
FIGURE 3.13 High power view of a 70 day chrysotile
induced macrophage showing chrysotile
fibrils in a lysosome.
Mag. x 12,500
FIGURE 3.1U Multinucleate giant cell in peritoneal




amounts (< 5%) in all asbestos induced PEC.
3.2.6.3 Scanning Electron Microscopy (SEM)
All SEM preparations of macrophages were prepared by incubating PEC
on glass coverslips for 1 hour in cRPMI then fixing so they are directly
comparable with spreading assays.
Fig. 3.15 (upper) shows two typical 3 day saline induced macrophages
with shallow surface ruffles; although attached to the coverslip the
cells have not spread. As shown in Fig. 3.15 (lower) a sub-population
of saline induced macrophages did spread but they were very much in the
minority as would be expected from the spreading assay results. Fig.
3.16 (upper) is a low power view of 3 day chrysotile induced macrophages
and reveals heterogeneity in the population with regard to spreading
activity with unspread, partially spread and spread cells being represented.
As shown in Fig. 3.16 (lower) a representative 3 day chrysotile induced
macrophage is larger than a saline induced macrophage, has more surface
ruffles and is more spread. Fig. 3.17 shows a high power view of a
typical 18 day chrysotile and saline induced macrophage and reveals the
more numerous and complex membrane ruffling of the chrysotile induced
macrophages.
3.3 Interaction of asbestos and asbestos activated macrophages with
an experimental tumour in vivo and in vitro
3.3.1 Tumour cell cytotoxic activity of asbestos induced macrophages
3.3.1.1 Thymidine release assay
Since asbestos induced peritoneal macrophages were found to be
activated by several criteria (3.2) experiments were carried out to
determine whether these macrophages were tumouricidally activated.
Fig. 3.18 shows the percent specific tumour cell cytotoxicity due
to crocidolite and chrysotile induced macrophages for 3 different
-11 8a-
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FIGURE 3.1$ Scanning electron micrographs of 3 day
saline induced macrophages.
Upper - 2 typical unspread macrophages.
Marker line = U
Lower - 1 typical unspread macrophage
and a well spread macrophage. Marker
line = 10 jpm.
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FIGURE 3.16 3 day chrysotile induced macrophages.
Upper - typical heterogeneity of macrophage
spreading. Marker line = 10 ^pm.
Lower - higher power view of a typical
spread macrophage. Line marker = U jum.
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FIEURE 3.17 High power views of 18 day induced macro¬
phages.
Upper - saline induced. Lower - chrysotile
induced. Line marker = 1 ^jum.
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RATIO
FIGURE 3.18 Mean percent specific cytotoxicity to tumour
cells of macrophages induced by intra¬
peritoneal injection of crocidolite (a),
chrysotile (a) at 3, 3 and 33 days, 3 day
C. parvum (o) induced macrophages present as
positive controls. Bars denote t one
standard deviation.
3 separate exf£ tor each time point
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experiments carried out at the 3 different time points. In this case
35 days was used instead of 70 days since the absence of tumouricidal
activity at 5 days made it unlikely that this property would develop at
all. A positive macrophage tumour cell cytotoxic control of C. parvum
activated peritoneal macrophages shewed a mean toxicity, towards the
tumour cell targets for all experiments, of 2h.7% at 5:1 and Sh.0% at
10:1 effector:target ratios. Specific cytotoxicity due to asbestos was
low at all times mostly remaining below 10j£ and only once exceeding 20%
(with 5 day chrysotile at 10:1 ratio) and was considered negligible.
3.3.1.2 Visual evidence
In order to visually demonstrate the outcome of a tumour cell killing
assay, in the manner of Hibbs et al (1980), an assay was scaled up into 8
well plates using 3 day saline, crocidolite, chrysotile and C. parvum
macrophages at 10:1 with tumour cells. After 2 days the plates were
stained with May-Grunwald Giemsa and photographed. Fig. 3.19 shows a
stained plate where the density of staining of tumour cells is directly
proportional to their number. The order of density of staining is
control} saline } crocidolite )> chrysotile} C. parvum. Although not
quantitative there is a suggestion that chrysotile induced macrophages
have slightly more cytotoxic potential than crocidolite induced macro¬
phages.
3.3.1.3 Electron microscopy of interactions between asbestos activated
macrophages and tumour cells
SM When asbestos activated macrophages were found not to be
appreciably tumouricidal compared to C. parvum activated macrophages
in the thymidine release assay, electron microscopy was carried out to
determine whether the ability of asbestos activated macrophages to
physically interact with the tumour cells was impaired. Macrophages
were incubated with tumour cells at 10*1 ratio for 2 days before
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FIGPRE 3.19 Scaled up macrophage/tumour cell killing
assay using saline, crocidolite, chrysotile
and C. parvum induced macrophages stained
to show the density of tumour cells at the




Fig. 3.20 shows non-tumouricidal 3 day saline induced macrophages
which have been incubated with CCH^ tumour cells; they have not spread
on the surface of the tumour cells as shown also by the higher power
view in Fig. 3.20. Fig. 3.21 shows tumouricidal C. parvum activated
macrophages in contact with CCRj tumour cells which are undergoing bleb
formation and lysis. It is particularly notable that the macrophages
are spread out on the tumour cell and there is therefore a large area of
membrane contact.
Fig. 3.22 shows chrysotile induced macrophages in contact with a
tumour cell; it is evident from photographs taken at low and high power
that these macrophages are not spread but have remained with a small area
of membrane contact.
Thus in the case of saline and chrysotile induced macrophages,
which were not tumouricidal, there was minimal contact between the macro¬
phage and the tumour cells while in the case of the tumouricidal C. parvum
activated macrophages there was spreading on to the tumour cell surface
with a resultant large area of membrane contact. It is possible that this
physical difference in macrophage/tumour cell interaction could underlie
the difference in tumouricidal potential of the macrophage populations.
3.3.2 In vitro tumour cell cytostatic activity of asbestos induced
macrophage supernatants
The results shown in Fig. 3.23 were obtained from £ separate exper¬
iments where 2k hour supernatants from 3 day asbestos and control macro¬
phages were tested in an assay of tumour cell proliferation in vitro.
The large standard errors reveal a considerable variation in response
of the tumour cells to the supernatants. There were no significant
inhibitory effects of any of the macrophage supernatants on CCH-j tumour
cell proliferation although there is a suggestion that chrysotile macro-
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FIGURE 3»20 3 day saline induced macrophages incubated
with tumour cells for 2 days.
Marker bars - upper 1* pi, lower h pi.
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FIGURE 3,21 C. parvum induced macrophages interacting
with tumour cells after 2 days co-culture.
Note extensive spreading of macrophages
on tumour cell surface.
Marker line - upper lower 2 pm.
FIGURE 3.22 Chrysotile induced macrophages interacting
with tumour cells after 2 days co-culture.










FIGURE 3.23 Effect of various macrophage supernatants on uptake
of thymidine by tumour cells. Mean percent uptake,
in the presence of 5, 25 or 50^ macrophage super¬
natant is shown, compared to uptake by tumour cells
alone. Bars denote 1 one standard error.
data from 5 separate exp.5
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phage supernatants could have some inhibitory activity.
It was notable that C. parvum activated macrophage supernatants were
not cytostatic although the macrophages themselves were cytotoxic in
thymidine release assays. This reveals that a diffusible cytotoxin
was not responsible for the cytotoxicity of the C. parvum activated
macrophages.
3.3.3 Experiments to detect the in vivo effects of asbestos and
asbestos activated macrophages on tumour growth
These experiments were carried out using the CCH^ subcutaneous tumeur
model in mice and attempts were made to detect tumour growth inhibition
by asbestos or asbestos induced PEC.
3.3.3.1 Effects of intraperitoneal asbestos injection on subcutaneous
tumour growth
(i) 5 mg chrysotile 3 days after 10^ s/c tumour cells
Fig. 3.2ii shows that ip injection of 5 mg chrysotile 3 days after
tumour cell inoculation resulted in significant (Day 13 P<0.01; Day 17
P < 0.001) reduction in tumour size compared to saline injected mice.
Fig. 3.25 shows the same experiment repeated to include a latex injected,
phagocytic stimulation, control group. Once again chrysotile caused
significant (Day 10 P<_0.02; Day 13 and 17 P< 0.002) reductions in
tumour size compared to the saline control; latex injection caused a
significant (P<0.01) reduction in tumour size on Day 10 compared to
the saline controls but by Day 13 and 17 the latex injected mice had
tumour sizes not significantly different from the saline injected controls.
(ii) 5 and 20 mg chrysotile 3 days after 5x10 s/c tumour cells
In an attempt to increase the effect of chrysotile in inhibiting
tumour growth 5 and 20 mg of chrysotile were given intraperitoneally
2
on day 3 following a reduced tumour cell inoculum of 5x10 tumour cells






5- DayO 10® Tumour cells s/c
Day3 5mg.CHRYS.
SALINE o-o
6 T 1 9 10 11 12 13 %15 16 17
DAYS
FIGURE 3^2h Effect of intraperitoneal chrysotile on subcutaneous
tumour growth. Significant differences between
saline and chrysotile injected - Day 13 P<0.01j
Day 17 P<0.001.
Symbols denote x - one standard deviation ("10 mice).
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DAYS
FIGURE 3.2$ Effect of intraperitoneal chrysotile ($mg) and latex
(1£) on subcutaneous tumour growth. Significant
differences between saline and chrysotile - Day 10
P<0.02j Day 13 and Day 17 P<0.002. Significant
difference between saline and latex - Day 10 P<0.01.



















1 20 21 22 23 24 25 26 27 28
DAYS
FIGURE 3.26 Effect of 5 mg and 20 rug chrysotile on tumours
grown from a reduced tumour cell inoculation of
2
5x10 cells. No significant differences.
Symbols denote x - one standard deviation ^10 mic e
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points between chrysotile and saline injected animals.
(iii) 5 mg and 20 mg chrysotile 2 days prior to 5x10 s/c tumour cells
In further attempts to emphasise the effect of chrysotile obtained
in 3.3.3.1(i) 5 and 20 mg of chrysotile were injected intraperitoneally
2
2 days before tumour cell inoculation with 5x10 cells. Fig. 3.27 shows,
by comparison with Fig. 3.28, that this protocol greatly enhanced the
growth inhibitory effect of C. parvum injection which caused significantly
(Day 28, 32 P< 0.001) smaller tumours than controls. Both 5 and 20 mg
of chrysotile in this protocol, however, had no significant effect on
tumour growth.
(iv) 5 mg crocidolite 3 days after 10^ s/c tumour cells
To determine whether crocidolite, in the same protocol, had the same
inhibitory effect as chrysotile on s/c tumour growth, 5 mg crocidolite
was injected s/c 3 days after 10^ s/c tumour cells (Fig. 3.28).
C. parvum was also injected and caused significantly (Day 10 P< 0.01 j
Day 13 P < 0.05; Day 17 P< 0.001) smaller tumours but 5 mg crocidolite
had no significant effect on tumour growth.
(v) Effect of quartz on tumour growth
Quartz given intraperitoneally as 20 mg 3 days prior to inoculation
with 10^ s/c tumour cells had no effect on tumour size except for a
significant (p< 0.02) increase in tumour size on Day 20 (Fig. 3.29).
Once again 20 mg of chrysotile had no significant effect on tumour growth
rate.
3.3.U Winn type assays using asbestos induced PEC
Three day chrysotile induced PEC were used at ratios of 10;1 and
100:1 in Winn assays of subcutaneous tumour growth. Fig. 3.30 shows
that at both ratios of PEC:tumour cells there was no significant effect
of chrysotile induced PEC compared to either CCH-j cells alone or CCH^
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FIGURE 3.27 Effect of 5 and 20 mg chrysotile injected
intraperitoneally 2 days before subcutaneous
inoculation with the low dose (5x10 ) of
tumour cells. No significant effects of
chrysotile in this regime. C. parvum
included as a positive control caused marked
significant reductions in tumour size on
days 28 and 32 compared to saline (P-C0.001 ).
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FIGURE 3.28 Effect of crocidolite (5mg) on subcutaneous tumour
growth. No significant difference in tumour size
between saline or crocidolite injected mice.
C. parvum included as positive control produced
significantly smaller tumours on Day 10 P<0.01j
Day 13 P<0.0£; Day 17 P<0.001.
Symbols denote x - one standard deviation [10 mice].
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FIGURE 3«29 Effect of chrysotile (20 mg) and quartz (20 mg) on
subcutaneous tumour growth. No significant effect
of chrysotile injection compared to saline;
significantly greater tumour diameter in quartz
injected compared to saline injected mice on day 10
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FIGURE 3«30 Effect of chrysotile PEC in Winn assays with tumour cells
at ratios of 10 ;1 (upper) and 100;1 (lower). Controls
comprise saline PEC:tumour cells at the same ratio and
tumour cells only. Significantly smaller tumour diameter
found only with chrysotile PEC at 10:1 ratio on day 13
(K0.02).
_ +
Symbols denote x - one standard error (10 mice).
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cells mixed with saline induced PEC at the same ratios except for
10:1 day 13 where chrysotile PEC caused a significantly (P< 0.02)
smaller tumour size compared to saline PEC; this difference had
disappeared by day 17 and 20.
3.3.5 Effect on tumour growth of mixing various amounts of crocidolite
with the inoculating tumour cells
In an effort to produce local macrophage activation at the tumour
inoculation site, it was decided to mix various doses of asbestos with the
inoculating tumour cells and measure the effect on tumour growth.
Crocidolite was chosen rather than chrysotile since it has a less active
surface and would be less likely to cause direct toxic effects on the
tumour cell membrane; crocidolite was incubated for an hour at 37°C in
cRPMI to coat the fibre and further reduce any direct toxic effects.
Fig. 3-31 shows a dose dependent retardation of tumour growth with
crocidolite added to the inoculating tumour cells. Significant
(P <0.05 to P< 0.001 see Fig. 3.31 for details) differences, compared
to tumour cells only, were produced by 50 and 500 }ig crocidolite at all
3 time points.
3.3.6 Effects of asbestos and asbestos leachate on growth of CCEj
tumour cells in vitro
3.3.6.1 Asbestos
Fig. 3.32 shows the pooled results of U separate experiments to
measure the direct effects of asbestos on tumour cell tritiated thymidine
uptake in vitro. It is evident that there is no stimulatory effect of
either crocidolite or chrysotile at low doses. Over the first 3 orders
of magnitude there is relatively little effect (up to 10 jug/well) with
crocidolite being slightly more inhibitory than chrysotile. At 1 00 p.?J
well, a highly unrealistic dose, the results become erratic with
-123a-
DAYS
FIGURE 3.31 Effect on tumour growth of mixing 5, 50 or 500 pg
2
of crocidolite with 5x10 inoculating tumour cells.
Significantly smaller tumours produced by 50 and
500 p.g of crocidolite conqpared to no crocidolite on -
Day 2b 50 )ig P<0.05; 500 jxg P<0.001. Day 28 50 ;ig
P<0.05; 500 pg P<0.001. Day 30 50 ;ig P<0.02j
500 ;ig P<0.01.
Symbols denote x - one standard error (10 mice).
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ASBESTOS/WELLl^g)
FIGURE 3.32 Effect of 0.01-100 yxg/ well of asbestos on uptake of
thymidine by CCH^ tumour cells.
Symbols denote x - one standard deviation.
(data from 3 separate exp5)
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crocidolite inhibiting thymidine uptake and chrysotile apparently
stimulating uptake. Fig. 3-33 shows that the effect of asbestos was
considerably less than that produced by inert latex particles given
over 5 orders of magnitude when latex produced a clear dose dependent
inhibition of thymidine uptake.
3.3-6.2 Asbestos leachate
Fig. 3.3J4. shows that there was no obvious dose dependent effect of
medium in which asbestos had been incubated (leachate) on tumour cell
proliferation with maximum inhibition of between 5 and 20% being present
between 0.5 and 50^ of leachate by volume.
3.3.7 Effect on tumour growth of having cultured the inoculating
tumour cells in vitro in the presence of crocidolite
In order to test whether incubation with crocidolite, prior to
injection into mice, could alter the tumourigenicity of the CCH^ cells
they were cultured with 2.5 Jig of crocodolite (pre-coated by incubation
with cRPMI) for 2 days than harvested and inoculated subcutaneously in
mice. Tumour growth was then monitored and as Fig. 3.35 shows, pre¬
incubation of CCRj cells with crocidolite had no significant effect on
their ability to form tumours compared with tumour cells grown in
parallel culture in the absence of crocidolite.
3.I4. The use of Concanavalin A to study the effect of asbestos on
macrophage membranes
3.1;.1 Visualisation of Con A receptors during interactions between
macrophages and asbestos
3.14..1.1 Light microscopy
Macrophages were treated with chrysotile asbestos for up to 1 hour









FIGURE 3♦33 Effect of increasing doses of latex on uptake of tritiated
thymidine by CCH^ tumour cells.
Symbols denote x - one standard deviation ^triplicate wells: repce
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% LEACHATE/WELL
FIGURE 3,3k Effect of asbestos leachate on uptake of tritiated
thymidine by CCH^ tumour cells.
Symbols denote x - one standard deviation.
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FIGURE 3«35> Effect on tumour growth of having pre-incubated the
inoculating tumour cells in crocidolite for 2 days.
Symbols denote x - one standard deviation(1 0 mice).
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receptors by FITC-ConA staining. Any changes in the disposition of
the Con A receptors in the membrane, following contact with asbestos,
would therefore be revealed. As described below only a few instances
were observed, where there was obvious perturbation to Con A staining.
Fig. 3.36 shows bright field and fluorescence illuminated exposures
of the same cells 15 minutes after the addition of chrysotile in serum
free conditions. The arrow indicates an area of bright fluorescence
at a point where a chrysotile fibre is being phagocytosed, or is in
contact with the macrophage membrane. Due to the curve in the fibre,
the fibre is making contact with the cell in a plane perpendicular to
the plane of the photograph as was discernible by focusing. Fig. 3.37
shows cells treated in the same way as those in Fig. 3-36j a straight
line of fluorescence is seen to be crossing one of the cells (arrowed)
and this coincides with a chrysotile fibre lying across the cell at the
same angle. Unfortunately the fibre in question is partly obscured in
the bright field exposure by a large defocussed fibre passing in a plane
well above that of the cell due to its curliness. Fig. 3.38 shows cells
30 minutes after addition of chrysotile in serum containing medium and
shows a macrophage apparently trying to engulf a long fibre (arrow).
At the point where the membrane closes around the fibre like a sleeve,
at its furthest extremity from the cell body, there is a slight but
distinct increase in fluorescence intensity. Fig. 3.39 shows cells 30
minutes after the addition of chrysotile in the presence of serum and a
macrophage (arrow) ingesting a small chrysotile fibre is seen to have a
concentration of fluorescence around the point of phagocytosis at the
membrane.
The number of cells showing some perturbation of the Con A staining,
at points of membrane/chrysotile interaction were few, representing less
than at all time points. It was however impossible to tell whether
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FIGURE 3.36 Macrophages incubated with chrysotile
asbestos then stained with FITC-Con A.
Upper photograph taken under bright field
illumination; lower under fluorescence
illumination. Arrow shows area of bright
fluorescence where fibre is in contact with
a cell in a plane perpendicular to the
paper. Mag. x 600
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FIGPRE 3.37 Macrophages prepared as in Fig. 3.36.
Arrow in lower indicated a straight line
of fluorescence which coincides with a
fibre lying across a macrophage but which
is not clearly seen in the bright field
(upper) view due to the defocussed fibre
lying above it. In the lower figure the
very faint outline of the fibre is seen




FIEURE 3.38 Macrophages prepared as in Fig. 3.36;
arrow indicates macrophage spread out
and ingesting a fibre. At the point
where the membrane closes around the




FIGURE 3.39 Macrophages prepared as In Fig. 3.36;
arrow shows concentration of fluorescence
at membrane where fibre enters the cell.
Mag. x 600
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some "concentrations" of fluorescence at the membrane, which were
apparently not asbestos associated, were in fact due to interactions of
the membrane with chrysotile fibres below the resolution of the micro¬
scope. It follows from this, also, that the perturbation in Con A
distribution shown here, represents those produced by the larger,
resolvable fibres.
Concentrations of fluorescence were present at points of contact
between macrophage membrane and chrysotile fibres in both non-serum and
serum containing conditions. The aggregation of fluorescence at points
of contact between asbestos fibres and macrophage membranes was always
present along with some "ring" staining of the sort obtained with normal
macrophages. The areas of increased fluorescence intensity were not,
therefore, capsj caps are usually present as aggregates of fluorescence
with the normal "ring" fluorescence absent since all the receptors have
been drawn into the cap. The difference between a cap and increased
intensity of fluorescence at any point is apparent by comparing Fig. 3.36
with Fig. 3.US.
Occasionally Con A positive "beads" were seen on fibres (e.g. Fig. 3.36)j
the exact nature of these was unclear although they could represent organic
material in the UICC sample or regions of adsorption of FITC-Con A on to
the fibre surface.
3.U.1.2 Electron microscopy
As shown in Fig. 3.U0 the ultrahistochemical demonstration of
macrophage surface bound Con A was successful with the black reaction
product confined to the plasma membrane and a few vesicles near the
membrane probably representing infoldings of the membrane caught in
section. Fig. 3.U0 also reveals Con A to be bound only to the free
surface of a macrophage which has been spread on glass although it is not
possible to ascertain whether the lack of reaction product on the adherent
-126a-
FIGURE 3*14.0 Macrophages stained with peroxidase to
reveal Con A bound to the surface.
Upper - high power view to show that
reaction product is confined to the surface.
Lower - low power view revealing the
majority of reaction product to be confined
to the free surface of the macrophages.
Magnification - upper x 7,500;
lower x 3,000.
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aspect was due to trauma to the adherent surface during removal of the
cells from the petri dish.
Close interactions between macrophage membrane and asbestos were
present at 30 and 60 minutes after addition of chrysotile to the cultures.
Fig. 3.Itl (upper) shows an area of membrane where a bundle of fibres is in
contact with macrophage membrane in serum containing conditions; the
distribution of reaction product at the membrane can be seen to be
unaltered by the interaction. As shown in Fig. 3»li1 (lower) at sites
of interaction between chrysotile and macrophage pseudopodal extensions
there is no evidence of obvious disturbance to the membrane distribution
of Con A receptors. Fig. 3*h2 upper and lower are higher power views
and once again there is no obvious disturbance to the distribution of
reaction product where the asbestos is in contact with the macrophage
membrane. Figs. 3-h3 upper and lower show phagosomes containing
chrysotile; the density of the reaction product on the phagosomal
membrane presumed newly derived from the plasma membrane at a site of
interaction between fibre and membrane, is similar to that of the overlying
plasma membrane.
These experiments showed that at no site of interaction between
chrysotile and macrophage was there obvious evidence of clustering of
Con A receptors either in serum containing or serum free conditions
using this ultracytochemical demonstration of Con A receptors.
It should be emphasised that the ultracytochemical method used to
demonstrate surface bound Con A was probably not capable of resolving
small local variations in Con A density due to a combination of the
coarseness of the reaction product and the thickness of the section
necessitated by the difficulty of cutting blocks with so much chrysotile
in them.
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FIGURE 3.1*1 Macrophages prepared as in Fig. 3.1i0. In
both the low (upper) and high (lower) power
views shown there is no evidence of
alterations in distribution of reaction
product at sites of membrane chrysotile
interaction.
Mag. - upper x 15,000; lower x 25,500.
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FIG-URE 3.h2 Macrophages prepared as in Fig. 3«^0.
Chrysotile in contact with macrophage
membrane over an extensive area but
failing to show any marked effect on
reaction product distribution.
Mag. - upper x 20,000; lower x 20,000
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FIGURE 3.U3 Macrophages prepared as in Fig. 3»U0.
Chrysotile present inside newly formed
phagosomes close to the macrophage
surfaces. No obvious differences in
distribution of reaction product in
phagosomes compared to the surface
membrane from which they were derived.
Mag. - upper x 15,000; lower x 25,500.
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3.1i.2 Concsmavalln A induced capping in macrophages
3.iu2.1 Appearance of Con A caps in activated macrophages
Control 3 day saline induced peritoneal macrophages incubated at
37°C with FITC-Con A then fixed and viewed under fluorescent illumination
had the appearance shown in Fig. 3.1jii (upper); even "ring" fluorescence
was present. Macrophages induced 3 days after chrysotile injection and
treated in the same way, however, had a population comprising more than
30% approximately of cells which had bright "caps" of fluorescence and
absence of ring staining as shown in Fig. 3.U1* (lower). Fig. 3»hS shows
both bright field and fluorescent views of a group of capped, chrysotile
induced macrophages showing the caps to be present, in general, at one
pole of the cell. The caps were similar to those described by Pick and
Wilner (1979) in peritoneal macrophages.
3.11.2.2 Proportion of capping macrophages induced in the peritoneal
cavity by different agents
As shown in Table 3.3 the proportion of macrophages which capped
on incubation with Con A was, on average, below 5% for saline induced
macrophages and also for macrophages induced by proteose peptone and
latex. Injection of chrysotile, crocidolite or C. parvum however
produced an increase in the percentage of capping macrophages. The
proportion of caps in 3 day chrysotile, crocidolite and 5 day C. parvum
was significantly (P<0.001) greater than that of 3 day saline, proteose
peptone or latex induced macrophages. The proportion of caps in 3 day
chrysotile induced macrophages was significantly (p<0.02) greater than
that in 3 day crocidolite induced macrophages.
3.11.2.3 Time course of capping
Fig. 3.I16 shows that both chrysotile and C. parvum induced macrophages
had an approximately similar rate of capping, reaching a plateau by 20
-128a-
FIGUEE 3.kit Upper: saline induced macrophages treated
with FITC-Con A for 30 minutes at 37°C.
Fluorescence is even and ring-like.
Lower: chrysotile induced macrophages
showing "caps" in a proportion of cells.
Mag. x 600
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FIGURE 3.1*5 Bright field (upper) and fluorescence
(lower) illuminated field of chrysotile




TABLE 3.3 Effect of injection of different agents on proportion
of capping macrophages (FITC-Con A 37°C 20 minutes).
Significant differences 3 day saline v 3 day chrysotile,
3 day crocidolite and 5 day C. parvum - P < 0.001j
3 day chrysotile v 3 day crocidolite - P<0.02.
MACROPHAGE PERCENT CAPPING NUMBER OF
SOURCE WITH FITC-CON A EXPERIMENTS
3 day saline U.1-2.3 8
3 day chrysotile 32.2-U.2
3 day crocidolite 22.8-2.6 3
£ day C. parvum 32.U-5.0 6
3 day proteose peptone 1.2-1.1 2
3 day latex 3.2-0.9 1
-128d-
FIGURE 3.1*6 Time course of capping in saline, chrysotile
and C. parvum induced macrophages.
x of duplicate coverslips: repr. exp.
I
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minutes with little increase thereafter. It was notable that, after 30
minutes, the caps became more diffuse, as though they were internalized
and no longer easily focused at the cell surface.
3.1u2.1i Temperature dependence of capping
Table 3.ii reveals the temperature dependence of capping using
C. parvum activated macrophages. At room temperature the percentage of
capping cells remained at control levels with a significant (P< 0.001)
difference between C. parvum macrophages at 37°C and at room temperature
with regard to percentage capping cells.
3.1i.2.5 Dose response of chrysotile induced capping
Fig. 3-U7 reveals that increasing doses of intraperitoneal chrysotile
caused a dose dependent increase in proportion of capping macrophages
which had reached a plateau by 2.5 mg, the dose used in this study.
3.U.2.6 Capping in a rapidly adhering subpopulation of activated
macrophages
Table 3.5 shows the proportion of capping macrophages in 3 day saline,
chrysotile and C. parvum induced macrophages adhered for 15 or 60 minutes
before washing. The use of a 15 minute adhering subpopulation was aimed
at trying to select out the most activated, and therefore rapidly adhering,
subpopulation. The number of cells in the 15 minute adhering fraction was
approximately 2/3 of the number in the 60 minute adhering fraction. It is
apparent from Table 3.5 that there was no evidence of increased proportions
of capping macrophages in the 15 minute adhering subpopulation compared
to the 1 hour adhering population.
3.1i.2.7 Pharmacological modification of capping
The microtubule disrupting drug colchicine and the microfilament
disrupting drug cytochalasin B were used to pre-treat activated macro¬
phages to ascertain the role of these cytoskeletal elements in capping.
Table 3.6 shows that neither drug had any effect on the low level of capping
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TABLE 3'h Dependence of capping in C. parami induced macrophages,
on temperature.
Significant differences 5> day C. "parvum 37°C v £ day
C. parvum room temperature P <C 0.001.
MACROPHAGE
SOURCE
TREATMENT % CAPS n
3 day saline
37 °C
20 min. U.1-2.3 8
5 day C. parvum 37°C20 min. 32.U-5.0 5





FIGURE 3,li7 Effect of increasing the intraperitoneal dose of
chrysotile on the proportion of macrophages capping
with Con A. x of2micecit each dose
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TABLE 3.5 Proportion of capping macrophages in 15 and 60 minute









3 day saline 1.0-2.3 U.2-1.9
3 day chrysotile 26.U-5.2 33.2-U.1
5 day C. parvum 30.0-1.8 33.5-6.8
xtsd of triplicate c/slips
TABLE 3.6 Effect of pretreatment with saline, colchicine or
cytochalasin B on Con A capping in 3 day saline and
chrysotile induced macrophages.
Significant difference;- 3 day chrysotile, saline v
cytochalasin B treatment P <C 0.001.
MACROPHAGE
SOURCE
PRE-TREATMENT* % CAPPING n
3 day saline saline U.2-1.6 3
n 10~Sl colchicine 5.6-U.8 h
H
-li
10 M cytochalasin B 3.0-5.2 h
3 day chrysotile saline 32.7-U.1 3
If 10~Sl colchicine 39.5-10.5 3
It 10~^M cytochalasin B 6.0-2.9 3
* o
Pretreatment was 1 hour at 37 C.
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present in 3 day saline induced macrophages. In the 3 day chrysotile
induced macrophages there was no significant difference between saline
and colchicine pre-treated macrophages with regard to percentage of
capping cells. Cytochalasin B pre-treatment did, however, significantly
(P< 0.001) reduce the percentage of capping chrysotile induced macrophages
down to control levels.
Cytochalasin B was prepared by diluting first in dimethyl-sulphoxide
and so the effect of dimethyl-sulphoxide alone on capping was tested.
As shown in Table 3.7 dimethyl-sulphoxide alone had no effect on capping
while cytochalasin B containing the same amount of dimethyl-sulphoxide
reduced the proportion of capping cells to less than 25% of the saline
treated control.
Lignocaine is a local anaesthetic known to act against the cyto-
skeleton and so the effect of this drug on capping was measured. As
shown in Table 3.8 lignocaine pre-treatment also reduced capping although
this result was confused by detachment of up to 50% of macrophages from
the coverslip by the time they were mounted.
3.U.2.8 Re-expression of Con A receptors following occupation of receptors
Saline induced macrophages showed re-expression of bright ring
fluorescence 3-U hours after treatment with unlabelled Con A (Fig. 3.U8)
Chrysotile induced macrophages also showed re-appearance of ring fluor¬
escence in the uncapped cells and bright fluorescent caps in a sub-
population of cells within the same time interval.
3-U.2.9 Capping in nude mice
Nude mice have been reported to have peritoneal macrophages in a
perpetual state of activation (Zinkernagel and Blanden 1975) and so
unstimulated peritoneal macrophages from nude mice were obtained and
tested for Con A capping compared to saline induced macrophages from
non-nude mice. As shown in Table 3.9 nude mice had a significantly
-130a-
TABLE 3.7 Effect of saline, DMSO or cytochalasin B pre-treatment
on the proportion of capping cells in chrysotile




10~S4 in 1% DMSO
39.8 35.8 9.3
+Pre-treatment was 1 hour at 37°C.
x of duplicate c/slips









TABLE 3.9 Percentage of capping macrophages in macrophages from








f xrsd of triplicate c|slips
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TIME AFTER TREATMENT
WITH UNLABELLED CON A
(hours)
FIGURE 3.14-8 Reappearance of membrane Con A fluorescence with time
following treatment with unlabelled Con A in saline and
chrysotile induced macrophages.
x of duplicate c/s:repn exp.
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(P<.0.01) greater proportion of capping macrophages than saline induced
macrophages from normal mice.
3.1*.2.10 Electron microscopy of capping cells
Saline and chrysotile induced macrophages were fixed for electron
microscopy before and after treatment with Con A under capping conditions.
(i) Scanning electron microscopy
The appearance of 3 day saline induced macrophages at SEM has been
described (Section 3.2.6.3; Figs. 3.15).
On treatment with Con A for 20 minutes at 37°C there was a striking
alteration in the membrane configuration of 25-50^ of the macrophages
and this was apparent as a change from the low ruffles seen in Fig. 3.15
to large frond-like processes shown in Fig. 3.U9; as is apparent from
Fig. 3»h9 (lower) some macrophages remained largely unaffected by Con A
treatments.
Chrysotile induced macrophages did not show such a marked increase
in membrane ruffling as did the saline induced macrophages on treatment
with Con A; a proportion of them did, however, have large conspicuous
blebs at one pole (Fig. 3.50) which could be homologous with the caps
seen at fluorescence microscopy. The difference in tone of the "bleb"
compared to the rest of the cell in Fig. 3.50 suggests that this region
of membrane has a different secondary electron emission to the rest of
the cell membrane and so tends to confirm that the physicochemical
nature of the bleb membrane is different. This presumably reflects
the concentration of Con A and its glycoprotein receptor in the bleb.
It was also notable that more chrysotile induced macrophages had spread
following Con A treatment.
(ii) Transmission electron microscopy of capped chrysotile macrophages
Three day chrysotile induced PEC were brought into siliconised tubes
and treated with Con A under capping conditions then processed as a
FIGURE 3.h9 Scanning electron micrographs of saline
induced macrophages treated with Con A.
Marker line h jum.
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FfGURE 3.50 Scanning electron micrographs of chrysotile
induced macrophages incubated with Con A.
Large "blebs" (arrows) showing secondary
electron emission different from the rest
of the cell may represent caps.
Marker line:- upper 10 jum; lower 2 jum.
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pellet for TM. Despite a comprehensive search no structural correlate
could be seen equivalent to the caps seen by light and scanning electron
microscopy. It is clear from Figs. 3.15 and 3.16 that 3 day chrysotile
induced macrophages have exceedingly complex surface infoldings. On
treatment with Con A this infolding and vacuolation was, on a qualitative
basis, seen to be slightly increased (Fig. 3.51) and the number of cells
which could be scored as having this pattern of surface membrane infolding
(in 200 cells assessed at 2,000 x magnification) rose from 33.6$ in non-
Con A treated to 59.7$ in Con A treated. No clear region corresponding
to a "cap" could be seen and this could be due to at least two possibilities:-
(i) capping was always carried out, in the light and SEM experi¬
ments discussed above, on adherent cells while for TEM the capping was
carried out on suspension where the occurrence of caps was never
investigated;
(ii) if 30$ of macrophages have caps, whole PEC comprising 65$
macrophages will have only 20$ of all cells with caps; the likelihood
of sectioning through a cap in a randomly oriented cell could be
conservatively guessed at 50:1; thus in 100 PEC sectioned it could be
predicted that only 1-2 macrophage caps would be visible on section.
3.1u 3 Use of [j Con A to assess the number of Con A binding
latex spheres was significantly (P< 0.001) less than binding to control
macrophages as shown in Table 3.10. The latex treated macrophages
had U2.2$ of the binding to untreated macrophages.
3.1i.3.2 Attempts to measure the effect of phagocytosis of antibody
sites in the macrophage membrane
3.1a.3.1 Effect of phagocytosis of latex spheres on Con A binding
Con A to macrophages which had phagocytosed
coated SRBC on [^^1 Con A binding
This method necessitated the lysis of the surface adherent
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FIGURE 3.51 Transmission electron micrographs of
chrysotile induced macrophages incubated
with Con A Tinder capping conditions.
Upper - low power view to show general
increase in membrane activity compared
with Fig. 3#11.
Lower - high power view of membrane and
associated vesicle traffic.
Mag. - upper x 7,600; lower x 18,500.
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TABLE 3.10 Binding of [1^l] Con A to control macrophages treated
with Dul A or latex spheres.
Significant difference P<0.001.
TREATMENT





TABLE 3.11 Binding of [ "ij Con A to control macrophages, control
macrophages treated with lytic buffer and control
macrophages treated with SRBC then lytic buffer.
Significant differences - control v control + lytic
buffer, P<0.001; lytic buffer v SRBC + lytic buffer,
P<0.05.








xtsd of 4-10 c/s: repr. exp!
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unphagocytosed SRBC's so that they would not interfere by binding
0 ^i] Con A at the macrophage surface. However, as shown in Table
3.11, treatment of the control macrophages with the lytic buffer alone
resulted in a significant (P< 0.001) reduction in Con A binding
compared to control macrophages treated with Dul A. Thus although
there was a reduction in binding by 30% (P<0.05) this was over and
above a h7% reduction in binding due to lytic buffer alone.
3.U.3.3 Binding of [125i] Con A following phagocytosis of asbestos
The binding of (i»J Con A to macrophages following phagocytosis
of both crocidolite and chrysotile asbestos was always greater than the
binding to controls. Table 3.12 shows the results of an experiment
where crocidolite phagocytosis resulted in a 20% increase in binding of
[1^l] Con A, while Table 3.13 shows an increase in binding of 8.5£
following phagocytosis of chrysotile. In 5> separate experiments using
asbestos, reduction in binding was never found following phagocytosis
and increases ranged from 8.5>-23«1$ over controls. Microscopic
examination of cells confirmed that phagocytosis had occurred in these
experiments and it was assumed that cell surface adherent fibres and
incompletely phagocytosed fibres were responsible for the increased
binding.
3.U.3.1* [1^l] Con A binding to control macrophages and macrophages
elicited with asbestos or C. parvum
The binding of P^l] Con A to equal numbers of control, asbestos or
C. parvum activated macrophages are shown in Table 3-1U and while saline
fl25 1and chrysotile elicited macrophages both bound similar amounts of L I)
Con A the C. parvum elicited macrophages bound significantly more (3ii..0^;
P CO.002).
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TABLE 3.12 Effect of crocidolite treatment on binding of ^ ^i]
Con A to control macrophages.
TREATMENT






TABLE 3.13 Effect of chrysotile treatment on binding of 2^I
Con A to control macrophages.
TREATMENT





* xts.d. oft-10 c/s : repr, expp
TABLE 3* 1 It- Binding of ['^IJCon A to saline, chrysotile and C. parvum
induced macrophages.
Significant difference - saline v C. parvum P^0.002
MACROPHAGE
SOURCE






x±s,d. of t-10 c/s: data from 3 separate exp?
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3.U•3-5 Trypsin accessibility of L I] Con A bound to the surface of
control and elicited macrophages
In order to gain information on the disposition of bound Con A in
the surfaces of control or activated macrophages the protease releasable
counts were determined following binding using in the first instance
trypsin and pronase. As shown in Table 3« 15 trypsin and pronase
released the same proportion of counts from both control and chrysotile
activated macrophages; trypsin was therefore used in subsequent
experiments. As shown in Table 3.16 the percentage of bound P^l]
Con A which could be released by trypsin treatment was the same for
control, chrysotile and C. parvum activated macrophages.
3.5 Effect of asbestos induced macrophage supematants on lymphocyte
mitogenesis
3.5.1 Attempts to detect Interleukin 1 activity in supematants from
macrophages activated by LPS treatment in vitro
Bacterial lipopolysaccharide (LPS) has been used extensively to
activate macrophages in vitro to release Interleukin 1 (IL1) activity
into the supernatant (Murphy et al 1980; Tenu et al 1980). Since
earlier work in this study had revealed that asbestos could activate
macrophages in vivo, it was suspected that asbestos activated macrophages
might also release increased amounts of IL1 activity. To develop the
IL1 assay, LPS treatment of macrophages in vitro was carried out in the
hope of obtaining a standard IL1-rich supernatant. Control macrophages
were treated with LPS for 2lx and 72 hours before collecting supernatants
which were tested in a thymocyte mitogenesis assay. As shown in Tables
3.17 and 3.18 supernatants had no enhancing effect on sub-optimal Con A
mitogenesis and therefore no evidence of IL1 activity; this held true for
both 72 and 96 hour assays.
-13Ua-
TABLE 3.15 Percentage of ^IJ Con A released from saline and





3 day saline 27.2-2.3 30.7-1.8
3 day chrysotile 30.2-0.6 31.5-0.9
#
TABLE 3*16 Percent of ^IJ Con A released by trypsin from






3 day saline 31.9-2.9
3 day chrysotile 33.2-1.3
5 day C. parvum 30.7-2.U
*
^•xts.d. of 3 separate e<p!
-13Ub-
TAELE 3.17 Effect on thymocyte mitogenesis of supernatants from
macrophages treated with LPS in vitro for 2b hours.
Label added on Day 2 or Day 3 of assay.
DOSE OF CON A




Con A only 810-99* 87-19 2671-75 17836-2102 29362^8017
Con A +
Supernatant




Con A only 192-100 37U-131 U078-851 1U822-1J407 19281-1001
Con A +
Supernatant
293-19h 2iiii-127 2U9^-652 10596-1292 18580-1033
cpm x- sd.T
TABLE 3.18 Effect on thymocyte mitogenesis of supernatants from
macrophages treated with LPS in vitro for 72 hours.
Label added on Day 2 and Day 3 of assay.
DOSE OF CON A




Con A only 62-13* 9li-25 803-20li 5296^601 222:Ui-U559
Con A +
Supernatant




Con A only 102-12 122-3U 2312-3h3 714-1U-1237 22758-98lUi
Con A +
Supernatant
197-219 291-110 182U-812 7712-98U 1li586-1787
*cpm x- sd. ttriplicate wells:repr. exp*
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3.^.2 Attempts to detect IL1 activity in supernatants from macrophages
activated by in vivo treatment
Both proteose peptone and Con A have been used to induce activated
macrophages in the peritoneal cavity and so macrophages obtained 3 days
after intraperitoneal injection of both agents were plated out, the
supernatants harvested, dialysed and used in the sub-optimal Con A
mitogenesis assay. It is clear from Table 3.19 that the dialysed
supernatants had no IL1 activity whether obtained 2k or U8 hours after
plating Con A or proteose peptone induced macrophages in serum-free or
serum containing medium.
In view of these failures to detect IL1 activity in supernatants
from macrophages activated in conventional ways, and in view of the
evidence frcoi sane of these experiments (e.g. Table 3.18) that suppression
of Con A mitogenesis could be a property of same of these supernatants,
the literature was reviewed and abundant evidence for suppressor activity
release by activated macrophages was found (e.g. Nelson 1976; Schechter
et al 1980). An asbestos induced macrophage supernatant was prepared and
found to exhibit suppressor activity and so standard supernatants were
prepared from 3 day saline, latex, crocidolite and chrysotile induced
macrophages and their properties investigated.
3.5.3 Effect of Con A dose on detection of suppressor activity
Fig. 3.52 shows the results of an experiment where 3 day saline and
chrysotile macrophage supernatants were tested in the Con A thymocyte
mitogenesis assay. A general effect is apparent, which was clear from
early experiments, that the suppressor effect of the activated macrophage
supernatant was maximal at 1 or 2 Con A. In most experiments
1 and 2 ^ug/ml Con A were the doses used to detect suppressor activity.
-135a-
TABLE 3.19 Effect on Con A mitogenesis of supernatants collected
after 2l* or 1*8 hours incubation of macrophages induced
with proteose peptone (pp) or Con A in the presence or
absence of Foetal Calf Serum (FCS). All supernatants
dialysed overnight against EPMI at 1*°C.












No Con A 690-129* 556-51 578-175 61*7-1 22 l*9l*-l*7 306-71 675-203
Con A 880-162 568-1*8 598-1*8 650-128 757-235 1*06-65 1*06-61
*8* / \



























FIGURE 3.52 Effect of saline and chrysotile induced macrophage supernatant
on Con A mitogenesis of thymocytes.
Symbols denote x - one standard deviationf triplicate wellsirepr. exp)
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3.5.h Suppressor effects of asbestos induced macrophage supernatants
Table 3.20 summarises the experiments using supernatants from macro¬
phages induced with asbestos, saline and latex in the Con A mitogenesis
assay at 1 and 2 jag/ml Con A. The results are expressed both as
mean - standard deviation of cpm of thymidine incorporated for all
experiments, and as mean - standard deviation of mitogenic index
obtained for each experiment. The mitogenic index was calculated in
the conventional way relating cpm due to any dose of Con A and cpm
produced by the same Con A dose in the presence of supernatant (see
Table 3.20). Comparing the data expressed as cpm the mean cpm with
saline induced macrophage supernatant were seen to be very similar to
cpm with Con A only, while with the asbestos induced macrophage super¬
natants the cpm were considerably less; latex supernatant at 1 ^ig/ml
Con A also had a mean which was less than that of saline macrophage
supernatant at that dose. There was, however, no significant difference
in thymidine incoiporation, expressed as cpm, with asbestos supernatants
(or latex) compared to either Con A alone or to mitogenesis in the presence
of saline macrophage supernatant. Statistical significance was confounded
by variation between experiments in mitogenic response of different
batches of thymocytes. The mitogenic index can be used to take into
account this well documented variation in mitogenic response between
experiments (Herberman 1978). When these results were expressed as
mitogenic indices for each experiment there was no significant difference
between latex macrophage supernatants and saline macrophage supernatants;
however, crocidolite macrophage supernatants at 1 and 2 jig/ml, and
chrysotile macrophage supernatants at 1 jig/ml, had significantly
(P<0.0£ and P< 0.02, see Fig. 3.61) lower mitogenic indices than saline
macrophage supernatants confirming significant suppressor activity in
these supernatants.
-136a-
TABLE 3.20 Effect of macrophage supernatants on thymocyte mitogenesis.
No significant differences in tritiated thymidine uptake
when expressed as cpm; when expressed as mitogenic index,
derived as:-
^
Mitogenic Index - ^ presence of aup- - mitogen
cpm in presence of mitogen only
significant suppressive effects produced by asbestos
supernatants compared to saline macrophage supernatants.
Significant differences compared to saline - Chrysotile
































Data for 6 separate experiments
Data for 3 separate experiments
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3.5*5 Dose response of suppression by asbestos induced macrophage
supernatants
Fig. 3.53 shews the effect 011 thymocyte mitogenesis of a 3 day
chrysotile macrophage supernatant present as 5, 25 and 50j£ of the total
incubation volume in each well. There is a clear dose response in the
mean cpm of tritiated thymidine associated with the thymocytes and even
at 5/6 there is evidence of suppression. Significant differences between
supernatant treated and control (cRFMI treated) wells were present with
50% supernatant (P<0.02 and P 4,0.05).
3.5.6 Effect of macrophage supernatants from mice injected with
asbestos long term
The following experiments were carried out in order to determine
whether mitogenesis suppressing factors were released only by macrophages
in the acute (3 day) phase following asbestos exposure or whether long
term dusted animals would also yield macrophages capable of releasing
such factors. Mice were available which had been kept 280 days after
injection of crocidolite in order to determine fibrogenic response and
so 2 of these mice were killed, peritoneal macrophages pooled, and 2h hour
supernatants prepared from the macrophages. These 280 day crocidolite
macrophage supernatants were tested alongside 3 day crocidolite macrophage
supernatants in the mitogenesis assay. Control mice injected alongside
the long term crocidolite mice (280 day saline macrophage supernatant)
served as a control for ageing effects. Fig. 3.5U shows the results of
an experiment where, as expected, 3 day chrysotile macrophage supernatant
was significantly suppressive to Con A mitogenesis at 1 jig/ml (P< 0.001)
and 2 jig/ml Con A (P<0.01)j 280 day crocidolite supernatant, however,
was not suppressive and in fact showed a significant degree (P< 0.002)
of stimulatory activity at 1 ^ig/ml Con A but was not significantly
different from the control at 2 Jig/ml Con A. These effects of 280 day
-137a.
CON A jug/ml)
FIGURE 3,$3 Effect of chrysotile induced macrophage supernatant
present in the incubation as 5> 25 or $0%, on Con A
mitogenesis of thymocytes. Significant reduction
with $0% supernatant at 1 jog/ml (p<0.02) and 2 ^ig/ml
















FIGURE Effect on Con A mitogenesis of 3 day and 280 day
saline and chrysotile induced macrophage super-
natants. - Bars denote x - one standard deviation.
Significant reductions compared to 3 day saline
produced by 3 day chrysotile at 1 jug/ml (P<0.001 )
and 2 jug/ml (P(0.01) Con A; significant stimulation
of mitogenesis produced by 280 day chrysotile
compared to 3 day chrysotile at 1 jig/ml Con A
(P<0.002)j significant stimulation of mitogenesis
produced by 280 day saline compared to 3 day saline
at 1 pg/mL Con A (P<0.05).(rePresentative exPt-)
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crocidolite macrophage supernatants were independent of the effects of
asbestos since the same effects were produced by 280 day saline macro¬
phage superaatants, i.e. significant stimulation at 1 jig/ml Con A
(P X°»0£) and no significant difference from 3 day saline at 2 jxg/ml.
These results mean that suppressor activity is present in super¬
natants of acute (3 day) induced macrophages but is absent from the
macrophage supernatants of long term (280 days) dusted mice.
3.5.7 Effect on mitogenesis of supernatant prepared by treating control
macrophages with chrysotile asbestos in vitro
In order to test whether the suppressor factor present in 3 day asbestos
induced macrophage supernatant was a non-specific factor released as a
result of cell damage, control macrophages were treated with asbestos
in vitro at a dose which caused >70$ killing after 3 days. The super¬
natant so obtained, cleared of cell debris and asbestos by centrifugation,
was tested in a mitogenesis assay along with 3 day chrysotile induced
macrophage supernatants. As shown in Fig. 3.55 the 3 day chrysotile
supernatant was significantly suppressor to mitogenesis at 1 ^ig/ml
(P<0.02) and 2 ^ig/ml (P <0.001 ) Con A; the supernatant prepared from
control macrophages treated with chrysotile in vitro was stimulatory to
mitogenesis at 1 jpg/ml Con A as judged by a significant (P< 0.02)
increase in thymidine incorporation while there was no significant
difference between this supernatant and the control at 2 ^ig/ml Con A.
It is evident that the suppressor activity released by 3 day asbestos
induced macrophages is not due to something being released as a result of
asbestos induced cell damage or death since treating macrophages with
asbestos in vitro with lethal doses of asbestos failed to cause the
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FIGURE 3.55 Effect of supernatant prepared by the in vitro
treatment of control macrophages with chrysotile
on thymocyte mitogenesis by Con A. 3 day
chrysotile (in vivo) macrophage supernatant
included as positively suppressor supernatant.
Symbols denote x 4 one standard deviation.
Significant inhibition of mitogenesis produced
by the in vivo chrysotile supernatant at 1 jug/ml
(P<0.02) and 2 ^ig/ml (P<0.001) Con A. Significant
enhancement of mitogenesis produced by in vitro
chrysotile/macrophage supernatant at 1 yig/ml Con A
(P<0.02).( representative exp1-
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3.5.8 Effect of dialysis on mitogenesis suppression by asbestos
induced macrophage supernatants
Fig. 3.56 shows the effects, on 3 day chrysotile macrophage super¬
natant suppression, of dialysing the supernatant against medium for 2li
hours. The 3 day chrysotile supernatant produced significantly less
thymidine incorporation than the 3 day saline supernatant at both
1 jig/ml Con A (P< 0.05) and 2 ^/ml Con A (P < 0.001). With dialysis,
however, this significance was abolished at 1 ^ig/ml Con A and at 2 yUg/ml
Con A the suppression was more than halved and, while there was still a
significant difference between the dialysed chrysotile macrophage super¬
natant and the control, the level of significance was reduced to P<0.05.
3.5.9 Effect of supernatants on a fibroblast cell line
To determine whether the suppressor activity in the 3 day asbestos
macrophage supernatants had any specificity to lymphoid cells, their
effect on proliferation of a fibroblast cell line was determined. As
shown in Table 3.21 there was no significant difference in thymidine
incorporation between untreated and 3 day saline macrophage supernatant
treated fibroblasts. With the asbestos macrophage supernatants there
was no significant difference between chrysotile supernatant and saline
macrophage supernatant while crocidolite superaatants caused a significant
(P<0.01) increase in thymidine uptake.
3.5.10 Use of nylon wool purified spleen cells as targets
In order to determine whether asbestos macrophage suppressor super¬
natants were active against mature lymphocytes as well as thymocytes they
were tested against nylon wool purified, T cell enriched, splenocytes.
As shown in Table 3.22 which can be compared with the summary Table
(Table 3.21) the 3 day chrysotile macrophage supernatants were rather less
suppressor to splenocytes than to thymocytes but the mitogenic indices
with chrysotile macrophage supernatants were still significantly less
-139a-
CON A (jjg/ml)
FIGURE 3,36 Effect of dialysis on chrysotile macrophage
supernatant mediated suppression of mitogenesis.
Significant reduction in mitogenesis caused by
chrysotile supernatant compared to saline super¬
natant at both 1 ;ug/ml (P<0.0£) and 2 ,ug/ml (P<0.001)
Con A; significant reduction caused by dialysed
supernatant at 2 jag/ml Con A only (P<0.01).
Symbols denote x - one standard deviation,
representative expt
-139b-
TABLE 3.21 Effect of treatment with variously induced macrophage
supernatants on uptake of tritiated thymidine by
fibroblasts.









pooled dala from 3 separate expts-
TABLE 3.22 Effect of 3 day chrysotile or saline macrophage
supernatant on nylon wool column purified splenocyte
if
mitogenesis expressed as mitogenic index .
Significant differences - chrysotile v saline 1 jug/ml






Mitogen index derived as in Table 3.20
pooled data from 2 separate expts-
3
-iUo-
than these produced by saline macrophage supernatants (P < 0.05 for both
1 and 2 ^ig/ml Con A).
3.5.11 Effect of serum frcm 3 day chrysotile injected mice on mitogenesis
To determine whether the factor suppressing mitogenesis, released by
asbestos induced macrophages, was present in the serum, mice were killed
3 days after saline, crocidolite or chrysotile injection and the serum
collected. Initially serum was used at 10^ in mitogenesis assays, but
as shown in Fig. 3.57, at this level there was almost complete inhibition
of thymidine uptake. When the same serum was present as 1%, inhibition
was much less but there was no evidence of increased inhibitory activity
in the sera from asbestos injected mice.
3.5.12 Effects of asbestos on mitogenesis
It was possible that asbestos itself could have some direct effects
on lymphocytes which could affect their function; it was also possible
that very small fibres, if exocytosed by macrophages during generation
of supernatants, might not be spun out and could thus contribute to the
properties of the supernatant. Asbestos was therefore tested in thymocyte
mitogenesis assays. It is clear from Fig. 3.58 that both crocidolite and
chrysotile were inhibitory to background thymidine incorporation by
thymocytes (0 ^ig/ml Con A) with crocidolite being significantly inhibitory
above 0.01jug/well (p < 0.02). With chrysotile only 0.001 jig/vell (P< 0.02)
and 10^g/well (P <0.05) were significantly inhibitory to thymidine uptake
in the absence of Con A. At 2 jig/ml Con A crocidolite had no effect on
mitogenesis across the 5 orders of magnitude of dose used; chrysotile,
however, was significantly stimulatory to thymidine uptake at all doses
(P<_0.05 to P CO.002). With U jug/ml Con A again there was no significant
difference in thymidine uptake between control thymocytes and thymocytes
incubated with doses of crocidolite across 5 orders of magnitude; chrysotile
was again significantly stimulatory at all doses (P < 0.05 to P<0.01).
-lliOa-
CON A(/jg^ml)
FIGURE 3.5>7 Effect on Con A mitogenesis of serum from
saline, crocidolite or chrysotile injected
mice as 1 and 10% of incubation volume.
x of 2 mice for each cond ition
-liiOb-
ASBESTOS(jug/well)
FIGURE 3.58 Effect of crocidolite and chrysotile on Con A mitogenesis
of thymocytes.
Symbols denote x - one standard deviation (repr. exp1)
Significant differences from no asbestos:- no Con A -
crocidolite above 0.01 ^jig/ml/well was inhibitory (P<,0.02);
chrysotile was inhibitory at 0.001 ug/well (P<0.02) and
10 ;ug/well (P<0.05).
2 ug/ml Con A - 0.001-10 ^ug/well chrysotile - significant
stimulation (P(0.05-P<0.002).
U jag/ml Con A - 0.001-10 ;ug/well chrysotile - significant
stimulation (P(0.05-P 0.01).
-1U1-
3.5.13 Effect of chrysotile leachate on thymocyte mitogenesis
Table 3.23 shows that 50% chrysotile leached medium-, present during
the mitogenesis assay, had no significant effect on thymidine uptake by
the thymocytes.
3.6 Attempts to detect differences in surface antigenicity between saline
and crocidolite induced macrophages using anti-sera raised against PEC
Anti-sera were raised in rabbits against 6 day saline and crocidolite
induced PEC and experiments were carried out to determine whether these
anti-sera, suitably absorbed, could be used to detect differences in
their respective macrophage components with regard to surface antigenicity
using a [12^l] Protein A binding assay.
3.6.1 Binding to thymocytes and control PEC following absorption of
anti-sera
Anti-serum 151 was raised against 6 day saline induced PEC and anti¬
serum 152 was raised against 6 day crocidolite induced PEC. All anti-sera
used were obtained 2 weeks after the end of the immunisation schedule
(151/2,• 152/2).
Non-specific anti-mouse activity was removed by absorption until a
target binding index of one was obtained:-
binding index J" Protein A (cpm) bound with immune serum at dilution n
02^l] Protein A (cpm) bound with prebleed serum at dilution n
^ y 8(i) Prebleeds Absorbing prebleed sera withIO, 10 or 10 thymocytes/
100 |il made no difference to binding which remained close to background
binding obtained by substituting PBS for the anti-serum step (Fig. 3.59)
This result was expected since the prebleeds were, in effect, normal rabbit
serum.
6 7(ii) Anti-sera As shown in Fig. 3.60 absorbing the anti-sera with 10 , 10
Q
or 10 thymocytes /100^il resulted in a dose dependent decrease in anti-
—lUl a—
TA'RT.'R Effect of chrysotile leachate on thymocyte mitogenesis




Mitogen only 769-219 hhS2-538 12,388-209U
+%Q% Chrysotile
Leachate 553-60 Uli75-758 1U,109-822
-lUlb-
6 8
FIGURE 3.$9 Effect of absorption of prebleeds with 10 -10 thymocytes




















































PREBLEEDS 151/2 151/2 152/2 152/2 152/2 152/2
UN/8S ASS JJNABS ABS ABS ABS
••• 106 107 1Cp
FIGURE 3.60 Effect of absorbing anti-sera with thymocytes on binding
to thymocytes and whole PEC.*
O
TABLE 3'2k Binding indices of 151 and 152, absorbed with 10 thymocytes/




















x- standard deviation (triplicate wells•• repreYpy
-1U2-
g
serum binding. With 10 thymocytes/100 ^yl all anti-thymocyte activity
was removed as shown by binding indices of 1.1 for 151 and 1.2 for 102
(Table 3.2li). After absorbing out the anti-thymocyte activity anti-PEC
activity remained. This was greater with 151; 152 had only of the
activity of 151 but, due to increased binding of the 151 prebleed the
binding indices of 151 and 152 to PEC were similar (Table 3»&).
3.6.2 Binding to 6 day saline and 6 day crocidolite induced PEC of
absorbed and unabsorbed anti-sera
As shown in Fig. 3.61, 151 bound in greater amounts to both saline
and crocidolite PEC than 152. It is also evident that absorbed 151
bound significantly (P/.0.001) more to saline PEC than to crocidolite
PEC. There was no significant difference in the binding of 152 to either
g
saline or crocidolite PEC. Absorption with 10 thymocytes/100 ^pl caused
significant (P<0.01 to P/0.001, see Fig. 3.61 for details) decreases
of ^ to | in the binding of both anti-sera to both targets; this decrease
represented the shared antigen component between thymocytes and PEC.
3.6.3 Binding of anti-sera to whole PEC and to the macrophage fraction
As shown in Fig. 3.62 both anti-sera bound less to adherent than to
whole PEC and the reduction in binding ranged from 33% to 53% (P < 0.05
to P^ 0.01j 152/2 v 6 day crocidolite not significant). Anti-serum
151 bound significantly (P< 0.001) more to saline macrophages than to
crocidolite macrophages but there was no significant difference in the
binding of anti-serum 152 to either type of macrophage.
3.6.I4. Kinetics of binding of the anti-sera
The previous experiments had established that activity was present,
in both anti-sera, against whole PEC and against the macrophage component.
All these experiments were carried out at a nominal anti-serum dilution
of 1/50 and in order to actually compare the anti-sera in terms of their
-Iii2a-
FIGURE 3.61 Binding of 1$1 and 1^2 to 6 day saline and 6 day
crocidolite induced whole PEC.
Significant differences - bvd P<0.001j avb P<0.01j
cvd P<0.001j evf P<0.001j gvhP<0.001.




FIGURE 3*62 Binding of anti-sera to total and adherent fraction
of 6 day saline and 6 day crociaolite induced PEC.
Significant difference - 151/2 saline v crocidolite
P<0.001 ( x-sd of triplicate wells: repr. exptV
-Un¬
binding activity it had to be confirmed that saturation binding conditions
pertained at this dilution. As shown in Fig. 3.63 saturation binding was
not reached at a dilution of 1/10 with any of the anti-serum directed
against either of the target adherent cells. It was apparent that
the greatest activity in both anti-sera was against the saline induced
macrophages.
In a further, final, attempt to obtain saturation binding the number
of target cells was reduced but as shown in Fig. 3.61i reducing the
number of targets and using anti-sera at 1/10 dilution failed to result
in significant binding over and above background (1/10 prebleed).
Attempts to detect differences in the surface antigenicity of 6 day
saline and crocidolite induced macrophages using the Protein A
assay and anti-serum raised in rabbits, was abandoned due to the low
specific "anti-macrophage surface" activity in the anti-sera.
3.6.5 Immunofluorescence
Although the two anti-sera could not be used to quantitate differences
between control and asbestos induced macrophages, immunofluorescence was
carried out using the two anti-sera to determine whether qualitative
differences could be detected between them in terms of the staining
pattern.
Fig. 3.65 (upper) shows 6 day saline macrophages incubated with pre¬
bleed serum (151/0) then FITC-Goc R and no membrane staining is seen;
a similar appearance was produced with 152/0. Fig. 3.65 (lower) shows
6 day crocidolite induced macrophages stained with 151/2 while Fig.
3.66 (upper) shows the same cells stained with 152/2; a similar
appearance with ring staining is evident with both anti-sera. Using
both anti-sera against 6 day saline induced macrophages the same





FIGURE 3.63 Effect of increasing the concentration of anti-sera
used in the assay on binding to macrophage targets.
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(xlO^/well)
FIGURE 3«6L Effect of decreasing the target cell concentration, on
anti-serum binding.




FIGURE 3.65 Upper - 6 day saline induced macrophages
pre-incubated with prebleed serum then
FITC-G o<.R.
Lower - 6 day crocidolite induced macro¬
phages pre-incubated with 151/2 (anti-serum















FIGURE 3.66 Upper - 6 day crocidolite induced macrophages
pre-incubated with 102/2 (anti-serum to
crocidolite induced macrophages) then FITC-OR.
Lower - 6 day saline induced macrophages pre-
incubated with 132/2 then FITC-G^R.
Mag. x 600.
-iliii-
In blocking experiments macrophages were exposed to one anti¬
serum followed by unlabelled G<*- R then the second anti-serum and
finally FITC-G^R. Blocking with either anti-serum resulted in
considerable reduction in membrane fluorescence but occasional cells
retained bright ring fluorescence as shown in Fig. 3.6? (upper) (6 day
crocidolite macrophages blocked with 151 then stained 152) and Fig.
3.67 (lower) (6 day saline macrophages blocked with 151 then stained for
152). These ring staining cells which represented cells recognised by
the second anti-serum but not by the first (blocking) anti-serum were
quantified as given in Table 3.25. Each anti-serum appeared to recog¬
nise membrane elements not recognised by the other, but in general 152
appeared to contain more activity against both 6 day saline and 6 day
crocidolite macrophages than 151 •
3.6.6 Complement mediated lysis
Using complement mediated lysis to assay for the cytotoxic antibody
activity of the 2 anti-sera revealed no real differences. As shown in
Table 3.26 cytotoxicity in all cases was between 11 and 21 % while the
various controls ranged from 0-10.6^ cytotoxicity.
3.7 In vivo autoimmune deposition of immunoglobulin on asbestos
induced macrophages
In these experiments attempts were made, using anti-serum to mouse
antibody on the surface of freshly harvested asbestos induced macrophages
and controls, 6 days, 1U days and 29k days after crocidolite injection.
3.7.1 Effects due to size and Fc receptor binding
Prebleed 151/0 and anti-serum 151/2 (unabsarbed) were used to detect
any differences between the two macrophage populations with regard to
Fc receptor and size respectively.
-lUia-
FIGURE 3.67 Figures represent preparations from
————"blocking experiments (see text for details).
Upper - 6 day crocidolite macrophages blocked
with 151 then stained for 152.
Lower - 6 day saline macrophages blocked with
151 then stained for 152.
Mag. x 600
-liiUb-
TABLE 3.25 Percentage of macrophages showing ring fluorescence
with either anti-serum and FITC-G«tR following blocking







6 day saline 29.5^.8 11.3-2.0
6 day chrysotile 33.1-6.9 9.9-0.1;
*
TABLE 3«26 Complement mediated cytotoxicity of anti-sera 151 and









151/2 + Heat Inactivated
Complement
9.6 U.O
152/2 + Heat Inactivated
Complement 2.7
1.0
PBS + Complement 7.9 0.0
151/0 + Complement 0.5 U.2
152/0 + Complement 1.1 3.3
151/2 + Complement 11.U-1.8 20.8-7.7





pooled data 2. - A- expts
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(i) Fc receptor Prebleed serum was used to detect Fc binding of antibody.
Table 3.27 reveals no significant difference in binding of 151/0 to
saline macrophages at all time points or crocidolite macrophages at all
time points.
(ii) Cell surface area As a general index of size unabsorbed 1^1/2
(raised against 6 day saline PEC) was used and no significant difference
in binding was found between saline and crocidolite induced macrophages
comparing all time points (Table 3.28). This suggests that there was
■no gross difference in surface area between saline and asbestos induced
macrophages at least with regard to normal macrophage antigens available
for recognition by 151/2.
3.7.2 Binding of rabbit anti-mouse immunoglobulin
Expressing the binding of anti-mouse immunoglobulin in terms of
binding of prebleed serum at the same concentration (1/50) yielded
binding indices for each experiment and these are shown in Table 3.28.
There is clearly no increase in macrophage cytophilic immunoglobulin
as recognised by the rabbit anti-mouse immunoglobulin in crocidolite
induced macrophages compared to saline induced macrophages at any time
point. Pooling the results from all the time points yielded a figure
for all experiments (Table 3.28) which showed no significant difference
between saline and crocidolite induced macrophages.
3.8 Long term effects of intraperitoneal asbestos in mice
At the onset of this study mice were injected ip with asbestos and
left to live out their life span to determine the long term effects of
asbestos in the model.
3.8.1 Fibrogenic effects
It was evident that all mice killed a long time after asbestos
injection had a considerable degree of fibrosis in the peritoneal
-1i*5a-
TABLE 3.27 Binding of anti-serum 1$1/2 and prebleed 151/0 (normal
rabbit serum) to saline and asbestos induced macrophages.
Figures represent mean - standard deviation of all
experiments, ie. 2 at 6 days, 2 at 1U days and 2 at
1*2 weeks.
1 2^l] PROTON A BOUND/ WELL
(x - sd cpm)
SALINE CROCIDOLITE
PBS 93-35 11U-23
151/0 (NHS) 11*9-68 180-1*6
151/2 (Unabsorbed) 808-391* 967-368
TABLE 3.28 Binding indices of anti-mouse immunoglobulins to saline
and asbestos induced macrophages various times after
injection of saline or asbestos.
Binding of Protein A (cpm) after treatment
t,. , with rabbit anti-mouse immunoglobulinBinding index = —7—;—;— —-2 .
Binding of Protein A (cpm) after treatment
with normal rabbit serum
6 DAYS 11* DAYS 1*2 WEEKS ALL EXPS.
Saline 1.6 * 2.1 1.6 1.8-0.3
Crocidolite 1.7 1.8 1.8 1.8-0.1
Each figure represents the mean of two experiments
at that time point.
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cavity. This was present as nodules (granulomas) and sheets of fibrous
tissue often binding portions of the peritoneal viscera together as
shown in Fig. 3.1. The principal cell type in these lesions was the
fibroblast although giant cells and macrophages were often seen.
Fig. 3.68 (upper) shows an area of fibrosis from a mouse which had
been injected with crocidolite 15 months previously. The centre of
the lesion is largely acellular collagen with a few giant cells while
the periphery consists of fibroblasts and macrophages; many fibres
of crocidolite are visible lying within the fibrous tissue and between
the cells. Crocidolite fibres are more clearly seen in the higher
power view shown in Fig. 3.68 (lower). Some asbestos fibres lying
within areas of fibrosis could be seen, at higher power, to have
refractile "beads" on them and on staining with Perle's reaction for
iron pigment these "beads" stained positively revealing them to be
asbestos (ferruginous) bodies (Fig. 3.69); it was notable that only a
minority of fibres had become coated as is evident from Fig. 3.69.
Mice injected at the same time as these mice, but which received
saline or latex, never showed any evidence of fibrosis in any of the
sections examined.
Five mice kept from 13-17 months after intraperitoneal injection of
2.5 mg of C. parvum showed no evidence of fibrosis in the peritoneal
cavity at autopsy or in sections of the peritoneal viscera.
3.8.2 Carcinogenic effects
3.8.2.1 Ascites and malignant cell lines
The major long term effect of ip asbestos in CBA/Ca mice was the
development of peritoneal ascites which led rapidly to death if undetected.
The typical appearance of a mouse killed after developing ascites is
shown in Fig. 3.70. As shown in Table 3.29, 17 mice in all developed
ascites following asbestos injection with a mean time to ascites
-1U6a-
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FIGURE 3.68 Fibrous lesion in the peritoneal cavity
of a mouse injected with crocidolite 15
months before killing.
Upper - Giant cells are visible in the
centre of the lesion (arrows) which is
essentially acellular collagen.
Lower - higher power view of adjacent
field to show crocidolite fibres embedded
in fibrous matrix.
Mag. - upper x 150; lower x 300.
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FIGURE 3.69 Asbestos fibres present in a fibrous lesion
~~
from the peritoneal cavity of a mouse killed.
after injection of crocidolite. Two of the
fibres have been coated (arrows) but many are
uncoated. Perle's reaction.
^ x
FIGURE 3.70 Comparison of control mouse (top) with mouse
having abdominal distension following long term
crocidolite injection. At autopsy the lower
mouse was found to have peritoneal ascites.
-ll*6c-
TABLE 3.29 Relationship of ip asbestos type and dose with time to
develop of peritoneal ascites.






Crocidolite 2.5 1*62-21 1*
Crocidolite 15.0 U29-75 5
Chrysotile 15.0 51*6-16 5
Amosite 5.0 1*76-10 3
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development of 1*78 1 1*9 days. The reason that several different doses
of asbestos were used (Table 3.29) as well as amosite (brown) asbestos
which was not otherwise used in this study, was that these animals were
injected very early in the study. It was not known at this stage
exactly which asbestos types or doses would be used but experience at
the Institute of Occupational Medicine suggested that it would take up
to 1§ years for tumours to develop so a range of asbestos types and
doses was used. It was gratifying to find that 2.5 mg of crocidolite
(the dose finally chosen for these experiments) did cause ascites
development.
The ascites so produced was never bloodstained but was a cell rich,
straw coloured fluid 2-5 ml in volume. The cellular content, when
measured, was approximately 3x10^ cells/ml of cells which were > 90%
macrophages on morphological grounds with a small percentage of lympho¬
cytes. No obvious malignant or abnormal cells were seen nor any
macroscopic or microscopic evidence of tumour deposits in the peritoneal
cavity. Notwithstanding these findings, on two separate occasions
ascites cells were maintained in long term culture in cRPMI and piled up
colonies of cells developed in the flasks after 5-6 weeks (Fig. 3.71).
In one case these piled up colonies were removed and subcultured until
a cell line was derived named 13MC1 (13 Months Crocidolite 1). When
these cells were injected subcutaneously in CBA/Ca mice, slow growing
tumours developed which invaded the underlying leg muscle (Fig. 3.72
upper) and metastasised to the draining node (Fig. 3.72 lower).
After 3 successive passages through the subcutaneous site during
which the rate of growth of the tumour increased, 13MC1 cells were injected
intraperitoneally where they grew rapidly as a nodular mesothelioma-
like tumour. Fig. 3.73 (upper) shows a mass of tumour nodules apparently
originating in the omentum of a mouse injected with 10^ 13MC1 cells.
Fig. 3.73 (lower) reveals that some of the nodules have acellular centres
-1li7a.
FIGURE 3*71 Piled up colony (dark area at left) with
outgrowing tumour cells which grew up from
ascites derived from a mouse which had been




FIGURE 3.72 13MC1 tumour growing subcutaneously in a
CBA/Ca mouse and showing (upper) invasion
of the underlying muscle layers. Lower
plate shows the lymph node draining the
tumour and invasion of the lymph node by
tumour cells (right) is evident.
Mag. - upper x 150; lower - x 90.
FIGURE 3.73 13MC1 cells growing intraperitoneally as
a nodular tumour.
Mag. - upper x 65; lower - x 150.
-11*8-
while some are cellular throughout.
3.8.2.2 Ascites transfer experiments
In view of the fact that malignant cells could be grown up from
the ascites developing in long term asbestos bearing mice, the direct
transfer of ascites to syngeneic recipients was carried out to try and
obtain an ascitic tumour which could be passaged in vivo. Table 3.30
summarises the results from these experiments where mice received 0.5 ml
of ascites from animals which had developed ascites in response to ip
crocidolite, chrysotile or amosite. Of 21 mice receiving ascites, 3
mice produced needle track tumours; 2 mice produced needle track tumours
plus nodular tumours in the peritoneal cavity plus ascites; 1 mouse
produced a needle track tumour and a peritoneal mass; 15 mice produced
no pathology.
3.8.2.3 13MC1 tumour cell line
(i) Immunogenicity In order to determine whether the crocidolite
induced ascites derived cell lines 13MC1, which grew in the peritoneal
cavity as a mesothelioma-like tumour, was immunogenic, an immunize and
challenge experiment was carried out. Fig. 3.7U shows the time to ascites
development of mice unimmunised or immunised with 10^ lethal1y irradiated
13MC1 cells and then challenged with 10^-10^ viable 13MC1 cells. In
the unimmunised group there is a linear increase in the time taken to
develop ascites with decreasing 13MC1 challenge. In the immunised
group there were no tumour takes up to 89 days after challenge when the
experiment was terminated; at autopsy, in the immunised group, there was
no evidence of peritoneal tumour or ascites.
(ii) pll* membrane glycoprotein The cell membrane glycoprotein
designated pll* has been claimed to be a universal marker of the trans¬
formed phenotype (Bowen and Kulatilake 1979) and an anti-serum to this
component was kindly provided by Br. D. Hannant. This anti-serum, of
-1U8a-













1157 k No No 166 Amosite
1218 1 No Needle track 1U3 Crocidolite
1227 h No No 206 Amosite
1256 2 No No 1U3 Amosite
1257 2 (i) Yes Peritoneal nodules
+ needle track 75 Chrysotile
(ii) Yes Peritoneal nodules
+ needle track 75 Chrysotile
1260 3 (i) No Needle track 62 Chrysotile
(ii) No Needle track 91 Chrysotile
(iii) No Peritoneal nodules
+ needle track
112 Chrysotile
1278 1 No No 10U Chrysotile
1299 k No No 87 Crocidolite
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TUMOUR CELLS i.p
FIGURE 3.7U Effect of immunisation with 10^ irradiated 13MC1 ascitic
tumour cells on the time to ascites development following
3 6
injection with 10 -10 viable tumour cells. Control
mice unimmunised.
Symbols denote x - one standard deviation.
Figures denote number of takes.
-11x9-
[125 ]
which only a volume was available, was used in a [ IJ Protein A
binding assay (as given in Section 2.11.5) to try and detect this
component in the 13MC1 cell line. Human embryonic lung fibroblasts
were used as negative controls and a range of rat mesotheliomas, derived
from primary asbestos induced peritoneal mesotheliomas of various
morphological type were kindly provided by Dr. R. Bolton. The data
shown in Table 3.31 can only be considered to be very provisional data
since it represents the results of only one experiment where 13MC1 cells
were included along with the other target cells. It was not possible to
repeat the experiment since supplies of the anti-serum ran out but Dr.
Hannant is presently raising more anti-serum in rabbits to the plii
component and this work will be repeated as soon as it is available.
The provisional results are included because they show that binding
of fltplli to 13MC1 cells is lower than for rat mesotheliomas and the
D23 hepatoma. Although the binding index of 1.0 is more than that
produced by the Human Bnbryonic Lung cells, a binding index of 1.0 was
produced by HEL cells in a separate experiment to that shown in Fig. 3.32
showing that the binding of ocplU to 13MC1 cells falls within the range
of untransformed cells.
TABLE 3.31 Binding indices of anti-pIli serum to various targets
and 13MC1 cells.
binding following treatment with 1/IGscplLi.
Binding index derived binding following treatment with 1/10 NRS

















In Chapter li the results of the present study will be discussed
and this will be approached in two ways. In parts U-1 to U-3 the
experiments aimed at elucidating the nature of the asbestos activated
macrophage will be interpreted; these studies include measurement
of activational characteristics, the use of Concanavalin A as a
membrane probe and attempts to detect evidence of a neo-antigen. In
parts U.U and i;.5 experiments into the consequences of asbestos
related macrophage activation will be discussed; these experiments
include interactions of asbestos activated macrophages with an
experimental fibrosarcoma and the effect of asbestos activated macro¬
phage supernatants on lymphocyte mitogenesis. Additionally in U.6
the carcinogenic effects of asbestos on the mouse peritoneal cavity
will be discussed. Finally in U.7 the possible relevance of the
present study will be discussed along with suggestions for further
work.
The index numbers of the relevant sections of Chapter 3 (Results)
will be given in brackets where key results are discussed.
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li.1 The effects of intra-peritoneal asbestos injection on the
peritoneal macrophage population
I4..I.I PEC number
In the first part of the study the effect of intraperitoneal
asbestos on some membrane related characteristics of the elicited
macrophage population were measured. It was apparent that the actual
number of macrophages which could be harvested from the peritoneal
cavity varied with time elapsed after asbestos injection. Thus there
was a highly significant increase in the number of PEC at 3 days but
the number at 18 days was not significantly greater than in the saline
injected controls; by 70 days there was again significantly more PEC
harvestable from the peritoneal cavity of asbestos injected mice (3.2.1).
The majority of these cells were macrophages at each time point and at
no time point was the number of PEC in the latex injected group greater
than the number in the saline injected group.
The biphasic variation in the number of PEC in the asbestos injected
group could represent either a real decrease in the number of cells in
the peritoneal cavity at day 18 or a decrease in cells which could be
lavaged by the technique used, e.g. through increased tenacity of
macrophage adherence to the peritoneal viscera. The latter phenomenon
has been described as the"macrophage disappearance reaction" (Shannon
and Love 1980) which represents an in vivo manifestation of MIF action
in delayed hypersensitivity following ip administration of an antigen
to a sensitised animal. The time course of the macrophage disappearance
reaction is, however, very different frcm the effect seen here, and
peaks at U hours after antigen administration. Also, by definition,
the macrophage disappearance reaction depends on a conventional delayed
type hypersensitivity response to antigen, whereas asbestos is certainly
not a conventional antigen. As discussed more fully below, in the
-152-
discussion of spreading, "MIF-like activity" can be generated by an
inflammatory reaction such as is produced by asbestos; the activity
in such a case is due to Bb which is the 6ii,000 MW fragment formed
by cleavage of Factor B by bound C3b during activation of complement
by the alternative pathway. Fibrin deposition on the surface of
macrophages has also been implicated in the action of MIF and in the
macrophage disappearance reaction (Hopper et al 1981) and the ability
of asbestos to activate the clotting cascade has recently been demon¬
strated (Hamilton et al 1981). It is possible therefore that asbestos
elicited macrophages could be immobilised by fibrin generated either
directly from the asbestos activation of the clotting cascade or via
secretion from asbestos activated macrophages leading to the splitting
of Factor B to yield Bb. It would have to be assumed that the fibrin
producing, or Bb generating activity had not peaked by Day 3 and had
passed the peak by Day 70. The possibility does however exist that
at both of these time points, also, some fraction of the macrophages
were immobilised and therefore not harvested.
These observations focus attention on a problem inherent in studies
using peritoneal cavity or alveolar macrophages, and that is the reliance
on macrophages readily lavaged from the site. If different test agents
produce a differential response in terms of the ability of the macro¬
phages to adhere to the peritoneal viscera and walls, then a sampling
bias is introduced. This is a bias which macrophage workers have
to accept but it should be borne in mind.
h.1.2 Membrane related changes in conventionally activated and asbestos
elicited macrophages
The assays chosen to study the effects of asbestos on the membrane
of macrophages were chosen to reveal activational type changes and were
phagocytosis, rate of spreading on glass and Fc receptor avidity; in
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addition 5' nucleotidase was measured, as a check, in 3 day chrysotile
induced macrophages. All of these parameters have been found to be
correlated with activation and are discussed below.
U. 1.2.1 Latex phagocytosis
This parameter is the least clearly correlated with macrophage
activation since both decreases (Al-Ibrahim et al 1978) and increases
(Nathan et al 1971) in phagocytosis have been reported following activation.
It is likely that both mode of activation and surface properties of
the phagocytosable particle are the major factors determining whether
increased or decreased phagocytosis is expressed (David and Remold 1976).
In the present study the asbestos induced macrophages had decreased
phagocytic potential at day 3 following asbestos injection (3.2.2). At
subsequent time points there was no difference in this parameter between
asbestos, saline or latex induced macrophages despite the fact that the
asbestos induced macrophages were activated as measured by other criteria.
At day 3 the asbestos macrophages were most activated, as assessed by
spreading, and this could have been a factor in the reduced phagocytosis;
equally likely, however, is that the macrophage membrane was refractory
to further phagocytosis due to recent phagocytosis of asbestos fibre.
Such an effect has been demonstrated following latex (Werb and Cohn
1972) and bacterial (Pesanti and Nugent 1981) phagocytosis.
U.1.2.2 Spreading
Increased spreading on glass was present in the asbestos injected
group compared to the control groups at all time points but was most
marked at 3 days (3.2.L). Increased rapid spreading on glass was one
of the earliest reported properties of activated macrophages (Cohn
and Benson 1965) and has been described in macrophages activated in vivo
with endotoxin, thioglycollate, Listeria infection and Trypanosoma
-15U-
infection (Bianco et al 1976) and in vitro with muramyl dipeptide
(Tanaka et al 1980), lymphokine (Adams et al 1973), alternative
pathway of complement component Bb (Gotze et al 1980), the inflammatory
mediator plasmin (Bianco et al 1976) and protease (Bianco et al 1980).
Increased rapid spreading of rat peritoneal macrophages harvested
following ip injection of crocidolite asbestos was described but not
quantified by Miller (1S79).
It has been suggested that the final common factor produced by
this diverse range of agents which cause spreading is Bb through activa¬
tion of complement via the alternative pathway (Bianco et al 1980) since
purified Bb has potent spreading inducing activity. In the assay system
used here with washed cells in de-complemented serum the spreading
activity could be carried over from the in vivo situation as already
activated membrane. It could also be stimulated in situ during the
assay through the generation of plasmin as a consequence of plasminogen
activator secretion as reported by Hamilton et al (1976) for asbestos
activated peritoneal macrophages. Since macrophages can also secrete
all the major components for activation of complement via the alternative
pathway (Nathan et al 1980) and since activated macrophages also secrete
C3 cleaving activity (Allison et al 1978) then local alternative pathway
activation could also generate Bb.
There is a close relationship between spreading and migration
inhibition and it has been suggested that MIF may act by causing direct
or indirect production of Bb (Gotze et al 1980). The exact role, if any,
of spreading in vivo is unclear but asbestos activated macrophages, if
spread, would be unlikely to chemoattract to a further inflammatory stimulus
or localised immune response; such a stasis could compromise the second
response. However, rather than speculate on the possible in vivo
significance of spreading it is sufficient to view in vitro spreading
of macrophages as a manifestation of altered secretion of the active
-155-
components discussed above.
U.1.2.3 Fc receptor avidity
Increased macrophage Fc receptor expression, manifest as increased
avidity for lightly sensitised SRBC's is a well documented index of
macrophage activation (Rhodes et al 1981). Increased Fc receptor
expression as measured by rosetting techniques or binding of labelled
complexes has been reported in oil elicited compared to resident peri¬
toneal macrophages (Rhodes 1975), in adjuvant activated compared to
resident alveolar macrophages (Arend and Mannik 1973) and to discriminate
between tumour derived macrophages, C. parvum and proteose peptone
activated, and resident peritoneal macrophages (Moore and McBride 1980);
rosetting techniques have also been used to detect differences in
activation in foreign body granuloma macrophages (Amsden and Boros 1979).
Specific rosetting techniques have also demonstrated increased avidity
of Fc receptors in monocytes from tumour bearing patients compared to
controls (Rhodes et al 1981) and monocytes of sarcoidosis patients
compared to controls (Schmidt and Douglas 1977). Miller (1979)
reported that the alveolar macrophages from rats inhaling crocidolite
were activated by Fc receptor avidity. In the present study macrophage
activation was present at all 3 time points as measured by the criterion
of increased Fc receptor avidity (3.2.3). The activated subpopulation
in the asbestos elicited macrophages were presumed to be the large cells
described below (3.2.6) since, in experiments where the subpopulations
of activated macrophages were separated by density gradients, the most
activated cells, by Fc receptor avidity, have been the larger, denser,
more rapidly sedimenting population (Walker 197U; Serio et al 1979;
Moore and McBride 1980).
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U.1.2.U 5' nucleotidase
As a further check on the indices of macrophage activation described
above, the plasma membrane bound enzyme 5' nucleotidase was measured
since the activity of this enzyme is known to be reduced to very low
levels in macrophages activated by inflammatory stimuli or lymphokines
(Bianco and Edelson 1978; Karnovsky and Lazdins 1978). The assay
was carried out on 3 day chrysotile and saline induced macrophages,
lysosomal hydrolases, including acid phosphatase are increased on
macrophage activation (Raz et al 1977) and since acid phosphatase can
be assayed using essentially the same phosphate release technique, the
level of acid phosphatase was also measured. The marked decrease in
membrane 5' nucleotidase and increase in lysosomal acid phosphatase,
in the asbestos compared to saline elicited macrophages, confirmed that
the asbestos elicited macrophages were activated (3.2.5).
U.I.2.5 Morphology
Morphologically the asbestos elicited macrophages were always
typified by a subpopulation of cells which were activated in appearance
(3.2.6). Activated macrophages, by light microscopy are typified by
their large, spread, granular and vacuolated appearance (Evans and
Alexander 1976; Raz et al 1977) and the asbestos elicited macrophages,
particularly at 3 days, fulfilled these criteria. The saline and latex
induced macrophages did not have an activated appearance being, in
general, small and unspread; when spread cells were present they did
not display the granular and vacuolated appearance of the spread asbestos
induced macrophages.
At scanning electron microscopy the 3 ana 18 day asbestos elicited
macrophages had the large, spread and ruffled appearance of cells with
increased membrane activity as described by Nabarra et al (1978) in
thioglycollate elicited macrophages. Increased ruffles and spreading
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were described by Miller and Kagan (1976) in SEM preparations of rat
peritoneal macrophages obtained following ip injection of crocidolite.
By transmission electron microscopy the 3 day asbestos elicited
macrophages had an appearance very similar to 3 day thioglycollate
induced macrophages with multiple vacuoles and infoldings of the surface
membrane (Nabarra et al 1979). In the 70 day asbestos elicited macro¬
phages the surface activity was reduced but there was clear morphological
evidence of activation as judged by increased numbers of granules, golgi
and associated vesicles, and mitochondria in keeping with the elevated
secretory status of activated macrophages. The appearance of the 70
day chrysotile activated peritoneal macrophages was very similar to that
described for alveolar macrophages obtained from the lungs of rats which
had been inhaling crocidolite in the long term and which were found to
be activated by Fc receptor and other criteria (Miller 1979).
It was noted that asbestos fibres could be detected in the vacuolar
system of macrophages 70 days after initial injection. This suggested
that either the macrophages which had taken up asbestos at the original
challenge had a long ( >70 days) residence time in the peritoneal cavity
or that asbestos became available to newly recruited macrophages through
death or exocytosis by previous asbestos bearing macrophages. Differing
evidence currently exists as to the origin of macrophages in the mouse
peritoneal cavity following an inflammatory stimulus. According to Daems
and co-workers (e.g. De Baker and Daems 1981) macrophages in the peri¬
toneal cavity mostly derive from division of pre-existing macrophages
and persist in the cavity for up to ii months. This model would certainly
explain the presence of asbestos inside macrophages 70 days after injection
and would suggest that a non-degradeable substance might persist in these
macrophages for the remainder of the animal's lifespan. In contrast
van Furth and co-workers (e.g. van Furth 1 981) have evidence that the
majority of peritoneal macrophages, both in the steady state and during
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inflammation, originate from peripheral blood monocytes. Such a model
is more dependent than the former on macrophage death or emigration
from the peritoneal cavity to make rociti for the incoming monocytes.
Although it was not quantified there was a very obvious decrease in
the number of asbestos bearing macrophages between days 3 and 18 and
between days 18 and 70; indeed by day 70 the presence of fibre in
macrophages was a rarity in TEM sections. Thus emigration of asbestos
bearing macrophages from the cavity seems to be a distinct possibility
and the final destination of the dust is of particular interest. The
complicating factor in such a simple consideration of macrophage kinetics
in relation to dust burden was the evidence that a large amount of
asbestos was sequestered in granulomas by day 70 (3.8.1). It is possible
that a major part of the injected fibre was walled off in these granulomas
while the remaining (? smaller fibres) asbestos could persist in the free
macrophage population by division and in long term residing macrophages.
This must, however, remain as speculation since macrophage kinetics
in the peritoneal cavity following injection of granuloma inducing agents
is unstudied.
U.1.3 The nature and extent of asbestos mediated macrophage activation
It is evident from ii.1.2 that macrophages elicited by asbestos in the
mouse peritoneal cavity in both the long and short term are activated as
measured by changes in several parameters; these macrophages will be
henceforth referred to as asbestos activated macrophages. It is
appropriate to consider what these changes reveal about asbestos activated
macrophages and the place of asbestos amongst other agents known to
activate macrophages.
U.1.3.1 Nomenclature
It has been said that the nomenclature of macrophage activation is
"generally unclear" (van Furth 1980), in or causing "confusion" (North 1978;
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Ogmundsdottir and Weir 1980) and "loosely applied" (Hopper et al 1979)'.
This disorder in terminology has arisen due to the huge literature
accumulating on the subject of macrophage activation, the multiplicity
of assays used to detect activation, and the number of agents, doses
and regimes used to obtain activated macrophages. There has also been
a tendency to think of activated macrophages as differentiating along
a well defined phenotypic line while there is good evidence that some
activational characteristics can be expressed independently of others
(North 1978; Nathan and Root 1977) and recent evidence tends to suggest
that every activating agent produces a different activational phenotype
(Werb and Chin 1981) at least expressed as the mean of the population which
is the figure produced by most assays.
As a response to the obvious lack of uniformity several appeals
have been made for standardisation of terminology and in general there
has been a call for a 3 tier systems- 1. Resident; 2. Elicited;
3. Activated; allocation of a population to a group however has been
the subject of disagreement. Karnovsky and Lazdins (1978) called for
"activated" to be reserved for macrophages activated by "immunological
means". The committee chaired by Morahan (1980) suggested that macro¬
phages differing from resident macrophages in any function could enter
the category of "activated"; the word activated was not apparently to
be used, however, and the agent employed to produce the change should
be given along with the origin and activated property. The cells used in
the present study could, by this system, be "mouse peritoneal macrophages
elicited 3 days after chrysotile asbestos injection for increased
spreading, increased Fc receptor avidity and decreased 5' nucleotidase".
By the system suggested by van Furth (1980) which has 6 categories, the
same cells would be "in vivo asbestos activated macrophages as measured
by increased spreading etc". Karnovsly and Lazdins (1978) and van Furth
(1980) recommend that the term stimulated should be avoided but it has
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frequently been used to describe activated macrophages which have not
attained tumouricidal/bactericidal status (e.g. Ogmundsdottir and Weir
1980). The term elicited is to be used for procedures which accumulate
macrophages and does not imply functional change although some such
alteration would generally be present.
The problems in the terminology of macrophage activation are
inherent in any attempt to define what is essentially a continuum of
states where the place of any cell in the continuum is determined by
multiple factors such as nature of stimulus, dose, state of animal,
time in culture, conditions of culture etc. Seen in the light of
current knowledge,what appears at first sight to be a retrograde step
suggested by North (1978), may in fact be a logical one;-
"it is desirable, therefore, to allow the meaning of the
term activated macrophage to remain vague until more
knowledge about the different manifestations of
macrophage activation is discovered" (North 1978).
U.1.3.2 The asbestos activated macrophage as a classical inflammatory
macrophage
Notwithstanding the lack of knowledge concerning the exact relation¬
ships between different indices of macrophage activation sane general¬
isations are possible. The first is that the fully activated state is
characterised by expression of tumouricidal/microbicidal function.
This can be assumed to be the evolutionary "aim" of the system in
mammals, i.e. to deal with invading microbes; this function has been
modified, in terms of the theory of immune surveillance, to detect and
eliminate tumour cells. It is also evident that resident macrophages
are not optimally responsive to the lymphokine signal which triggers
macrophages to attain tumouricidal/microbicidal status whereas inflammatory
macrophages have undergone the functional changes which render them
susceptible to lymphokine activation (Ruco and Meltzer 1978; Hibbs et al
1980). Allied to this fact may be the well documented alterations in
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the response of activated macrophages to a second stimulus compared to
resident macrophages. An altered response to a second stimulus, such
as phagocytosis, Con A or PHA, has been reported with regard to plasminogen
activator secretion (Gordon et al 197U), IL1 (Unanue 1978a), fibroblast
stimulating factor (Martin et al 1981) and hydrogen peroxide release
(Nathan and Root 1977). Recently a third layer of complexity has been
reported with the demonstration that proteolytic enzymes prime activated
macrophages to give a greater response to a triggering membrane stimulus
(Johnston et al 1981). This "primed" status of activated macrophages,
enabling them to react differently to resident macrophages in response
to a 2° or 3° stimulus makes their response in vivo particularly
difficult to assess due to the multiple interactions which are possible.
It is evident that asbestos is an inflammatory stimulus and so it
would be expected that asbestos elicited macrophages would have the
characteristics typical of inflammatory macrophages. This is borne
out by the activational parameters measured which show asbestos activated
macrophages to be similar to macrophages induced by sterile irritants
such as thioglycollate or oil which also have increased spreading,
decreased 5' nucleotidase (Cohn 1978) and increased Fc receptor avidity
(Rhodes 1975). The differentiation signals involved in asbestos mediated
macrophage activation can only be guessed at but direct activation
of macrophages in de-complemented serum has been reported for asbestos
(Davies et al 197U) and such direct activation has recently been attributed
to release of endogenous C3b by macrophages (Schorlemmer et al 1981)
which then acts as an autostimulator for macrophage activation; alter¬
natively asbestos has been shown to activate the canplement (e.g. Saint
Remy and Cole 1980) and kinin (Hamilton et al 1981) cascades which are
also capable of generating activating intermediates.
As harvested classical inflammatory macrophages are not tumouricical
(Hibbs et al 1978; Cohn 1978) and the use of an in vitro tumour cell
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killing assay showed that asbestos activated macrophages were not
tumouricidal to any degree which could be considered to have any
relevance in vivo (3.3.1.1). The asbestos activated macrophage can
therefore be considered to be a classical inflammatory macrophage.
It is necessary here to consider another problem of nomenclature
in macrophage activation concerning the tumouricidal status of activated
macrophages which has relevance to the nature of asbestos activated
macrophages. The apparent conflict arises from (i) the frequent
assertion that inflammatory macrophages from the peritoneal cavity
are not, or only slightly, tumouricidal (Hibbs et al 1978; Meltzer et al
1979; Hopper et al 1979) and (ii) reports, principally by Schorlemmer
and co-workers, that macrophages can be activated by inflammatory
generating agents which activate complement by the alternative pathway
to generate C3a which has potent cytolytic activity for tumour cells
(Ferluga et al 1978; Schorlemmer et al 1977a; Allison et al 1978) and
is less active against normal cells (Temple and Allison 1980). This
apparent conflict can be resolved by making the distinction between
(i) chronic and (ii) transient, low grade inflammatory producers.
Schorlemmer and co-workers deal with chronic inflammation inducers such
as zymosan, streptococcal cell walls and LPS, all of which activate
complement by the alternative pathway and which have many effects on
inflammation associated cells; in terms of eliciting inflammatory
macrophages into the peritoneal cavity, however, the usual agents are
thioglycollate, proteose peptone, oil and caseinate which do not activate
complement and produce only mild and transient inflammation. This is
another case of loose terminology in relation to macrophage activation.
Since asbestos does activate complement by the alternative pathway
(Wilson et al 1977; Hasselbacher 1979; Saint Remy and Cole 1980) it
would be predicted that asbestos activated macrophages would generate
C3a and therefore possess tumouricidal function but they do not.
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In this connection it is of note that tumouricidal activation has been
described for subcutaneous glass coverslip elicited macrophages (Poste
1979). Glass has many properties similar to asbestos, being a silicate
mineral, non-degradable, carcinogenic (Brand et al 1976) and having the
capability to activate the alternative pathway via plasmin through
activation of the clotting system (Ryan and Majno 1977). Poste
reported that between days U and 7 after implantation of coverslips
there was up to hh% macrophage cytotoxicity towards a tumour line in
vitro.
One possible explanation for the failure of asbestos activated
macrophages to express tumouricidal activity could lie in the reported
ability of prostaglandin E to inhibit tumouricidal function (Schultz
et al 1978). It is clear that the level of prostaglandin E secreted
by activated macrophages is sufficient to cause self-inhibition of
tumouricidal function under appropriate conditions (Taffet and Russell
1980). In keeping with the sequential triggering concept in activated
macrophages, which was discussed above, Bonney et al (1981) have shown
that Prostaglandin E release by activated macrophages can be increased
by latex phagocytosis for up to U days after removal from the animal.
Asbestos has been reported to cause prostaglandin release by macrophages
(Humes et al 1977j Sirois et al 1980) and it is possible that persistent
activation of macrophages by asbestos both directly and via the complement
system, allied to the huge phagocytic stimulus produced by asbestos
(1.6x10 fibres/mg in UICC crocidolite - Brown et al 1978) could result
in prolonged prostaglandin secretion and thereby inhibition of tumouricidal
function. A second possible mechanism whereby asbestos could inhibit
tumouricidal function is through the agency of trace elements including
cadmium, which have recently been demonstrated to inhibit macrophage
mediated tumour cell cytotoxicity (Nelson et al 1982). Cadmium is one
of the many trace elements present in the UICC asbestos samples and these
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elements, leaching from fibre within macrophages, could inhibit
tumouricidal function. A third explanation for the lack of tumouricidal
activity relies on the lymphokine theory of macrophage activation to the
tumouricidal state. If, in vivo, lymphokine is mandatory for attainment
of the tumouricidal state with inflammatory macrophages as the target
population required, then the vital lymphokine step is missing in the
model used here. The effect of asbestos treatment on the lymphokine
secretory status of lymphocytes in vivo is unknown but Miller et al (1979)
have reported alveolar macrophage activation and manifestations of cellular
immunity in the lungs of rats inhaling crocidolite asbestos; lymphokine
levels were not, however, measured. This cellular immunity showed same
properties of antigen specific T cell proliferation by sensitised
lymphocytes in response to a putative membrane neo-antigen on asbestos
dusted macrophages. As discussed later there was no evidence in the
present study of a humoral response to a putative neo-antigen in asbestos
activated peritoneal macrophages while attempts to detect the neo-antigen
using xenogeneic, heterologous anti-sera failed due to low specific anti-
macrophage activity. If increased lymphokine is generated in the
asbestos inhalation model either by the above mentioned antigen specific
T. cell proliferation, or due to a generalised adjuvant effect, this does
not seem to be the case in the peritoneal cavity following asbestos
injection since the tumouricidal function was not present. This could
be due either to the use of the peritoneal site or the single injection
model compared to the multiple exposures produced by a daily inhalation
regimen.
Depressed levels of lymphokine production would be predicted from
the suppressor effects of asbestos activated macrophage supernatants
discussed below (Iu5).
Scanning electron microscope studies of tumour cell/macrophage
interactions revealed that non-tumouricidal saline and asbestos elicited
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macrophages did not spread out on tumour cells but remained rounded
with a small area of membrane contact; C. parvum macrophages, which
were tumouricidal, could be seen to be spread out on dead and dying
tumour cells (3.3.1.3). Such close interaction between tumour cells
and tumouricidal macrophages has been reported in other transmission
electron microscope studies (Hanna et al 1976) and scanning electron
microscope studies (Kaplan and Seljelid 1977) and it is possible that
such a close interaction is necessary for tumour cell killing.
U.1.3.3 Existing evidence that asbestos can activate macrophages
The current state of knowledge with regard to the effects of asbestos
on macrophages other than cytotoxic effects, is shown in Table U.1 and
reveals that if the in vitro dose is low enough or the macrophages are
derived from animals treated with asbestos in vivo by inhalation or
injection then there is abundant evidence of macrophage activation.
At the start of this study, in 1979, only selective release of lysosomal
hydrolases (Davies et ad 197U) and plasminogen activator release
(Hamilton et al 1976) were reported as markers of activation following
in vitro or in vivo treatment of peritoneal macrophages with asbestos;
only the work of Miller (Miller and Kagan 1976; Miller et al 1979)
suggested that alveolar macrophages could became activated following
asbestos inhalation. The present study has confirmed the macrophage
activating potential of asbestos using different criteria and has shown
that, at least in the model used, the macrophages were not tumouricidal.
In addition, during the course of the study, further evidence for the
macrophage activating potential of asbestos has been published (Table U.1).
U.2 The use of Concanavalin A as a probe in macrophage/asbestos
interactions
Lectins have been used extensively as probes of membrane structure
and function in biological research. Due to their specificity for
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carbohydrate groups and their large size lectins do not traverse the
membrane except by endocytosis; their association with cells under
controlled conditions to prevent endocytosis is therefore directly
proportional to the amount of specific carbohydrate moieties at the
cell surface. While titration of surface carbohydrate groups is one
use of lectins, the cross-linking of specific binding sites at the
cell surface by the valencies of the lectin is the property utilised
in the other major application of lectins, i.e. as membrane perturbing
agents. Lectins, on binding and cross-linking receptors, can engender
transmembrane signals which elicit a sequence of metabolic events which,
depending on the cell in question, culminate in for example trans¬
formation in lymphocytes, or stimulation of oxygen metabolism in
activated macrophages.
Concanavalin A is a lectin derived from Canavalia ensiformis and is
composed of U identical sub-units each comprising 237 amino acids and
one binding site for the specific carbohydrate ot D marmosetD glucose
(Cunningham et al 1976). This means that Con A is tetravalent with
regard to its carbohydrate binding sites and can cross-link adjacent
groups either within the cell surface milieu or between adjacent cells
causing them to agglutinate. Con A in particular and also other lectins
have been used extensively to show differences between cells in terms of
their surface glycoproteins; for example between transformed and un-
transformed cells (review by Noonan 1978; Nicolson 1976b). Macrophage
plasma membranes have been investigated using a number of lectins and
have been reported to bind many of them including Con A (e.g. Oliver and
Berlin 1976), Lotus tetragonolobus lectin (Hcmma et al 1981), wheat germ
agglutinin (Hadley et al 1977), phytohaemagglutinin and pokeweed mitogen
(Loor and Roelants 197U). In addition macrophage differentiation has
been shown to be associated with differences in the expression of cell
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surface carbohydrates which can be detected by lectins, e.g. differences
in the amount of wheat germ agglutinin binding between monocytes and
mature macrophages (D.e Water et al 1981) and expression of a novel
glactose-rich glycoprotein receptor, which binds Griffonia simplicifolia
I-BU isoleetin, in activated but not resident macrophages (Maddox et al
1982).
Con A has been particularly utilised to investigate its binding, or
receptor, glycoprotein in the macrophage membrane and has been used in
studies on the effects of spreading and phagocytosis on Con A binding
sites (Lutton 1973) and the effect of the pollutants ozone and nitrogen
dioxide on alveolar macrophage Con A binding sites (Goldstein et al 1977).
The macrophage Con A receptor glycoprotein has itself been analysed and
found to be a transmembrane glycoprotein (Adachi et al 1980) as would be
expected from its ability to be mobilised by the cytoskeleton when it
interacts with these elements at the inner face of the membrane. These
cytoskeletal associations of the Con A receptor glycoprotein have
received attention in studies on the ability of the receptor to neap"
under suitable conditions (i.e. incubation with FITC-Con A at 37°C) as
has been demonstrated in other cells such as neutrophils and lymphocytes
(Oliver and Berlin 1976). Thus 30% of resident alveolar macrophages
(Williams et al 1977), 0% of resident peritoneal macrophages (Pick and
Wilner 1979) and approximately 10^ of caseinate elicited peritoneal
macrophages (Williams et al 1979) have been reported to cap on incubation
with FITC-Con A. The role of the cytoskeleton has been confirmed by the
general increase in caps found following colchicine pre-treatment (Oliver
and Berlin 1976; Williams et al 1977; Pick and Wilner 1979; Williams
et al 1979). With microfilament disrupting agents there is a more complex
response with increases in the proportion of capping alveolar macrophages
(Williams et al 1977; Williams et al 1979) but no ability to increase
caps in peritoneal macrophages (Williams et al 1979; Pick and Wilner 1979).
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In the present study Con A was utilised in three ways:-
(i) to visualise the specific membrane glycoprotein (Con A receptor
glycoprotein) following interactions between asbestos and macrophages;
(ii) to study the capping of Con A receptors in asbestos activated
macrophages;
(iii) to enumerate the Con A receptors on macrophages using ^ij Con A.
U-2.T Effect of asbestos interaction with the macrophage membrane on
the Con A receptor glycoprotein
This study was conceived to test the frequent assertion, made
principally by Harington and co-workers (Harington et al 1975; Harington
1976) that asbestos may interact with cell membrane glycoproteins causing
clustering and leading to osmotic disturbance. This is seen as the
underlying mechanism in haemolysis, "early macrophage cytotoxicity" in
serum free conditions and in phagolysosomal rupture in late macrophage
cytotoxicity in the presence of serum (Harington 1976). Using light
microscopy and FITC labelled Con A to visualise the Con A binding sites
there was occasional evidence that the Con A receptor glycoprotein was
concentrated or clustered at areas of contact between fibre and macro¬
phage membranes. This was manifest as areas of bright fluorescence
coinciding with areas of contact between fibres and macrophages (3-U-1)-
These accumulations of fluorescence were, however, rare events despite
the many cells obviously undergoing interactions with fibre. This
suggested that there was something special about these interactions which
did show evidence of clustering. The most likely candidate in this
matter was size, with only large fibres being resolved by bright field
and large fibres causing the greatest membrane clustering; these two
factors could combine resulting in association of clustering with large
fibres. There were, however, many more cases where large fibres were
interacting with membrane in absence of any change in the pattern of
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fluorescence. It seems possible also that the disturbance could be
artefactual representing the trapping of FITC-Con A between fibres and
membrane or selective adsorption of FITC-Con A on to fibre in contact
with membrane. Cells showing clustering of fluorescence at points of
contact with fibre were so rare, within a population where so many cells
were in contact with fibre in the absence of clustering, that artefact was
a distinct possibility. The possibility of artefact is further increased
by the presence of clusters in both serum free and serum containing
conditions when an effect could only be expected in the serum free
conditions since the active Mg groups are rapidly protein coated and
masked in protein solution.
Transmission electron microscopic preparation of macrophage/
chrysotile interactions, with the Con A binding sites demonstrated ultra-
histochemically, also failed to reveal convincing evidence of accumulation
of Con A binding sites at points of membrane/fibre contact (3.U.1.2).
This result is similar to that found for another inert particulate, latex,
where no alteration in the pattern of cell surface Con A binding sites
was observed at points of attachment between particle and membrane
(Eguchi et al 1979). It appears that, with respect to the macrophage
membrane Con A receptor glycoproteins, there is no effect on their
disposition on attachment to the membrane of a non-toxic particulate
(latex) or a toxic one (chrysotile) although it remains possible that
the reaction was too coarse to reveal any very fine effects.
li.2.2 Con A induced capping in asbestos activated macrophages
li.2.2.1 Role of activation in Con A induced capping
Experiments to determine the proportion of macrophages which formed
caps on incubation with FITC-Con A revealed that both C. parvum and
asbestos activated macrophages had significantly increased numbers of cells
which capped on incubation with FITC-Con A (3.li.2.2). This figure was
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32^ for C. parvum and chrysotile activated macrophages and 22^ for
crocidolite activated macrophages; control macrophages had \x% capping
cells. Since latex elicited macrophages had control levels of capping
it is clear that phagocytosis alone is not always sufficient stimulus
for inducing the capping sub-population. Since proteose peptone elicited
macrophages also had low levels of spontaneously capping cells, then not
all macrophage activating agents induce an increased capping population.
The finding of significantly increased levels of capping macrophages
in resident" peritoneal macrophages frcsn nude mice compared to saline
induced macrophages of ordinary mice (3.1i.-2.9) confirmed that capping is
related to activation since nude mice have macrophages which have been
reported to be in a constant state of activation (Zinkernagel and Blanden
197?). However, the testing of an early adhering population, putatively
the most activated macrophages, did not demonstrate a higher percentage
of capping cells (3-U.2.6).
Evidence that macrophage activation plays a role in Con A capping
exists in previously published work;- thus Pick and Wilner (1979) reported
that resting peritoneal macrophages had 0% capping cells while Williams
et al (1979) using peritoneal macrophages induced with caseinate, a
procedure likely to cause some macrophage activation, found approximately
10% capping macrophages. Similarly the finding of 30^ capping guinea
pig alveolar macrophages is in keeping with the suggestion that resident
alveolar macrophages are in a consistently higher state of activation
than resting peritoneal macrophages (Hopper et al 1979).
U.2.2.2 Role of the cytoskeleton in Con A capping
Pharmacological modification of capping was carried out using the
microfilament disrupting drug cytochalasin B and the microtubule disrupting
drug colchicine. In the present study colchicine had virtually no effect
in promoting capping (3.U.2.7) although previous studies have demonstrated
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that, with colchicine treatment the level of Con A capping can be
increased 2-30 fold (Williams et al 1977; Williams et al 1979; Pick
and Wilner 1979). It is clear however that in all of these studies
the majority of macrophages were not colchicine sensitive being either
spontaneously capping or non-capping despite colchicine treatment.
In the present assay system, with CBA mouse peritoneal macrophages,
the mobility of the Con A receptor glycoprotein is clearly not inhibited
by colchicine sensitive microtubules. It seems likely that, as suggested
by Pick and Wilner (1979), there are sub-types of microtubules and micro¬
filaments which are not colchicine or cytochalasin B sensitive and the
proportion of these elements may be liable to species and sub-species
variation. The abolition of capping in activated macrophages following
cytochalasin B treatment (3.U.2.7) confirms that microfilaments are
necessary for capping in peritoneal macrophages (Williams et al 1979)
and spleen cells, presumed to be lymphocytes (De Petris 197U)-
The finding that lignocaine inhibited capping in activated macro¬
phages (3.1;.2.7) is in keeping with the previously reported cytoskeletal
disrupting (Nicolson et al 1976) and capping inhibitory (Ryan et al 197U)
properties of tertiary amine anaesthetics such as lignocaine.
Experiments demonstrating that Con A receptors are regenerated after
U hours with both saline and chrysotile elicited macrophages revealed
that there was no fundamental defect in the membrane receptor generative
ability of chrysotile activated macrophages compared to control macro¬
phages (3.1;.2.8). This timing is also in agreement with Button (1973)
who reported regeneration of Con A receptors Ul" hours after phagocytosis
of latex by macrophages as measured by recovery of Con A binding.
U.2.2.3 Electron microscopy of capped macrophages
At scanning electron microscopy large bleb-like protrusions were
present on the surface of a proportion of chrysotile induced macrophages
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(3.U.2.10) which had been treated with Con A under capping conditions;
these blebs were absent from similarly treated saline induced macrophages.
The secondary electron emission from these blebs was different from the
rest of the cell suggesting that the physicochemical make up of that
portion of membrane was different from the rest of the cell; such a
difference could be due to the accumulation of Con A receptor glyco¬
proteins in the "cap".
Saline induced macrophages treated with Con A under capping conditions
showed, at scanning electron microscopy, an increase in macrophages with
leafy, frond-like processes in keeping with an increase in membrane activity.
By transmission electron microscopy the already complex membrane
infoldings of 3 day chrysotile activated macrophages was seen to be
increased, on a qualitative basis, when these cells were treated with Con
A under capping conditions (3.li.2.10). Also the number of cells showing
extreme membrane infoldings was approximately doubled. It thus appears
that asbestos in vivo has a "Con A-likeH effect on the macrophage membrane,
which is emphasised by treatment with Con A in vitro. As discussed
previously there are probably many factors generated by acute asbestos
inflammation in the peritoneum which could have some of the membrane
perturbing properties of Con A (e.g. plasmin, other proteases, Bb) and
which could prime the macrophage membrane to further perturbation by
Con A. By transmission electron microscopy no structures analogous to caps
were seen in relevant populations although caps have been described at
transmission electron microscopy in alveolar macrophages treated with
Con A (Williams et al 1977). It seems likely therefore that not enough
sections were examined to obtain a good section of a cap since these would
be relatively rare (3.1;.2.10).
U.2.2.U The possible role of Con A recptor number and position in capping
It was possible that the transmembrane signal engendered by Con A
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binding, and which lead to capping, could be switched on in activated
macrophages due to an increased number of receptor sites on such cells.
The relative number of Con A binding sites on the surface of control
and activated macrophages was therefore assessed by binding of (_1^lJ
Con A. In initial experiments the finding of a significant reduction
in Con A binding following latex phagocytosis was in agreement
with the original experiments of Lutton (1973); this suggested that
our assay system which was based on button's was comparable.
1*125 1
The total {_ IJ Con A binding to asbestos activated macrophages
was the same as for control macrophages (3.U.3.k). Previous work
concerning the effect of environmental pollutants on lectin binding
to alveolar macrophages revealed no effect of ozone or nitrogen dioxide
on binding of tritiated thymidine Con A compared to controls (Goldstein
et al 1977); Hadley et al (1977) however found increased binding of the
lectin wheat germ agglutinin to ozone treated macrophages. C. parvum
activated macrophages bound approximately 30$ more Con A than
control and asbestos activated macrophages (3.1i.3.1i). Since activation
can occur via several different pathways and the interaction of the
various differentiation signals can be very canplex (as discussed in
U.1.3.2) it is not surprising that there is considerable variation in
activational phenotypes (Hopper et al 1979; Werb and Chin 1981). Due
to the very different natures of asbestos and C. parvum it is likely
that they activate macrophages by different pathways. As discussed above,
asbestos and C. parvum activated macrophages do possess different
activational phenotypes with C. parvum macrophages being tumouricidal while
asbestos activated macrophages are not. The increased binding of [1^lJ
Con A to C. parvum macrophages could therefore reflect functionally
related differences in the membrane of tumouricidally activated macrophages.
Increased binding could also be due to increased cell surface poly-
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saccharide as reported for macrophages involved in cell-mediated
immunity (Hammond and Dvorak 1972). Notwithstanding these explanations
for increased numbers of Con A binding sites in C. parvum activated
macrophages it was apparent that Con A receptor number was not the
major factor in capping since asbestos activated macrophages, which
which did not have a large capping subpopulation.
It was possible that the differences in capping potential of control
and activated macrophages might reside in the exact position of the Con A
receptor glycoprotein. Although the Con A receptor glycoprotein has
been shown to be predominantly transmembrane in organisation (Adachi et al
1980) it was possible that in control macrophages there might be an
increased proportion of peripheral membrane, or even glycocalix situated,
Con A binding glycoproteins, while in capping macrophages the transmembrane
organised Con A binding glycoprotein, able to link with the cytoskeleton,
might predominate. Differences in the protease releasability of Con A
bound to surfaces of control and transformed fibroblasts have been
reported suggesting that proteases can detect fine qualitative differences
in the Con A receptor sites within the complex milieu of the cell surface.
Using trypsin on control and activated macrophages, however, revealed no
difference in the bound Con A which was trypsin releasable (3.U.3.5).
An alternative explanation for the mechanism of capping in activated
macrophages lies in the increased oxidative metabolism frequently reported
in such macrophages (review Nathan 1982). Oliver et al (1977) demon¬
strate that the important microbicidal and tumouricidal agent, could
have a direct role in tubulin oxidation in polymorphonuclear leukocytes
by causing inhibition of microtubule assembly and thereby promoting
capping. Nathan and Root (1977) have reported that activated macrophages
respond to membrane perturbing agents, such as Con A or phagocytosis, by
capped, bound the same amount Con A as control macrophages,
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release of H^O^. Thus the capping in activated macrophages could be due
to increased production in these cells. This explanation of capping
in activated macrophages is an attractive one despite the failure in the
present study to show a role for colchicine sensitive structures in
capping and the reported differences in cytoskeletal requirements for
capping between macrophages and polymorphonuclears (Williams et al 1979).
U.2.2.5 Phagocytosis of different particulates and Con A binding
Three different particles were used to study the effect of phagocytosis
on 125J Con A binding:- latex, opsonized SRBC's and asbestos. It was
hoped to compare the percent membrane internalization, as measured by
decrease in Con A binding, on phagocytosis of these different
particles. This was done in order to test the hypothesis that macrophages
phagocytosing fibres might exceed the normal constraints on the proportion
of membrane which can be internalized and might start to internalize
transport areas of membrane which are normally selectively excluded from
phagosomal membrane (Tsan and Berlin 1971). This did not prove possible
due to the persistent finding of increased binding of [ ^^Ij Con A
following asbestos phagocytosis (3.U.3.3) presumed due to binding of
l^x] Con A to surface adherent and partly phagocytosed fibre. The
study did however reveal that ingestion of opsonized red cells did cause
reduction in [1^l] Con A binding (3-U-3-2). It was of interest, however,
that treatment of macrophages with red cell lytic buffer alone caused
marked reduction in binding of f^^lj Con A. This has some relevance
for studies of membrane related parameters following removal of con¬
taminating red cells with lytic buffer since a recovery period in
culture may be necessary to allow regeneration of the glycoproteins
stripped from. the cell surface by treatment with the buffer.
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U.3 Investigations on a putative neo-antigen expressed in the membrane
of asbestos activated macrophages
Miller and co-workers (Miller and Kagan 1977; Miller et al 1979;
Miller and Kagan 1981) have provided indirect evidence that asbestos
inhalation, in the long term, can cause alveolar macrophage activation
and expression of an asbestos related neo-antigen. This neo-antigen
is then envisaged as being recognised by the host immune system as
foreign so precipitating a cell mediated immune response with sensitised
T lymphocytes being present in the spleen of dusted animals; co-culture
of spleen cells and macrophages from dusted rats is then analogous to
an antigen specific T cell proliferation and thymidine is incorporated
(Miller and Kagan 1981). Wahl et al(l980b) have shown that fibroblast
stimulating factors are produced during antigen specific T cell pro¬
liferation and so the above events could be important in asbestos
related lung fibrosis. The indirect evidence that the lymphocyte
proliferation is antigen specific resides in the demonstration of
macrophage/T cell rosette formation (Miller et al 1979) which is similar
to that produced during conventional antigen specific T cell/macrophage
interactions (Lipsky and Rosenthal 1975) and the demonstration that the
proliferation is not due to aldehyde moieties on the macrophage surface
(Miller and Kagan 1981). There was a non-specific lymphoproliferative
component in these reactions and the role of diffusible factors was not
investigated, the data being interpreted on the basis of membrane changes
only.
In the present study it was appropriate therefore to try and detect
evidence of neo-antigen expression in asbestos activated peritoneal
macrophages and this was attempted in two ways:-
(i) By raising xenogeneic anti-sera to control and asbestos activated
macrophages and attempting to demonstrate differences in specificity
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follcwing suitable absorption}
(ii) By attempting to detect increased surface Ig in asbestos activated
macrophages as evidence of an auto-immune humoral response to the
putative neo-antigen; indirect evidence for such a humoral response
was obtained by Miller and Kagan (1977) as increased immune adherence in
alveolar macrophages from rats which had inhaled crocidolite.
li.3-1 Use of anti-sera raised against asbestos and saline induced
macrophages
Anti-sera contained significant activity against CBA/Ca mouse
thymocyte (3.6.1) and this activity could be absorbed out with thymocytes.
Activity against PEC remained (3.6.2) but was again reduced when only
adherent PEC (macrophages) were used as targets (3.6.3). When the anti-
macrophage activity was found to be present experiments were carried out
to ascertain whether the binding assay, routinely carried out in pre¬
liminary experiments at 1/50 dilution of anti-sera, represented saturation
binding conditions. Saturation binding was required for comparison of
the anti-sera specificities but even at 1/10 dilution saturation binding
was not present with the standard number of target macrophages used
(3.6.U). Less target cells were tried but the counts became so low in the
tests that they were not significantly greater than background binding given
by the pre-bleeds. The low level of specific anti-macrophage activity
caused the experiment to be abandoned.
Immunofluorescence failed to demonstrate any qualitative differences
in the two types of anti-serum with regard to pattern of binding to the
two macrophage types (3.6.5). Complement mediated lysis also revealed
a low level of specific anti-macrophage activity in the anti-sera (3.6.6).
No adequate explanation can be offered for the low level of anti-
macrophage activity present in the rabbit anti-sera. There was abundant
evidence of immune response to common mouse antigens as shown by the high
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level of binding of the anti-sera to thymocyte and which could be
absorbed out with thymocytes. Similarly there was a high level of
binding to PEC but this was greatly decreased when only adherents were
used as targets; it appears therefore that the greatest part of the
activity was directed against non-macrophage components of the PEC,
i.e. lymphocytes and polymorphs. Essentially two methods of raising
xenogeneic anti-macrophage sera have been used with either cells
emulsified in Freunds adjuvant (Unanue 1968; Isa 1971;) or whole cells
(Panijel and Cayeux 1968; Hirsch et al 1969; Kaplan and Mohanakumar 1977)
as the immunogens; both immunization regimes yielded specific anti-sera.
If the present study can be repeated both immunization schedules will be
used and also more rabbits, in the hope of obtaining specific anti-
macrophage sera of high activity. Ideally monoclonal antibodies to
control and asbestos activated macrophages would be obtained to try and
detect differences (see U.7.2).
li.3.2 Attempts to detect surface Ig on asbestos activated macrophages (3.7)
In an attempt to detect a humoral response to the putative neo-antigen
an anti-mouse Ig serum was used in combination with [ ^^l] Protein A.
6, 1U and 29b day crocidolite and saline elicited macrophages were used
and no difference was ever detected between crocidolite and saline macro¬
phages with regard to surface Ig (3.7). By the criterion of surface
Ig therefore there was no evidence of a neo-antigen.
U.3.3 Macrophage activation and membrane antigen modulation
It is useful to review the published data on membrane antigenicity
in activated macrophages with specific reference to the concept of an
asbestos related macrophage neo-antigen and ask two questionss-
(i) is there any evidence that macrophage activation by other agents
causes alteration in membrane antigenicity?
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(ii) is there any reason to suspect an immune response to such neo-
antigens?
In answer to the first question there are several studies which have
revealed altered antigenicity in activated macrophages compared to
resident macrophages. Kaplan and Mohanakumar (1977) reported that an
anti-serum to P388 D1 cells (activated macrophages by many criteria) was
cytotoxic to pyran and C. parvum activated macrophages but not to
glycogen or thioglycollate activated or resident macrophages. Waldrep
et al (1981) using relevant anti-sera demonstrated new antigens in a
lymphokine treated macrophage cell line that was absent from untreated
cells suggesting that a macrophage differentiation signal was capable
of inducing expression of a new antigen(s). Using direct biochemical
methods, differences in membrane glycoproteins have also been demonstrated
between resident and activated macrophages. Tin et al (1980) using lacto-
peroxidase/glucose oxidase labelling demonstrated qualitative and
quantitative differences in the membrane glycoproteins between resident,
thioglycollate and endotoxin activated macrophages. A similar result
was reported by Kaplan and Olstad (1981) using biosynthetic labelling
of membrane determinants, with both qualitative and quantitative
differences evident between resident and ascites activated macrophages.
Pearlstein et al (1978), using lactcperoxidase iodination of resident
and starch elicited macrophages detected a novel 195,000 MW membrane
glycoprotein expressed by the starch elicited macrophages, but absent in
the resident macrophages. Indirect methods, using lectins, have also
yielded evidence for differences in membrane glycoprotein between mono¬
cytes and macrophages (De Water et al 1981 ) and between resident and
activated macrophages (Maddox et al 1982).
It is evident therefore that conventional activating agents cause
altered antigenicity or increases in existing antigens, the latter being
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difficult to disprove, and so the expression of neo-antigen on asbestos
activated macrophages might be expected. It remains possible, however,
that alveolar macrophages might be less liable to antigenic modulation
than peritoneal macrophages, which have been discussed so far, since
Davies and Stossel (1981) found only small differences between resident
and adjuvant elicited alveolar macrophages with regard to membrane
proteins; they did however observe that their technique did not have
high resolution.
If new antigens are expressed by activated macrophages in response
to endogenous differentiation signals in vivo the question then arises
as to whether such a finely evolved host defensive response would evoke
an autoimmune response. There is no reference in the PAGR/SDS studies,
discussed above, of large amounts of 50K or 25>K components which could
represent heavy or light chain respectively; it is true however that
the time span for eliciting activated macrophages may not be sufficiently
long for a full autoimmune humoral response to develop. It has recently
been suggested that autoimmunity is a far more common occurrence than
was previously supposed with, for instance, around $0% of B lymphocytes,
following immune response to a conventional antigen, secreting IgM
specific for IgG (rheumatoid factor ) (Dresser 1978). Similarly a
common type of immunostimulation, malarial infection, has been shown to
result in high levels of autoimmunity including antibodies against the
membrane of parasitized red cells with generation of specific T helper
and B cells (Rosenberg 1978). The adaptive value of such autoimmune
responses could lie in regulation of immune response (idiotype networks)
and in opsonization for rapid clearance, e.g. in the case of parasitized
red cells.
In view of the above facts it seems likely that asbestos activated
macrophages, and other kinds of macrophages activated in vivo in the
course of host defence, could elicit autoimmune responses; the absence
-181-
of evidence for such a response in the present study could be explained on
the basis of the peritoneal site or the single exposure model used.
If other diseases in the lung, e.g. pneumonia, which result in both
activated macrophages with neo-antigens and autoimmunity, do not have
fibrosis as a sequel than it is necessary to look for another factor
associated with asbestosis. It seems likely that a major factor is the
persistence of the dust and further work is required to assess whether
the fibroblast stimulation in asbestosis is due to a factor (i) released
by asbestos activated macrophages or (ii) lymphocyte derived due to
antigen specific T cell proliferation to neo-antigens on the former;
both could have a role.
In parts iuU and U.5 experiments will be discussed which examined the
possible consequences of asbestos induced macrophage activation for host
defence. These experiments essentially involved tumour growth in vivo
and in vitro following asbestos treatment and associated experiments (U.U)
and the effects of asbestos activated macrophage supernatants on lymphocyte
mitogenesis and associated experiments (U.5).
I4..I4. Effects of asbestos on am experimental fibrosarcoma model
As part of the study into the activational status of asbestos elicited
macrophages the in vitro tumouricidal activity was measured. It should be
stressed, however, that interactions of asbestos activated macrophages with
tumour cells is of fundamental importance in terms of the carcinogenic
effects of asbestos and so a series of experiments were carried out on this
subject. These experiments were aimed at measuring the effects of "asbestos
activated macrophages and asbestos on tumour growth in vivo and in vitro.
As discussed previously (U«1.3-2) the asbestos elicited macrophages were
not apparently cytotoxic to tumour cells in a tumour cell killing
assay. In addition the supernatants from 3 day asbestos activated
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macrophages were tested in an in vitro assay to measure cytostatic effects
on tumour cell proliferation. Such cytostatic factors have been reported
to be released from activated macrophages (Keller 1981) and would not be
detected by a pre-labelling killing assay but would be detected by a post-
labelling proliferation assay. There was however no evidence for the
presence of cytostatic factors in the supernatants of asbestos activated
macrophages, nor from saline, latex or C. parvum elicited control macro¬
phages (3.3.2). Since C. parvum activated macrophages were always
tumouricidal in the tumour cell killing assay, the cytostatic assay there¬
fore revealed that direct interaction between C. parvum macrophages and
targets was required and that a diffusible cytotoxic factor, similar
to that described by Sharma et al (1980), was not responsible for
C. parvum macrophage killing of tumour cells.
As might be expected frcri the in vitro cytocidal and cytostatic assays,
the in vivo experiments where asbestos was injected into mice and the
growth of a concomitant tumour monitored, failed to show any consistent
effect of asbestos on tumour growth. An intriguing finding however was
that 5 mg chrysotile ip caused small significant reductions in tumour
growth while 2.5 mg and 20 mg did not (3.3.3.1). Using the same regimen,
C. parvum injection caused significant reduction in tumour growth but
altering the regimen to one which profoundly increased the ability of
C. parvum to inhibit tumour growth caused 5 mg chrysotile to lose its
effect. Both 5 and 20 mg of crocidolite ip failed to cause reduction
in tumour growth. These results are difficult to interpret but one
interpretation is that the mechanism whereby 5 mg chrysotile caused
reduced tumour growth was different from the mechanism whereby C. parvum
inhibited tumour growth. Numerous studies have shown that C. parvum acts
in large part through the generation of tumouricidal macrophages and so
it follows that 5 mg chrysotile must operate through some other mechanism
possibly through a general adjuvant effect on other anti-tumour responses
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e.g. NK cells.
The Winn assay experiments tended to confirm the general trend
present in other assays, that ip asbestos did not generate tumouricidal
macrophages. Control and chrysotile induced PEC mixed with tumour cells
at 10:1 and 100:1 then injected subcutaneously revealed no significant
differences in tumour growth (3-3-^4.). This suggested that the difference
between site of primary macrophage activation (peritoneal cavity) and
tumour growth (subcutaneously on leg) was not a major impediment to the
manifestation of any tumouricidal/tumouristatic effects in the in vivo
system described above. As a further check however, crocidolite was
mixed with the tumour cell inoculum so that local macrophage activation
at the site of the tumour could further promote macrophage/tumour cell
interactions. Crocidolite was chosen because of its lower surface
activity than chrysotile so reducing the chances of direct toxic effects
of the fibre on the tumour cells and in addition it was coated by
incubation with FCS. These experiments yielded a direct dose related
decrease in tumour size with increasing amounts of crocidolite in the
inoculum (3.3.5). While it was possible that local activation of
tumouricidal or tumouristatic macrophages had occurred at the site of
the tumour due to crocidolite, it remained possible that the crocidolite
had exerted a direct dose dependent toxicity on the tumour cells in the
inoculum; the effect of crocidolite and crocidolite leachate was
therefore tested on tumour cells in culture. Both crocidolite and
chrysotile and leachates were found to have very little effect on
tumour cells in culture except at the highest doses of both crocidolite
and crocidolite leachate, which were markedly inhibitory (3.3.6).
This high dose of crocidolite (100 jug/well) was similar to, or less
than the equivalent dose of crocidolite which the tumour cells in the
inocula were exposed to. This raised the distinct possibility that
the inhibition of tumour growth produced by including asbestos in the
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inocula was indeed a direct toxic effect of asbestos on the tumour cells
and local crocidolite mediated activation of macrophages to a tumouricidal
or tumouristatic state does not have to be invoked.
The effect of asbestos and asbestos activated macrophages in the
fibrosarcoma model used here can be summarised as:-
(i) using in vitro assays asbestos activated macrophages were not
appreciably tumouricidal nor did they release factors which were tumour
cell cytostatic
(ii) in Winn assays chrysotile induced PEC were not inhibitory or
stimulatory to tumour growth
(iii) ip injection of crocidolite never caused significant effects,
compared to controls, on concomitant tumour growth while the single
intermediate dose of chrysotile (5 nig) which caused inhibitions of
tumour growth did not appear to bring about its effect via macrophages.
(iv) although crocidolite mixed with tumour cells and inoculated sub-
cutaneously caused inhibition of tumour growth this could be explained
by a direct toxic effect of crocidolite on the tumour cells which was
evident at similar doses in in vitro experiments.
It can be assumed therefore that asbestos in CBA/Ca mice, neither
inhibits nor potentiates the growth of an experimental fibrosarcoma
through the agency of macrophages.
The ability of asbestos to activate macrophages to the tumouricidal
state may be intuitively unexpected since asbestos is a carcinogen.
However glass can cause macrophage activation to the tumouricidal state
(Poste 1979) and is tumourigenic (Brand et al 1976). Schistosome eggs
have also been found to be tumourigenic (Brand et al 1976) while macro¬
phages from schistosome egg granulomas have been reported to be activated
(Amsden and Boros 1979) and although the tumouricidal function was not
assayed for, it is very likely that they are tumouricidal. Thus it would
not be unprecedented for asbestos to cause tumouricidal macrophage
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activation and also, eventually, tumours. The relationship between
inflammation and tumour growth is not clear and asbestos is both a
chronic inflammation generating agent and a carcinogen. Data is
conflicting with Fauve et al(l977) reporting that a non-specific
inflammatory stimulus, magnesium silicate in calcium phosphate, in the
feet of mice, caused increased resistance to challenge with Lewis lung
carcinoma cells. Nelson et al (1981) and Nelson and Nelson (1981)
used a variety of mitogens as inflammatory inducing agents and reported
that while some of these agents were able to suppress tumour growth,
their ability was not clearly related to apparent intensity of inflammatiom
and some of the agents enhanced tumour growth. It has been suggested
that inflammatory mediators may have an important role in tumour growth
and that macrophage secretions such as' plasminogen activator and proteases
may be central (Vassalli et al 1977). Many, if not all promoting agents
are powerful inflammatory generating agents and there may be a parallel
between the ability of some producers of chronic inflammation to
eventually cause fibroblast division and fibrosis, and the ability of
promoters to cause tumour cells to divide; macrophages could be
important cells in this model as discussed in (1.12.2). Asbestos
has many of the properties of a promoter (e.g. Topping and Nettesheim
1980) and asbestos activated macrophages release plasminogen activator
(Hamilton et al 1976) and proteases, which have been implicated in
maintenance of the transformed phenotype (Quigley 1979). The possibility
that macrophages might contribute to the actual transforming event was
suggested by the work of Weitzman and Stossel (1981) who showed that
phagocytes (neutrophils and monocytes) were mutagenic in Ames type
bacterial mutation tests. The authors suggested that oxygen metabolites,
^2^2 ^2 * were resPonsible» and activated macrophages are a particu¬
larly rich source of these metabolites (Nathan 1982). The accumulation
of macrophages so characteristic of asbestos inflammation could create
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ideal conditions for the elevated levels of such substances.
Clearly further work is necessary to elucidate the relative
importance, the in vivo significance and the factors controlling
which role a given macrophage population plays in tumour growth, i.e.
(i) tumour cell killer; (ii) releaser of tumour growth promoting
factors; (iii) releaser of tumourigenic oxygen metabolites. The
activational state is clearly a likely major factor in which of these
phenotypes, if any, is dominant and the role of asbestos is of particular
interest.
li.5 Suppressor action of asbestos activated macrophage supernatants
on lymphocyte mitogenesis
In view of the central role of the macrophage in immunoregulation
and the alteration of function on activation (reviewed in 1.11.1) it
was appropriate to consider the possible altered role of the asbestos
activated macrophage in immune responses.
The best characterized and most reported of a family of lymphocyte
modulating factors released by macrophages (Diamenstein et al 1979) is
IL1 first described by Gery and Waksman (1972) in mice although it has
also been described in humans (Diamenstein et al 1979). IL1 has frequently
been demonstrated through its ability to potentiate Con A or PHA mitogenesis
in thymocytes (Gery and Waksman 1972; Blyden and Handschumaker 1977;
Beller and Unanue 1980) and it can also replace macrophages in helping
antibody synthesis by B cells (Koopman et al 1978). IL1 has been
extensively characterised and purified (Blyden and Handschumaker 1977;
Mizel 1979; Economou and Shin 1980).
In the original description of macrophages as the source of IL1 Gery
and Waksman (1972) noted that agents which stimulated macrophages increased
IL1 production. Subsequently activated macrophages have been used as a
source of IL1:- alveolar macrophages, BCG elicited, LPS treated in vitro
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(Murphy et al 1980), P388 D1 cells treated with phorbol myristate
acetate (Mizel 1979), peritoneal macr(phages resident or thioglycollate
elicited treated with LPS in vitro (Tenu et al 1980), human peripheral
blood monocytes treated with LPS in vitro (Blyden and Handschumaker 1977).
It seemed relevant therefore to examine the asbestos activated macrophage
supernatants for IL1 activity.
In order to calibrate and optimise the thymocyte assay several
different conventional methods of obtaining IL1-rich macrophage super¬
natants were tried including LPS treatment in vitro for 2k and U8 hours
and induction of activated macrophages in vivo with proteose peptone
and Con A; no IL1 activity was ever detected in these supernatants
(3.5.1). In an attempt to discover the reason for this failure to
detect IL1 activity in these supernatants a search of the literature was
undertaken and a large number of publications was discovered demonstrating
a suppressor factor present in supernatants frcm activated macrophages
(reviews by Nelson 1976; Schechter et al 1980). Reviewing the data
fran the above experiments, aimed at detecting IL1 activity, revealed
abundant evidence of suppression of mitogenesis; it was apparent therefore
that the conditions under which supernatants were generated, or the
conditions of the thymocyte mitogenesis assay, were such that suppressive
activity was being detected in activated macrophage supernatants.
Using saline and latex elicited macrophages as controls, and asbestos
elicited macrophages, supernatants were prepared and tested in the sub-
optimal Con A mitogenic assay. Doses of 1 and 2 ^ig/ml were found to
best detect suppression and so these were used routinely.
Both crocidolite and chrysotile induced macrophage supernatants
were found to be significantly inhibitory to thymocyte mitogenesis when
the data were expressed as mitogenic indices at 1 and 2 ^lg/ml Con A;
chrysotile was significantly inhibitory to mitogenesis at 2 pg/ml Con A
(3.5.U). The inhibition produced by $0% asbestos supernatant in the
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incubation mixture was approaching 50% in some assays suggesting that
almost complete abolition of mitogenesis could be produced by carrying
out the assay in 100^ supernatant. Neither latex nor saline elicited
macrophages released suppressor activity into supernatants (3.5.U).
The inhibition of mitogenesis produced by asbestos supernatants was
dose related (3.5.5). The inhibitory effect of chrysotile supernatant
was an acute effect with macrophages obtained 280 days after chrysotile
injection showing no suppressor activity in their supernatants and indeed
with there being a significant stimulatory effect present; However,
280 day saline injected macrophages also showed a stimulatory effect
and so the former effect was age specific rather than asbestos specific
(3.5.6).
In order to test whether the suppressive agent was actively
secreted by asbestos activated macrophages or whether it was passively
released by dead or damaged macrophages, control macrophages were treated
with a lethal dose of chrysotile in vitro. The centrifuged supernatant
was then tested in a mitogenesis assay and found not to be inhibitory
to thymocyte mitogenesis (3-5.6) and so it could be assumed that the
suppressor factor(s) was a secretion from macrophages and not a cell
component released due to toxic effects on the macrophages. In an
attempt to characterise the suppressor factor(s) a sample of chrysotile
activated macrophage supernatant was halved and one half dialysed over¬
night before testing along with the undialysed aliquot in the thymocyte
mitogenesis assay. Dialysis was found to abolish suppression at 1 jig/ml
Con A and reduce suppression by more than half at 2 )ug/ml Con A (3.5.8).
This suggested that the major suppressive component was < 16,000 MW
but that there was also a minor, large, non-dialysable, suppressor
component.
Experiments on the effect of the asbestos macrophage supernatants on
tumour cells (3.3.2) and fibroblasts (3.5.9) showed that the supernatants
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were not inhibitory to these cells so confirming that the inhibitory
effect was lymphocyte specific. Further evidence in support of lympho¬
cyte specificity was demonstrated by the finding of significant suppressor
effects of the supernatant on mature T lymphocytes (nylon wool column
purified splenocytes ) (3.5.10). The suppressor factor was not detect¬
able in the serum of mice 3 days after asbestos injection (3.5.11) over
and above the suppressor activity which is expected in control serum
and which is well documented (Nelson 1976). It was possible that
asbestos exocytosed by asbestos activated macrophages during preparation
of the supernatant and too small to be spun out by centrifugation, could
be exerting a direct suppressive effect on the thymocyte mitogenesis
assayj the effects of asbestos on thymocyte mitogenesis were therefore
tested. While both crocidolite and chrysotile were inhibitory to back¬
ground proliferation neither was inhibitory to mitogenesis at 2 and U
pg/ml Con A (3.5.12). Chrysotile, however, was significantly stimulatory
to mitogenesis at 2 and h p-g/ml Con A. Thus asbestos in the asbestos
activated macrophage supernatants could not be responsible for the
suppression. The fact that chrysotile could cause stimulation of mito¬
genesis could have some significance in vivo and requires further study.
This part of the study has revealed that asbestos activated peri¬
toneal macrophages release a factor into the supernatant which is
inhibitory to lymphocyte mitogenesis. Such factors have been previously
reported to be released by peritoneal macrophages activated in vivo with
such diverse activating agents as peptone (Keller 1976), C. parvum
(Wing and Remington 1977), T. gondii infection (Wing and Remington 1980)
and LPS (Nelson 1976). In addition activated macrophages have been
shown to inhibit a number of proliferation independent lymphocyte functions
such as MIF release (Varesio and Holden 1980), MAF release (Varesio et al
1981) and cytotoxic T cell generation (Klimpel and Henney 1978)
suggesting that inhibition of mitogenesis is indicative of a more relevant
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and generalised suppression which may have relevance in vivo.
Unlike lymphocyte activating factor, the macrophage derived
suppressor factor(s) have not been well characterised. Nelson et al
(1976) reported that activated macrophages from endotoxin treated mice
produced a suppressor factor which was removed by dialysis and was
replaced by potentiation of mitogenesis. Essentially the same result
was found by Calderon and Unanue (1975) using supernatants from peptone
induced macrophages, who reported the suppressor factor to be <1U,000
MW (Calderon et al 197li). In the case of the asbestos macrophage
derived inhibitory activity, the active principle was largely dialysable
but removal of the inhibitory component did not reveal potentiating
activity.
The events which lead to an activated macrophage expressing either
inhibitory or potentiating activity to lymphocyte proliferation have
been the subject of discussion (Nelson 1976$ Nelson et al 1976) and it
is likely that since both enhancing and inhibitory factors may be present
in a supernatant then the sum of these two may determine the functional
activity of the supernatant. In addition, ratio of macrophages to
lymphocytes has been shown to be a major factor in co-culture experiments
(Wing and Remington 1977); the exact role of such a variable in the
case of supernatants is complex. Time in culture has been shown to
have a profound effect on the ability of activated macrophages to be
suppressive (Wing and Remington 1980) when during the first 2h hours of
culture inhibitory activity was manifest, while during subsequent culture
stimulating activity was present. The functional state and nature of
the target lymphocytes is also of obvious importance and Wadee and
Rabson (1981) have demonstrated that suppressor supernatants from
activated macrophages operate by switching on suppressor T cells in the
target population; obviously the origin of the lymphocyte population,
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with regard to the presence of such cells, is of central importance in
whether a suppressor supernatant can operate via this pathway.
A role for prostaglandin, albeit not fully understood, has been
suggested by Schechter et al (1980) and a prostaglandin producing
suppressor cell has been described (Goodwin et al 1977). In addition
Mullink and von Blumberg (1980) have shown that drugs which inhibit
prostaglandin biosynthesis are inhibitory to macrophage dependent
suppression of PHA lymphocyte mitogenesis. It seems likely that some
of the inhibitory effects of activated macrophages could therefore
be explained on the basis of prostaglandin release by these cells.
Furthermore some of the conflicting evidence of inhibition by activated
macrophages could be due to the reported effects of different tissue
culture buffers on prostaglandin release by macrophages (Brune 1980).
The reported ability of asbestos to activate peritoneal macrophages
to release prostaglandin (Humes et al 1977; Sirois et al 1980) makes
it possible that these ubiquitous agents could be involved in suppression
of lymphocyte mitogenesis by asbestos activated macrophages.
Suppression of cell mediated immunity has been frequently reported
in asbestotics (Kang et al 197U; Kagan et al 1977(a); Haslam et al 1978;
Wagner et al 1979; Gaumer et al 1981) and a macrophage derived factor
could have a role in these findings. In the present study no evidence
was found for excess inhibitory activity in the serum of 3 day asbestos
injected mice although Kagan et al (1977a) described an inhibitor of
PHA. mitogenesis in the serum of sane asbestotics.
U.6 The carcinogenic response of the CBA/Ca mouse peritoneal cavity
to asbestos injection
The experiments relating to development of ascites and production of
tumour cell lines from asbestos injected mice were outwith the mainstream
of the present study and so discussion of the experiments and results
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will be brief.
Classical, solid, multinodular mesotheliomas were never produced
by asbestos injection in the CBA/Ca mouse model in the present study
although such tumours have been produced in mice in previous studies
(Davis 197Ut>; Wirth 1975). Ascites did, however, develop and was
rapidly fatal; ascites bearing animals were therefore killed as soon
as abdominal distension was detected. The time taken to ascites
development was not obviously dependent on the asbestos type or dose, with
all ascites developing within U00-600 days after injection (3.8.2.1).
Transfer of ascites to normal syngeneic hosts did not reliably result
in tumour or ascites development (3.8.2.2) although solid tumours,
needle track tumours and ascites did develop occasionally. The ability
of these occasional ascites to grow as tumours was not obviously related
to the asbestos type which caused the original ascites (3.8.2.2).
When ascites was grown in culture to provide a permanent cell line,
13MC1, this was found to be tumourigenic with fibrosarcanatous morphology
in the subcutaneous site and to be mesothelioma-like with nodules and
ascites when injected intraperitoneally (3.8.2.1). In the peritoneal
cavity 13MC1 grew in a well defined manner with time to development of
ascites being inversely proportional to number of tumour cells inoculated
ip. Immunising with lethally irradiated 13MC1 cells provided resistance
to subsequent challenge with tumour cells demonstrating that the 13 MC1
Protein A binding assay revealed 13MC1 cells to be low or negative with
regard to expression of the surface marker designated plU and reported
to be a universal marker of malignancy (Bowen and Kulatilake 1979)
Mesothelioma cell lines have been previously derived from rat
asbestos induced tumours and grown in nude mice and in culture to study
their morphology (Gormley et al 198Cb). The characteristics of rat
cell line was immunogenic (3.2.2.3).
(3.2.2.3).
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asbestos induced mesotheliomas have also been studied by passage
through syngeneic rats and by growth in culture (Brown et al 1980).
These workers reported that neither groups immunised following surgical
excision of primary tumour nor by implantation of irradiated tumour
fragments, showed resistance to challenge with viable tumour cells.
Further evidence for lack of immunogenicity in mesotheliomas was
provided by Qnbleton et alfl976) who failed to detect lymphotoxicity to
allogeneic mesothelioma cells in the peripheral blood of mesothelioma
patients. Cole et al (1982) however, reported immune responses to rat
asbestos induced peritoneal mesotheliomas manifest as specific lympho-
toxicity in peripheral blood cells to allogeneic mesothelioma cells.
In the present study the asbestos induced mesothelioma-like cell line
13MC1 was immunogenic with 10^ immunising irradiated cells holding back
10^ challenging viable tumour cells.
Immunogenic tumour specific transplantation antigens have been
described as a major feature of chemically induced tumours (Baldwin
1976) and virally induced tumours (Moore 1978). The present study
therefore does not preclude either chemical-type carcinogenesis in
asbestos carcinogenesis, as suggested by Craighead and Mossman (1982),
or a viral aetiology, as suggested by Kanazawa et al (1979) for meso¬
thelioma. As a test of the possible ability of asbestos to cause
expression of tumour viruses, CCH^ tumour cells were incubated in the
presence of crocidolite then injected subcutaneouslyj a control group
were injected with the same number of tumour cells which had not been
incubated with crocidolite. Any effect of asbestos in causing increased
tumour virus expression would be expected to be evident as increased
growth of the tumour cells when injected subcutaneously but there was no
difference in rate of tumour growth between the crocidolite incubated and
control groups (3.3.5).
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It seems possible that the conflicting findings of immunogenicity
of mesotheliomas could be due to differences in site of origin of
mesothelioma since Brown et al (1980) used pleural derived experimental
mesotheliomas and found them non-immunogenic while both Cole et al
(1982) and the present study used peritoneal experimental mesotheliomas
and found evidence of immunogenicity. Provisional data on the presence
of the postulated canmon marker of malignancy, designated plii, in 13MC1
cells suggested, that it was present in lower quantities than in either
rat hepatomas or rat mesothelioma cell lines. The plli compbnent has
been suggested to be present in all tumour cells (Bramwell and Harris
1978; Bcwen and Kulatilake 1979) and low expression or absence frcm
13MC1 cells would be of great interest. However the data must be
regarded as provisional until more anti-plit. can be obtained and
cells.
U.7 Conclusion
U.7.1 Relevance of the present study to asbestos related disease
The present study was undertaken to investigate the effects of
asbestos on macrophages in vitro with special reference to the macro¬
phage membrane. If such a study is to be of any relevance the results
should shed some light on the possible events occurring when asbestos
exposure leads to disease in humans and so the mouse peritoneal macrophage
model must reasonably meet the following criteria:-
(i) the rodent is a valid model for extrapolation to humans;
(ii) the macrophage is a valid cell to study in relation to the aetiology
of asbestos related disease;
(iii) the peritoneal macrophage is a valid alternative to the alveolar
macrophage for such studies.
Condition (i) has been amply documented to be satisfied since
Protein A binding assay against 13MC1
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asbestos inhalation by rodents results in development of interstitial
fibrosis, lung carcinoma and mesothelioma (reviewed in 1.8). Condition
(ii) is satisfied in view of the importance of the macrophage in control
of fibroblast proliferation, immune response and tumour growth (reviewed
in 1.11). Condition (iii) does present particular difficulties
since it has been frequently shown that alveolar macrophages do behave
differently from peritoneal macrophages in important respects (reviewed
in 1.11.1.14.). Notwithstanding these differences, the demonstration in
'
the present and previous studies that both a carcinogenic and fibrogenic
response can be elicited in the peritoneal cavity with asbestos, suggests
that, in important respects, the peritoneal macrophage functions in ways
similar to the alveolar macrophage.
If the extrapolation is justified, therefore, the major findings
of the present study indicate that:-
In generalt-asbestos inhalation could result in macrophage activation
in the lung with all the corolleries for altered secretion and function
which activation carries with it for inflammation, fibroblast proliferation,
immunoregulation and tumour development (reviewed in Chapter 1).
In particular
(i) the asbestos activated macrophage may not inhibit or potentiate,
directly, the growth of tumour cells (but see ii);
(ii) the asbestos activated macrophage may release an immunosuppressive
factor (possibly prostaglandin E) causing local or generalised
immunosuppression; this macrophage derived factor could have a
role in the suppression of cell mediated immunity which has been
consistently documented in asbestosis (reviewed in 1.6.1); immuno¬
suppression could be a factor either directly or indirectly in
tumour development and immunoregulation of fibroblast proliferation.
(iii) the ability of asbestos activated macrophages to spontaneously
cap with Con A suggests that altered membrane function may have
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important consequences for other membrane related functions not
investigated here, e.g. antigen presentation; capping may also
be indicative of increased and 0^~ release (as discussed in
(U.2.2.1;) which could cause epithelial damage and prolong
inflammation.
ii.7.2 Suggestions for future research
During the preparation of the present study many suggestions for
further work have arisen with regard to the role of the macrophage in
asbestos related disease. Some general comments will therefore be made
with regard to potential future direction of research in this field.
1) Although a peritoneal macrophage model was used in the present
study alveolar macrophages must be viewed as the cells of choice to
study the effects of asbestos on macrophages; however peritoneal
macrophages are convenient alternatives and much valuable and relevant
information can be obtained through the intraperitoneal injection model.
Utilising this model,multiple injections could be used to more realistically
mimic the sequential exposure produced by daily inhalation and a number
of secondary variables could be introduced such as relevant activating
agents (e.g. bacteria known to infect the lung), surfactant,animal age etc.
Asbestos inhalation experiments should be carried out, although they are
much more expensive than intraperitoneal exposure, and various aspects
of structure and function iri the elicited macrophage population should be
studied.
2) The mechanism(s) whereby asbestos activates macrophages is of obvious
importance. Several pathways exist for activation including (i) auto-
stimulation through C3b, proteases etc; (ii) externally mediated, i.e.
through direct action of asbestos in activating complement by the
alternative pathway so generating C3b. This would be of particular
importance if clinical control of progressive disease was to be considered.
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3) While many aspects of macrophage secretion in relation to activation
are worthy of study it is relevant to pick out a few which are of
particular interest. Oxygen metabolites, and 0^", are released by
activated macrophages and these could have an important role in epi¬
thelial damage and persistence of inflammation. Secretion of
is also liable to the activation/triggering model whereby activated
macrophages release increased amounts of any secretion but treatment
with a triggering agent can increase this release many fold. The
questions which can be asked are:-
(i) can asbestos activated macrophages release increased
(ii) can they be triggered by conventional membrane perturbing agents
to increase release?
(iii) can asbestos act as a triggering agent to conventionally activated
macrophages?
The same questions can be posed for release of fibroblast stimulating
activity which is also liable to sequential triggering and has particular
relevance to asbestos fibrosis.
1;) The presence of neo-antigens in asbestos activated macrophages was
not elucidated in the present study although there was no evidence for an
obvious humoral immune response to these cells. In order to determine
whether the fibroblast proliferation so typical of asbestosis is due to
release of fibroblast stimulating factors from activated macrophages or
from antigen specific T cell proliferation in response to neo-antigens
on the former, or both, is a major target for study. It should be
possible to add membrane preparations or even separated membrane fractions
to lymphocytes from dusted animals and detect antigen specific T cell
proliferation; it would be relevant to try and detect fibroblast
stimulating activity in the supernatants. More indirectly, conventional
anti-sera and monoclonal antibodies could be raised to membrane preparations
from asbestos activated macrophages whose specificity and ability to
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block antigen specific T cell proliferation to asbestos related macro¬
phage neo-antigens could be demonstrated.
5) Although the results of this present study were essentially negative
with regard to effects of asbestos activated macrophages on tumour
growth this type of study could be extended. In particular the inter¬
action of such macrophages with more relevant tumour models, e.g.
carcinoma cell lines, mesothelioma cell lines. Again, as in all of
these studies, alveolar (or pleural) macrophage/tumour cell interaction
would be of particular relevance.
In view of some evidence suggesting that tumour promotion can inhibit
activation to the tumouricidal state it would be of particular interest
to ascertain whether asbestos activated macrophages can attain the
tumouricidal state on treatment with appropriate differentiation
signals, e.g. lymphokine, LPS.
6) With regard to direct effects of asbestos on membrane glycoproteins
the present study did not reveal convincing evidence that direct inter¬
actions between chrysotile asbestos and the macrophage Con A receptor
glycoprotein caused clustering of the latter. Ideally this effect would
be studied by freeze fracture which reveals the disposition of membrane
glycoproteins with high resolution and great clarity. Those experiments
carried out to try and assess whether fibre phagocytosis compromised
the normally well conserved topographic distribution of macrophage
membrane function were a failure. These postulated effects would be
better studied by measuring specific transport, e.g. adenisine or lysine
during and following phagocytosis of asbestos and a conventional
particulate.
7) Further work should be carried out to characterise the immuno¬
suppressive factor released by asbestos activated macrophages.
8) In addition to the foregoing it is necessary to examine the full
range of immune functions which macrophages perform with regard to
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their expression in asbestos activated macrophages, e.g. antigen
presentation, helper function in lymphocyte proliferation, quantitative
Fc and C3 receptor mediated immune phagocytosis.
These studies would help clarify the role of the asbestos activated
macrophage in asbestos related diseases.
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Summary
Macrophages activated in vivo with Corynebaclerium pnrvuni and asbestos showed an increased
sub-population of cells which capped spontaneously on incubation with fluoresceinated
Concanavalin A compared to saline-induced control macrophages. This capping was unaffected
by colchicine but was inhibited by cytochalasin 13. The spontaneous capping of activated
macrophages did not appear to be directly related to the total number of Concanavalin A receptors
as measured by sjX'cific ,2d-labe!lcd Concanavalin A binding to activated and control
macrophages. Capping also did not appear to be related to the position of Concanavalin A
receptors as judged by trypsin accessibility of bound 'N-labelled Concanavalin A.
Introduction
Macrophages occupy a centra! role in the inflammatory (Allison cl al., 1978) and
immune systems (see papers in Unanue & Rosenthal, 1980). The plasma membrane of
the macrophage is seen as the primary site of the sensory and effector roles of this cell
including endocytosis (Walters & Papadimitriou, 1978), macrophage-lymphocyle
interactions in antigen recognition (Rosenthal ct al., 1975; Lipscomb ct al., 1981),
handling of immune complexes via specific receptors for immunoglobulin and
complement (Mantovani, 1981) and functional responses to lymphocyte products via
specific lymphokine receptors (David ct al., 1980).
Macrophages can undergo profound changes in their metabolic, cy toe I remica I,
morphological and secretory status in response to a variety of agents (Ogmundsdotlir &
Weir, 1980) and, while there is some disagreement over terminology, these changes can
be collectively called activation (Colin, 1978; Morahan, 1980). Macrophage activation
results in changes in many surface properties such as ectoenzyme activity, pinocylosis
(Colin, 1978), Tc receptor activity (Rhodes, 1975) and surface morphology (Nabarra ct
al., 1978).
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Macrophages can specifically bind a number of lectins to their plasma membrane
including Concanavalin A (Qliv.er & Berlin, 1975), Ixilus Iclragonolobus lectin (I lomma ct
al., 1981), wheat germ agglutinin (Uadley ct 'al., 1977), phytohaemagglulinin and
pokeweed mitogen (Loor &: Roelants, 1974). Concanavalin A (Con A) specifically binds
to D-mannosy! and D-glucosyl residues at the cell surface and the macrophage Con A
receptor has been studied with regard to the effect of spreading and phagocytosis
(Lulton, 1973), ligand-induced capping (Williams ct al., 1979) and transmembrane
organization (Adachi ct al., 1980).
Intraperitoneal asbestos injection in mice induces an activated macrophage
population (Donaldson ct al., 1982) and activated macrophages may play a role in the
aetiology of asbestos-related disease (Miller, 1978); Con/ncbactcrium parvum-activated
macrophages are well known for their growth regulating effect on tumour cells (see
papers in James cl al., 1977).
In the present paper, we report on the mobility and number of Con A receptors on
macrophages activated in vivo with asbestos and C. parvum. These experiments form





Male CB.A/pmice 12-16 weeks old at the time of injection, were used throughout. Mice were
housed under conventional conditions and were killed by ether inhalation when required.
Macrophages
Control macrophages were obtained three days after intraperitoneal injection of 0.5 ml sterile
Dulbecco's phosphate-buffered saline 'A' (Dul A). Activated -macrophages were obtained five
days after the intraperitoneal injection of 0.2 ml (1.4 nig) of Con/ncbaclcrium parvum (C. paroum)
<heat killed; Wellcome) or three days after intraperitoneal injection of 2.5 mg chrysotilc asbestos
(UICC sample) in 0.5 ml sterile Dul A. In some experiments macrophages were obtained three
days after intraperitoneal injection of 1% latex spheres (Baclo latex 8.1 ^m diameter; Difco) in
Dul A or 10''" Proteose peptone (Difco) in Dul A.
Macrophage cultures were prepared by washing out the peritoneal cavity with 3x2 ml of
RPM1 1640 medium (Gilx:o) containing 10 U/ml heparin (Pularin). In 12:l-]abelled Con A binding
experiments, the proportion of adherent cells was ascertained and found to be 74.2% for saline,
49.3"" for chrysotile and 65.6% forC. parvum. Activated peritoneal exudate cells were adjusted to
yield the same concentration of adherent cells as saline peritoneal exudate cells - 4.5 x 10''/ml in
RPMI 1640 plus antibiotics and 10% foetal calf serum (Gibco). One hundred microlitres of exudate
cell suspension were pipetted onto washed 6 x 22 mm glass coverslips and incubated for 1 h at
37" C. These coverslips were then vigorously washed in phosphate-buffered saline (PBS) to
remove non-adherent cells; the resulting adherent cell cultures are referred to as macrophage
cultures.
Concaunvaliu A
Con A was obtained from Pharmacia (London), fluoresceinated Con A (FITC-Con A) from
Sigma (London), and Na125! from Amersham International (Amersham).
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riTC-Con A-induced Clipping
Two hundred microlitres of FITC-Con A (20 /< ('Viiil Dul A) were pipetted onlo macrophage
cultures which were then incubated for 20 in in at 37° C. Coverslip cultures were washed, fixed in
cthanol and mounted on slides in PBS-glycerol (1:1 v/v). Coverslips were examined in a
fluorescence microscope and the percentage of capped macrophages in 200 cells was assessed for
each coverslip.
In experiments on pharmacological modification of capping, colchicine (0.1 mM) and
cytochalasin 13 (0.1 mM) (Sigma, London) were prepared in PBS and 100 p\ of each drug added to
macrophage cultures; cultures were then incubated at 37° C for up to 1 h prior to treatment with
FITC-Con A at 37" C for 20 min. orml
The specificity of the ITTC-Con A binding was demonstrated by a reduction to 0barely
detectable fluorescence by pre-incubation either with 20/rg/ml unlabelled Con A or in the
presence of 50 mM methyl mannoside, the specific ligand for Con A.
1Klodination of Con A
Con A was iodinated by the chloramine T method ofHunter (1973) and passed down a Sephadex
G25 column to remove unbound 125I. In the pooled 125I-labelIed Con A-containing fractions eluted
from the G25 column, 90-95% of ,:5I counts were trichloracetic acid-precipitable and the specific
activity was, on average, 90/iCi/mgCon A.
Ubl-labclled Concanavalin A binding assay
One hundred microlitrcs of '"l-labelled Con A (200/rg/ml) were pipetted onto macrophage
coverslip cultures, or coverslip only controls for non-specific binding, and left for 15 min at room
temperature. Coverslips were then extensively washed in PBS and the coverslip associated counts
determined in a gamma counter. The average background counts due to non-specific binding to
coverslips ranged from 10-20% of the binding to macrophage coverslip cultures. A minimum of
eight replicate coverslip cultures was used for each condition.
The specificity of tlac ,2SI-labelled Con A binding to macrophages was demonstrated by a
reductionfof the)background binding in the presence of 50 mM methyl mannoside, the specific
ligand for Con A. Any confusing effects due to endocytic uptake of ,2SI-la belied Con A was ruled
out by demonstrating no effect on binding following pre-treatmcnt with the endocytosis
inhibitors iodoacclate (1 mM) and sodium azide (2 mM). /.
For phagocytosis experiments, 100/d 1% Latex spheres (Bacto latex 0.81 //m diameter; Difco)
were added to macrophage cultures. Cultures were then incubated for 1 h at 37' C followed by
vigorous and extensive washing to remove unphagocytoscd Latex before assaying for 12'I-Iabelled
Con A binding.
Trypsin accessibility of Con A binding sites
Following binding of '-^-labelled Con A, coverslips were placed in 0.1 mg/ml trypsin (Difco) in
I'BS and allowed to incubate for 15 min at room temperature. Coverslips were then agitated in the
trypsin solution and removed with forceps; trypsin-associated and coverslip-associated counts
were then determined. The trypsin-released counts were expressed as a percentage of the total
counts.
Statistics




Saline-induced control macrophages had a small population of cells which formed caps
spontaneously on incubation with FITC-Con A at 37° C (Table 1). BothC. parvum-and
asbestos-activated macrophages had populations of spontaneously capping
macrophages approximately eight limes greater than the saline controls (Table 1). Both
Latex- and Proteose peptone-induced macrophages had proportions of spontaneously
capping macrophages similar to the saline-induced macrophages (Table 1).
Time course of cnjiping
The time course of FITC-Con A-induccd capping was similar for both C. parvum- and
asbestos-activated macrophages (Fig. 1) reaching a plateau by 20 min and increasing
little thereafter.
Table 1. Proportion of macrophages from various sources capping on incubation with
FITC-Con A (20 //g/ml) at 37° C or room temperature (20° C). 200 cells counted.
Conditions of Mean % (±SO.)
FITC-Con A capped Number of
Macrophage source treatment macrophages experiments
3 day saline 20 min, 37° C 4.1 ± 2.3 8
3 day asbestos 20 min, 37° C 32.2± 4.2 5
5 day C. parvum 20 min, 37° C 32.4± 5.0 6
5 day C. parvum 20 min, room temp. COO+100 3
3 day Proteose peptone 20 min, 37° C 1.2 ± 1.1 2
3 day Latex 20 min, 37° C 3.2 ± 0.0 1
Fig. 1. Time course ofCon A-induccd capping in asbestos- and C. panmm-activated macrophages
and in saline control macrophages incubated with FITC-Con A (20/<g/ml) at 37° C.
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Pharmacological modification of capping
Colchicine and cytochalasin prc-trealment did not significantly affect the incidence of
capping in control macrophages. Colchicine prc-trenlment caused a slight insignificant
!/ increase in the proportion of rappingjoctivated macrophages whereas cytochalasin
pre-trcatment reduced capping of activated macrophages to control levels (Table 2).
Table 2. Effect of pre-treatment with the microtubule-disrupting drug colchicine,
and the microfilanient-disrupting drug cylochalnsin B, on FITC-Con A-induced
capping in control and activated macrophages. 200 cells counted.
Pre-treatmcnt
. Mean % (± SI).)
before FITC-Con A capped Number of
Macrophage source (20 min., 37° C) macrophages experiment?
3 day saline Saline ] h, 37° C 4.2 ± 1.6 3
0.1 mM colchicine
(1 h, 37" C). 5.6 — 4.8 4
0.1 mM cytochalasin
'B' (1 h, 37° C) 3.0 ± 5.2 4
3 day asbestos Saline 1 h, 37° C 32.7± 4.1 3
0.1 mM colchicine
(1 h, 37° C) • 39.5 ± 10.5 3
0.1 mM cytochalasin
'IV (1 h, 37° C) 6.0 i 2.9 3
jt.ie
sf, Fig. 2. (a) Three day asbestos-induced macrophages incubated with FITC-Con A (20/ig/ml) at
N 37° C for 1 h; capping cells arrowed, (b) Three day saline-induced macrophages treated as above;
no capping sub-population. Scale bar: 10 /on.
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Tabic 3. (a) Effect of Latex phagocytosis on ,J!Tlabolled •
Concanavalin A- binding; non-six-'cific binding to control - 33s<\ ± t,0o r
f~~ "x .. . ' ~ / CQsJni) P'"*vAi.'n A /Con AJlo equal numbers of control and activated
/macrophages; non-specific binding to control coverslips =
cm if ^/^ 10 957- 367 counts per
'ifid fvMA r>+
C J [1251] CountsIcoverstip
Macrophage source (mean ± S.D.)
(a) '
- / . U* *
Control macrophages 28 046± 3945 V vw$£ft X
Control macrophages after Latex) f \
phagocytosis 16 227 ±2515
(b)
Control macrophages 38 960 ±2616
3 day asbestos 36 361 ± 2084
5 dayC. patvum 52 207± 4855
"Control macrophages = 3 day saline induced.
Appearance of caps
The caps produced in activated macrophages following incubation with F!TC-Con A for
20 min at 37° C are shown in Fig. 2 along with saline-induced non-capping
macrophages for comparison. Some evidence for pinocytic uptake of FITC-Con A was
evident as pale speckled fluorescence, most noticeably in the activated populations.
j y - r
Binding of 127-labelled Con Aj.cffcct of phagocytosis J
Phagocytosis of Latex particles by control macrophages resulted in a significant (42.4%;
P < 0.001) reduction in "TTabelled Con A binding compared to appropriate controls
(Table 3).
Binding of "s/-labelled Con A to activated macrophages
,2SI-labelled Con A bound to asbestos-activated macrophages to the same extent as to i
control macrophages (Table 3); C. pannun-activated macrophages bound significantly
more ,25I-labclled Con A (27.2%; P < 0.001) than control macrophages. j
Table 4. Percentage of '^-labelled Con A bound to
control and activated macrophages released by
trypsin (0.1 mg/ml, 15 min, room temp.).
Mean % (±S.D.) In/psin-rcleased
Macrophage source counts
3 day saline 31.9 ± 2.9
3 day asbestos 33.2 ± 1.3
5 day C. parvum 30.7^.4Y^kc -
/\ o k«.n '
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Trypsin accessibility of u*l-lnbcllcd Con A binding sites
The proportion of ,:5I-lnbelIed Con A binding sites which were accessible to
trypsin ization was the same for control and both types of activated macrophage
(Table 4).
Discussion
Experiments to determine the proportion of macrophages which formed caps on
incubation with FITC-Con A revealed that both C. panntni- and asbestos-activated
macrophages had capping sub-populations of 32%. This figure contrasts with 4%
capping macrophages in the control, saline-induced macrophages. Since Latex-induced
macrophages had control levels of capping, ibis clear that phagocytosis alone is not
always a sufficient stimulus for inducing the capping sub-population. Since Proteose
peptone-induced macrophages also had low levels of spontaneously Con A capping
cells, not all macrophage-activating agents induce an increased capping sub-population.
Evidence that macrophage activation may play a role in Con A-induced capping exists j\/'
in previously published work. Thus Pick & Wilner (1979) found that resting peritoneal ^
macrophages had no capping cells while Williams ct al. (1979^using peritoneal
macrophages induced with sodium caseinate, a procedure likely to induce some
activation, found approximately 10% spontaneously capping macrophages. Similarly,
the finding of approximately 30% spontaneously Con A capping guinea-pig alveolar
macrophages is in keeping with the suggestion that resting alveolar macrophages, as
measured by several parameters, are in a consistently higher activalional state than
resting peritoneal macrophages (Hopper c/ al., 1979).
Pharmacological modification of capping showed that, in our hands, colchicine had
virtually no effect in promoting capping although previous studies have demonstrated
that with colchicine treatment the level of spontaneously induced Con A caps in
macrophages can be increased 2-30-fold (Williams ct al\, 1977, 1979; Pick & Wilner,
1979). It is clear, however, that in all these studies, the majority of macrophages were
not colchicine-sensitivc, being either spontaneously capping or non capping despite
colchicine treatment. In our assay system with CBA mouse peritoneal macrophages, the
mobility ofCon A receptors is clearly not inhibited by colchicine-sensitive microtubules.
The abolition of capping in activated macrophages following cytochalasin B
pre-treatmcnt confirms that microfilaments are necessary for Con A-induced capping in
peritoneal macrophages (Williams ct al., 1979) and spleen cells, presumed to be
lymphocytes (Dc Petris, 1974).
Nathan & Root (1977) have reported that macrophages activated by a range of agents
in vivo responded to Con A and other membrane perturbing agents by releasing
hydrogen peroxide the important endogenous macrophage microbicidal agent. Olive re/ ^ \
al. (1977), from their study, suggested that an increase in hydrogen peroxide content-in ^
polymorphonuclear cells al least, could have a direct role in tubulin oxidaliot^and ^ 0rYxf~
therefore inhibition of microtubule assembly, leading to an increase in capping. This
explanation of capping in activated macrophages, reflecting an increase in oxidative
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metabolism, is an attractive one despite our failure to find an obvious role for '
microtubules using colchicine and .the reported difference in the cytoskeletal
requirement for capping between macrophages and polymorphonuclear leucocytes
(Williamsr'f al., 1979).
In order to ascertain whether the increased ability of activated macrophages to cap ;
spontaneously on incubation with FITC-Con A was related to the total number of
Con A receptors on the surface of control and activated macrophages, the binding of
,2SI-labe!!ed Con A to such macrophage populations was compared. In initial
experiments, the finding of a significant reduction in 12l-labelled Con A binding
following Latex phagocytosis was in agreement with the original experiments of Lutton
(1973); this suggested that our assay system, which was based on Lutton's, was
comparable.
The total ,2sI-label!ed Con A binding to asbestos-activated macrophages was the same
as for control macrophages. Previous work concerning the effect of environmental
pollutants on lectin binding to alveolar macrophages has shown that ozone and nitrogen
dioxide do not cause an increase in the binding of ?H-labelled Con A to alveolar
macrophages compared to control macrophages (Goldstein ct al., 1977). Hadley et al.
(1977), however, found increased binding of the lectin wheatgerm agglutinin to
ozone-treated macrophages.
C. parvum-activated macrophages bound approximately 30% more U5I-labelled Con. A
than control and asbestos-activated macrophages. Since activation can occur via several
different pathways or combinations of pathways (Rabinowitz & Hamburg, 1980) and
since activation is not an al! or none process but is rather a sequential adoption of
properties obtained through differentiation signals, it is not surprising that there is
considerable variation in activational phenotypes (Cohn, 1978; Hopper ct al., 1979).
Due to the very different natures of asbestos andC. parvum, it is likely that they activate
macrophages via different pathways. Asbestos- and C. parvum-activated macrophages
possess different activational phenotypes, C. panmm macrophages being tumouricidal
while asbestos-activated macrophages are not (Donaldson ct al., 1982). The increased
binding of ,2fTIabeIled Con A to C. parvum-activated macrophages could, therefore,
reflect a functionally related difference in the membrane of the tumouricidally activated
macrophage. Increased binding could also be due to increased cell surface
polysaccharide as reported for macrophages involved in cell-mediated immunity
(Hammond & Dvorak, 1972).
The foregoing discussion, on the heterogeneity of expression of the activated
macrophage phenotype, emphasizes the danger of regarding the Con A capping
described above as a universal member of macrophage activation until it has been
shown to occur with a range of activating agents in vivo and in vitro.
While trypsin accessibility of Con A binding sites is reported to be altered between
fibroblasts and their transformed counterparts (Marques, 1978^1he change?)from the -V Or,\\tS
unactivated to the activated state in peritoneal macrophages did not result in a change in ,AiC' Cb"'j
the proportion of membrane-bound ,2sI-labelled Con A which was trypsin releasable.
x HISTOCHEMISTRY: ART No. S2.A o ?■
Con A cnpping in activated macrophages
Thus,'although the total number of Con A binding sites Was increased in the C.
patvum- induced macrophages compared to both saline- and asbestos-induced
macrophages, there was no difference in the trypsin accessibility of these additional
binding sites.
Conclusion
These experiments have demonstrated that interaction between the macrophage
membrane Con A receptor glycoprotein and the cytoskelelon is altered in a
sub-population comprising approximately one-third of activated macrophages, as
shown by the ability of this sub-population to cap spontaneously on incubation with
FITC-Con A. The capping was found to be niicrofilament-mediated. The ability to cap
'
in the activated macrophage sub-population did not appear to be due simply to an
alteration in the number of Con A receptor sites on activation, since two different
activating agents were used to induce capping but only one caused a significant increase
in Con A receptor sites. Trypsin treatment released similar amounts of bound Con A
from the surfaces of control and activated macrophages suggesting that, by the criterion 'J
of trypsin accessibility, the position of the Con A receptorpin the complex milieu of the ■ v m
macrophage surface,-^was the same in both control and activated macrophages. These \
results support previous findings that the macrophage Con A receptor glycoprotein is a
transmembrane molecule and can be linked to the cytoskeleton as shown by its ability to
cap under various conditions. We suggest that macrophage activation may fx? a factor in
the contradictory reports on the proportion of peritoneal macrophages which can cap
spontaneously with Con A treatment; differences in activation could also explain the
difference in spontaneous Con A capping reported between alveolar and peritoneal
macrophages. Such an alteration in membrane glycoprotein-cytoskelelal association
can be envisaged as a further manifestation of the well-documented membrane related
changes which accompany macrophage activation and could also reflect their increased
oxidative metabolism.
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The effect of single intraperitoneal injections of UICC crocidolite, U1CC chrysotile. and a
latex control particulate on the induced murine peritoneal macrophage population was mea¬
sured. Spreading. Fc receptor avidity, and phagocytosis were measured 3, 18, and 70 days
after injection. When activation of the induced macrophage populations was found at all
three times with asbestos, but not with latex, experiments were undertaken to determine
whether the asbestos-activated macrophages had attained the full tumoricidally activated
state. An in vitro assay measuring macrophage cytotoxicity to tumor cells revealed that the
tumoricidal potential of asbestos-activated macrophages was low at 3 and 5 days and negli¬
gible by 35 days after injection. An in vivo assay measuring the effect of asbestos on tumor
growth generally supported the contention that asbestos-activated macrophages were not
tumoricidal. although one dose of UICC chrysotile did produce a small, significant reduction
in grow th of a concomitant tumor. It was concluded that a single intraperitoneal asbestos
injection in mice induces activated macrophages which do not become fully tumoricidal.
INTRODUCTION
The pathology associated with asbestos exposure in man and animals is well
documented and includes lung fibrosis, mesothelioma, and carcinoma of the lung
</] (Harrington ct al., 1975; Becklake, 1976; Selikoff and Lee, 1978). Additionally,
disturbances of the immune system have been detected in asbestos workers
(Kagan el al.. 1977; Haslam ct al., 1978; Lange, 1980), although the place of these
disturbances in the etiology of asbestos-related disease is speculative.
The alveolar macrophage, due to its intimate interaction with foreign particu¬
lates during their clearance from the lung, has been intensively studied as to its
possible role in these diseases (Miller, 1978). The toxic effect of asbestos, partic¬
ularly chrysotile, on normal macrophages in culture has been compared to the
action of silica and a model of asbestos-induced lung fibrosis has been evolved
whereby macrophages, damaged and dying following asbestos phagocytosis, re¬
lease hydrolytic enzymes and cell contents leading to stimulation of fibrogenesis
(Allison, 1971). This model was subsequently modified when it was shown that
normal macrophages in culture could be stimulated by low levels of asbestos to
selectively release hydrolytic enzymes without cell death (Davies et al., 1974).
Evidence that this stimulatory, rather than toxic, effect of asbestos was operative
in vivo was obtained by Miller and Kagan (1976), who found activation of the
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using an in vivo diffusion chamber containg macrophages and chrysotile asbestos
at a dose found by Davies et al. (1974) to be stimulatory but not toxic, found
evidence that a diffusible fibrogenic factor was released from the asbestos-treated
macrophages.
Miller (1978) emphasized the likely importance of the secretory products of
asbestos-activated macrophages in chronic asbestos inflammation, while the mul¬
tiple roles of the macrophage in both humoral and cellular immunity (see reviews
in Nelson, 1976; and Unanue and Rosenthal, 1980) suggest that immunological
factors may also be important. The macrophage is also important in tumor devel¬
opment (see papers in James et al., 1977) and so the role of the asbestos-activated
macrophage in asbestos tumorigenesis requires investigation.
Although peritoneal macrophages differ in some properties from alveolar mac¬
rophages (Walker, 1976), they have been used as convenient alternatives in
studies of the pathogenesis of asbestos-induced fibrosis (Miller, 1978). Injection of
dust into the peritoneal cavity has also been used frequently as an alternative to
inhalation since fibrosis and mesothelioma can also be produced in the peritoneal
cavity using suitable dusts (Selikoff and Lee, 1978).
The experiments reported here were undertaken as part of a study into the
effects of asbestos on cell membranes. The effect of a single intraperitoneal injec¬
tion of asbestos on spreading activity, Fc receptor avidity, and phagocytic activity
was measured since these properties of the macrophage membrane are known to
I be altered on activation (Cohn, 1978; Rhodes, 1975). The asbestos-induced
peritoneal macrophages were found to be activated by the criteria of enhanced
spreading and Fc receptor avidity. In view of the suggestion (Cohn, 1978; Hibbs et
al., 1980) that activation is a sequential development of properties leading to the
fully microbicidal tumoricidal macrophage and since in the present study activa¬
tion was present as measured by the criteria of spreading and Fc receptor avidity,
the tumoricidal potential of the asbestos-activated macrophages was measured
using an in vitro assay. An in vivo assay measuring the effect of intraperitoneal
asbestos on the growth of a concomitant subcutaneous (s/c) tumor was also used.
General. Male CBA/Ca mice 10-14 weeks of age at the time of injection were
I used throughout. Groups of three mice were injected intraperitoneally with (a) 2.5
| mg of crocidolite asbestos (UICC sample) in 1 ml of Dulbecco A; (b) 2.5 mg of
chrysotile asbestos (UICC sample) in 1 ml of Dulbecco A; (c) 1 ml of 1% latex
| (Bacto-latex, 0.81-/am diam, Difco); and (d) 1 ml of Dulbecco A. Groups of
animals were killed 3, 18, and 70 days after treatment. Two separate experiments
were carried out and the results were pooled.
Preparation of peritoneal exudate macrophages. Mice were killed by ether
overdose at the selected time points and the peritoneal cavity was washed out with
6 ml of RPMI 16/40 medium containing 10 U/ml Heparin. The peritoneal exudate
cells (PEC), which were always >95% viable by trypan blue exclusion, were
washed and adjusted to 1 x lO'Vml in RPMI containing 10% fetal calf serum (FCS).
| One hundred microliters of this suspension were dropped onto 6 x 22-mm cov-
erslips which were incubated on racks for 1 hr at 37°C to allow for attachment of
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macrophages. Before they were used in any assay these coverslip cultures were
washed vigorously in a large volume of phosphate-buffered saline (PBS) to re¬
move nonadherent cells. Cultures for the spreading assay were stained immedi¬
ately after the 1-hr incubation and the other assays were carried out with 4 hr.
Spreading assay. After exactly 1 hr of incubation washed coverslip cultures
were placed in May Griinwald solution and a May Griinwald/Giemsa stain was
carried out. The number of spread macrophages in a total of 200 cells was ex¬
pressed as a percentage.
Fc receptor assay. Sheep red blood cells (SRBCs) (Oxoid) sensitized with a 1:10
or 1:1000 solution of anti-SRBC serum, or 1:10 normal rabbit serum, were pre¬
pared at 1% in RPMI. One hundred microliters of sensitized SRBCs were added to
coverslip cultures and left for 30 min at room temperature. Coverslips were
washed carefully and inverted on a drop of toluidine blue on a glass slide. More
than two red cells attached to a macrophage constituted a rosette and the number
of rosette-forming cells in 200 cells was expressed as a percentage. Nonspecific
rosettes demonstrated with normal rabbit serum-coated SRBC were present as a
background of 7.6 ± 2.2% (SD).
Phagocytosis assay'. One hundred microliters of 1% latex were added to cov¬
erslip cultures and incubated at 37°C for 1.5 hr. Coverslips were then vigorously
washed in PBS to remove free latex and the coverslip was inverted on a drop of
toluidine blue on a glass slide. The number of cells which had phagocytosed latex
in a total of 200 cells was expressed as a percentage.
In vitro assay ofmacrophage cytotoxicity to tumor cells. The method used was
essentially the radioactive release assay described by Mantovani et al. (1980) with
' the modification of Poste (1979), where the radioactivity associated with the target
cells at the end of the assay period was measured. Cultured CCH, fibrosarcoma
tabdied. target cells (James et al., 1979) were labtjled by culturing in RPMI with 10% FCS,
antibiotics, and 30 p.Ci [3H]thymidine. Cells maintained in this way had a specific
activity of 10.000—30,000 cpm/10'; cells and spontaneous loss of activity over the 2
days of the assay was around 10%/day. To obtain the macrophage effector cells,
PEC were collected 3, 5, and 35' after saline or asbestos injection and 10", 5 x 10\
10"', and 5 x 10' cells were seeded into triplicate wells of Falcon 24-well plates.
UbtW-'^Wells were washed after 1 hr to remove nonadherent cells. 10"' washed and labeled
target cells were then added to each well yielding ratios of initial PEC to target
- cells of 10:1, 5:1, 1:1, and 0.5:1. After 2 days of culture 0.2% ethylene diamine
rii2 tetrajicetic acid (EDTA) was added to detach the tumor cells and their removal
was further aided by pipetting. The EDTA-released tumor cells were harvested
onto glass fiber paper in a cell harvester (Skatron) and the amount of
[3H]thymidine associated with the tumor cells was assessed by scintillation
1 Previous data have revealed that induction of the tumoricidal response in macrophages following
j stimulation is an early and rapid eventJ7e-rg-Hexmanitnd SheltamrZfrrr-./: Cnnrer 42Htr4 f '=5TtriEdays-
iTorjfuC—/ia«.'u«i.4£oit<x-197.9>-and-4-days-for-stibcutaneoOT-glass-cove.rshp!j We therefore expected
, any tumoricidal macrophage induction by asbestos possibly by Day 3 and certainly by Day 5. Induc-
j tion of the tumoricidal state suddenly, a long time after initial stimulus, has no precedent known to us:
! choice of the 70-day time point instead of the 35-day one would therefore have provided no additional
information.
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counting. As a positive control 5-day Corynebacterium parvitm (1.4 mg heat
killed, Wellcome Laboratories)-induced macrophages were included in all ex¬
periments. Since asbestos was always injected in saline suspension and saline
alone was found to induce a small amount of tumor cell cytotoxic activity in the
peritoneal macrophage population,'specific toxicity to tumor cells was calculated




tumor cell bound counts following
culture with asbestos-induced macrophages
tumor cell bound counts following
culture with saline-induced macrophages
x 100
Three separate experiments were carried out for each time point.
| The effect of intraperitoneal asbestos injection on the growth of a concomitant
subcutaneous tumor. As an adjunct to them vitro assay of macrophage cytotoxic¬
ity to tumor cells an assay designed to detect any effects of asbestos on tumor
growth in vivo was utilized. Various amounts of asbestos, saline, or C. parvum
were injected intraperitoneal^ either 2 days prior to, or 3 days after, subcutane¬
ous inoculation with 10r' or 5 x 102 CCH, fibrosarcoma cells. Groups of ten mice
were used for each condition and tumor growth was measured as the mean of the
two major diameters of the tumor.
Analysis of results. Results were analyzed for significance using the t test.
RESULTS
The mean number of cells in the control peritoneal exudate was approximately 4
x 10': throughout and the latex-induced exudates never differed from this level
(Fig. 1). The asbestos-induced exudates, however, contained approximately five
times the control number of cells at Day 3, had fallen to control values at Day 18,
















Fig. I. Mean number of peritoneal exudate cells harvested from mice at various times after in¬
traperitoneal injection of 1 ml saline (control), 1 ml 19c latex. 1 ml/2.5 mg U1CC crocidolite or 1 ml/2.5
mg U1CC chrysotile. Bars denote ± one standard deviation.
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I tween 50 and 709? of the cells in all exudates were macrophages by adherence
difference; the remainder of the cells were polymorphs, which were increased at 3
days, and lymphocytes, with a few mast cells also present.
Both chrysotile and crocidolite injection resulted in the presence of activated
macrophage populations in the peritoneal cavity at all three time points as judged
by increased spreading (Fig. 2) and increased ability to form Fc rosettes with
lightly sensitized SRBCs (Fig. 3). Spreading activity of asbestos-induced mac¬
rophages was maximal at 3 days, declining thereafter, but at all three time points
the percentage spread was still significantly greater (P = < 0.02, see Fig.-2 for
details) than that of saline-induced macrophages. Fc receptor avidity of
asbestos-induced macrophages, demonstrated by increased ability to bind and
form rosettes with lightly (1:1000 dilution of anti-SRBC) sensitized SRBC, re¬
mained similar at all three time points, being significantly greater (P = < 0.05, see
Fig. 3 for details) than that of latex- or saline-induced macrophages. The latex-
induced macrophages were never different from the saline-induced macrophages
in any parameter except for the 3-day Fc receptor avidity which was significantly
greater (P = < 0.05). The mean proportion of macrophages able to phagocytose
latex was decreased on Day 3, but only significantly reduced (P = < 0.05) for
crocidolite (Fig. 4). At succeeding time points, however, all macrophage popula¬
tions had the same proportion, approximately 95%, of cells able to phagocytose
latex. At Day 3, and to a lesser extent at Day 18, phagocytosed asbestos fibers
were clearly visible inside crocidolite-induced macrophages and also inside
chrysotile-induced macrophages, although chrysotile is less easily seen by light
microscopy. The presence of such an ingested fiber load at Day 3 may have
rendered some macrophages refractory to further phagocytosis during the latex
phagocytosis assay.
The in vitro assay for macrophage cytotoxicity to tumor cells revealed that,
compared to the C. parvum-eUchcd positive control macrophages, asbestos was



















Fic.. 2. Mean percentage of macrophages spread after plating onto glass coverslips and incubating
for 1 hr at 37°C. Macrophages from PEC induced as in Fig. 1. Bars denote ± one standard deviation. At
all three time points there was a statistically significant increase in the spreading of crocidolite-'and
chrysotile-induced macrophages compared to saline-induced macrophages. Levels of significance:
3-day crocidolite and chrysotile. P = < 0.01: 18-day crocidolite and chrysotile, P = < 0.01: 70-day
crocidolite, P = < 0.002; 70-day chyrsotile, P = < 0.02.
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Mean percentage of macrophages forming Fc rosettes with SRBCs coated with l: 10 and
| LlOGldilutions of anti-SRBC serum. Macrophages from PEC induced as in Fig. I. Bars denote ± one
j standard deviation. At all three time points crocidolite- and chrysotile-induced macrophages had a
' statistically significant increase in the percentage able to form rosettes with lightly sensitized SRBC
compared to saline-induced macrophages. Levels of significance: 3-day crocidolite and chrysotile. P =
< 0.01; 18-day crocidolite, P = < 0.05; 18-day chrysotile, P = < 0.01; 70-day crocidolite and
chrysotile, P - < 0.02. At 3 days latex also produced a significant-increase (P = < 0.05) in this
parameter over saline-induced macrophages.
At 3 days, with chrysotile and crocidolite, macrophages had mean toxicities be¬
tween 10 and 15%, while 5-day chrysotile-induced macrophages had attained a
mean of 20% toxicity; 5-day crocidolite macrophages had only 5% mean toxicity.
By 35 days the two asbestos types had very low cytotoxicities to the target cells.
The highest toxicities obtained were always at the greatest effector: target ratio of
10:1. In this system 5-day C. purr/mi-induced macrophages produced a mean from
all experiments of 27.4% toxicity at 5:1 and 54.0% toxicity at 10:1.
The low level of tumor cell cytotoxic activity induced by intraperitoneal asbes¬
tos was reflected in the results of the in vivo assay measuring the effect of in¬
traperitoneal asbestos on the growth of a subcutaneous tumor (Table 1). Treat¬
ment with chrysotile 3 days after subcutaneous inoculation with 10" tumor cells
was the only regimen which produced small but significant reductions in tumor
size compared with saline-injected controls: this result was obtained in two sepa¬

















Fig. 4. Mean percentage of macrophages which had ingested latex particles following incubation for
1.5 hr in 1% latex. Macrophages from PEC induced as in Fig. 1. Bars denote ± one standard deviation.
At 3 days crocidolite-induced macrophages had a significantly smaller (P = < 0.05) population able to











Fig. 5. Mean percentage specific cytotoxicity to tumor cells of macrophages induced by in¬
traperitoneal injection of 2.5 mg UICC crocidolite. 2.5 mg UICC chrysotile. or 1.4 mg C. parvum. See
text for calculation of specific cytotoxicity. Bars denote ± one standard deviation.
intraperitoneally did not produce significant reductions in tumor size. The use of 5
mg crocidolite in the same regimen also failed toproduce significantly smaller
tumors. Decreasing the dose of inoculating tumor cells to 5 x 102 in the hope of
emphasizing the 5-mg chrysotile effect resulted in abolition of the effect. Treating
with 5 mg chrysotile 2 days before inoculation with 5 x 10: tumor cells, a regimen
which greatly increased the efficacy of C. parvum in reducing tumor growth
(Table 1), produced no significant reduction in tumor growth over that of saline-
injected controls.
DISCUSSION
This study has shown that a single intraperitoneal injection of both chrysotile
and crocidolite asbestos induces increased numbers of cells in the peritoneal
exudate at 3 and 70 days, while the number of cells at 18 days was close to that of
saline-injected controls. Latex injection never produced a cellular exudate greater
in magnitude than that produced by injection of saline. The biphasic variation in
numbers of peritoneal exudate cells with time following asbestos injection
suggests that the cytotactic stimulus for recruitment of cells into the peritoneal
cavity does not simply decay with time after the acute large-scale recruitment at
Day 3 but is renewed between Days 18 and 70.
The macrophages present in the asbestos-induced exudate were activated at all
three time points as measured by the criteria of increased Fc receptor avidity
(Rhodes, 1975) and increased macrophage spreading (Cohn, 1978). Increased
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TABLE 1
Effect of Various Doses of Intraperitoneal Asbestos, Given either before or after
10" or 5 x 102 Subcutaneously Administered CCH, Fibrosarcoma Cells,
on the Mean Diameter of the Tumor
Number of tumor
cells injected












10" 2.5 mg chrysotile + 3 16.8. ± 1.2 17.6 ± 1.2
10" 5 mg chrysotile + 3 13.8 ± 0.8 15.6 ± 1.2"
10" 20 mg chrysotile + 3 14.5 ± 3.4 15.6 ± 3.3
5 x 102 5 mg chrysotile + 3 12.3 ± 2.1 13.1 ± 2.9
5 x 102 5 mg chrysotile _2 13.2 ± 3.9 13.0 ± 3.8
10" 5 mg crocidolite + 3 12.3 ± 0.7 13.6 ± 2.0
10" 1.4 mg C. parvum + 3 10.1 ± 1.8 13.6 ± 2.0"
5 x 102 1.4 mg C. parvum _2 r-rn+100c4 13.0 ± 3.8"
° For mice injected with 10" CCH, cells the size given is for Day 17: for mice injected with 5 x
CCH, cells the size given is for Day 31.
" Significant difference P = <0.002.
c Significant difference P - <0.001.
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phagocytosis is also a marker of macrophage activation (Cohn, 1978), although
decreases in phagocytosis with activation have also been reported (David and
Remold, 1973). In the present study the 3-day crocidolite and chrysotile mac¬
rophage populations had a smaller percentage of macrophages which could
phagocytose latex than did the 3-day saline-induced macrophages: only crocido¬
lite macrophages, however, were significantly less. The 3-day saline-induced mac¬
rophages also had a mean phagocytic population which was smaller, but not
j significantly, than at subsequent time points. It must be emphasized that the assay
used here measured the proportion of cells able to phagocytose latex and not the
amount of latex phagocytosed by the total population. The macrophages induced
1 by intraperitoneal injection of latex only once differed significantly from control
values in any measurement, thus confirming that latex is not a macrophage-
activating agent (Schnyder and Baggiolini, 1978).
The in vitro assay for macrophage cytotoxicity to tumor cells revealed a low
level of tumor cell cytotoxicity in the 3- and 5-day asbestos macrophages and the
virtual absence of such activity by 35 days. This low level of tumoricidal activity
was present despite evidence of macrophage activation by spreading and Fc re¬
ceptor avidity, suggesting that, in the murine peritoneal model, asbestos induces
only partial activation in the major proportion of the activated population and that
only a small proportion have obtained the fully activated state.
The in vivo assay measuring the effect of intraperitoneal asbestos on tumor
growth produced conflicting, mostly negative, results. Chrysotile produced sig¬
nificant reductions in tumor size at 5 mg but not at 20 mg, while crocidolite at 5 mg
i did not produce significant reductions in tumor size. Adoption of a regimen which
profoundly increased the ability of C. parvum to produce reductions in tumor size
caused 5 mg chrysotile to lose its effect in reducing subcutaneous tumor growth.
ASBESTOS-INDUCED MACROPHAGES
These results are difficult to interpret, but one interpretation could be that the
mechanism whereby 5 mg chrysotile ip reduces tumor size is different from the
mechanism whereby C. parvum ip brings about the same effect.
A model of macrophage activation to the tumoricidai state has evolved, sug¬
gesting that there is a complex multistep pathway to the fully tumoricidai state
involving serial intermediate stages obtained by differentiation signals (Russell et
al., 197$: North, 1978; Cohn, 1978; Hibbs et al., 1980). Such studies have
suggested that macrophages activated to a nontumoricidal state by sterile inflam¬
matory irritants, BCG, or toxoplasma infection are in a condition where they can
be raised to the fully tumoricidai state by endotoxin treatment or, as is more likely
in vivo, by the lymphokine MAF (macrophage-activating factor) produced as a
result of a cell-mediated immune response (Russell et al., 197/; Hibbs et al.,
1980). A corollary of this model is that only newly recruited macrophages are
capable of being activated to the tumoricidai state and indeed Poste (1979) has
shown experimentally that only newly recruited inflammatory macrophages can
have their tumoricidai function induced, or natural tumoricidai function aug¬
mented, by lymphokine treatment.
The results of the present study could be interpreted, therefore, as evidence that
a single injection of asbestos provides the inflammatory stimulus, and a large
influx of newly recruited macrophages into the peritoneal cavity was certainly
observed at Day 3, but that levels of MAF were insufficient to induce the fully
activated tumoricidai state at any of the time points. In this respect it is of interest
that Miller et al. (1979) observed alveolar macrophage activation and manifesta¬
tions of cellular immunity in the lungs of rats inhaling asbestos, although they did
not measure lymphokine levels. It is possible, therefore, that the single injection,
peritoneal model used in the present study is an unsuitable one for studying
asbestos activation of macrophages due either to the use of the peritoneal site or to
the single dose compared to the multiple dosing produced by inhalation. If, how¬
ever, the model used here does result in a cellular immune response and MAF
generation then the asbestos-induced macrophages could be rather insensitive to
its effect in generating tumoricidally activated macrophages. Such a refractory
state, if it existed, could be a contributory factor in asbestos carcinogenesis.
The results presented here for the tumor cell cytotoxicity of asbestos-activated
macrophages are rather less than that for inflammatory macrophgaes generated
using glass, another insoluble irritant which is also carcinogenic (Bischoff and
Bryson, 1964). In this study Poste (1979) collected macrophages on subcutane-
ously implanted glass coverslips and demonstrated greater than 40% spontaneous
toxicity to tumor cells for a limited period between 4 and 7 days.
In the present study no attempt was made to measure la antigen expression in
the membrane of asbestos-elicited macrophages. Ia expression is an important
parameter in the antigen-presenting function of macrophages and it has been
shown to be inducible in peritoneal macrophages by ip injection of activating
agents (Beller and Unanue, 1981). Complete characterization of the asbestos-
activated macrophage and its role will require study of the kinetics of Ia expres¬
sion and the antigen-presenting ability of these macrophages.
The present study has shown that a single intraperitoneal injection of asbestos
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results in the induction of activated peritoneal macrophages in the short and long
term, but in neither case is the fully activated, tumoricidal state attained. These
results lend support to previous findings that asbestos can activate alveolar mac¬
rophages following inhalation (Miller and Kagan, 1976) and can activate peritoneal
macrophages in vitro as shown by increased release of lysosomal enzymes in the
absence of cell death (Davies et al., 1974). They also confirm the findings of
Hamilton (1980), who showed that intraperitoneal asbestos produced macrophage
activation as judged by increased plasminogen activator secretion.
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